Allowed Publications
Slot System
Featured Buckets
Featured Buckets Admin

Solitary Papule on the Nose

Article Type
Changed
Fri, 12/06/2019 - 09:55
Display Headline
Solitary Papule on the Nose

The Diagnosis: Sclerosing Perineurioma 

Sclerosing perineurioma, first described in 1997 by Fetsch and Miettinen,1 is a subtype of perineurioma with a strong predilection for the fingers and palms of young adults. Rare cases involving extra-acral sites including the forearm, elbow, axilla, back, neck, lower leg, thigh, knee, lips, nose, and mouth have been reported.2-4 Perineurioma is a relatively uncommon and benign peripheral nerve sheath tumor with exclusive perineurial differentiation.5 Perineurioma is divided into intraneural and extraneural types; the latter are further subclassified into soft tissue, sclerosing, reticular, and plexiform types. Other rare forms include the sclerosing, Pacinian corpuscle-like perineurioma, lipomatous perineurioma, perineurioma with xanthomatous areas, and perineurioma with granular cells.6,7  

Clinically, sclerosing perineurioma usually presents as a solitary lesion; however, rare cases of multiple lesions have been reported.8 Our patient presented with a solitary papule on the nose. Histopathologically, sclerosing perineurioma demonstrates slender spindle cells in a whorled growth pattern (onion skin) embedded in a hyalinized, lamellar, and dense collagenous stroma with intervening cleftlike spaces. Immunohistochemically, the spindle cells of our case stained positive for epithelial membrane antigen (quiz images). Other positive immunostains for perineurioma include claudin-1 and glucose transporter 1 (GLUT1). Perineurioma lacks expression of S-100 but can express CD34.2 As a benign tumor, the prognosis of sclerosing perineurioma is excellent. Complete local excision is considered curative.1  

Angiofibroma, also known as fibrous papule, is a common and benign lesion located primarily on or in close proximity to the nose.9 Angiofibromas can be associated with genodermatoses such as tuberous sclerosis, multiple endocrine neoplasia type 1, or Birt-Hogg-Dubé syndrome. When angiofibromas involve the penis, they are called pearly penile papules. Ungual angiofibroma, also known as Koenen tumor, occurs underneath the nail.10-12 Both facial angiofibromas (>3) and ungual angiofibromas (>2) are independent major criteria for tuberous sclerosis.13 Clinically, angiofibroma presents as a small, dome-shaped, pink papule arising on the lower portion of the nose or nearby area of the central face. Histopathologically, angiofibromas classically demonstrate increased dilated vessels and fibrosis in the dermis. Stellate, plump, spindle-shaped, and multinucleated cells can be seen in the collagenous stroma. The collagen fibers around hair follicles are arranged concentrically, resulting in an onion skin-like appearance. The epidermal rete ridges can be effaced (Figure 1). Increased numbers of single-unit melanocytes along the dermoepidermal junction can be seen in some cases. Immunohistochemically, a variable number of spindled and multinucleated cells in the dermis stain with factor XIIIa. There are at least 7 histologic variants of angiofibroma including hypercellular, pigmented, inflammatory, pleomorphic, clear cell, granular cell, and epithelioid.9,14 

Figure 1. Fibrous papule. Increased dilated vessels and fibrosis in the dermis with an onion skin–like appearance around hair follicles. Scattered stellate, spindled, and multinucleated cells can be seen (H&E, original magnification ×100).


Desmoplastic nevus (DN) is a benign melanocytic neoplasm characterized by predominantly spindle-shaped nevus cells embedded within a fibrotic stroma. Although it can resemble a Spitz nevus, it is recognized as a distinct entity.15-17 Clinically, DN presents as a small and flesh-colored, erythematous or slightly pigmented papule or nodule that usually occurs on the arms and legs of young adults. Histopathologically, DN demonstrates a dermal-based proliferation of spindled melanocytes embedded in a dense collagenous stroma with sparse or absent melanin deposition. The collagen bundles often show artifactual clefts and onion skin-like accentuation around vessels. Melanocytes may be epithelioid (Figure 2).16 Immunohistochemically, DN expresses melanocytic markers such as S-100, Melan-A, and human melanoma black 45, but epithelial membrane antigen is negative. Human melanoma black 45 demonstrates maturation with stronger staining in superficial portions of the lesion and diminution of staining with increasing dermal depth.18 Many other melanocytic tumors share histologic similarities to DN including blue nevus and desmoplastic melanoma.17,19,20  

Figure 2. Desmoplastic nevus. A proliferation of spindled and epithelioid melanocytes embedded in a dense collagenous stroma. Clefts within sclerotic collagen bundles can be seen (H&E, original magnification ×100).

Palisaded encapsulated neuroma, also referred to as solitary circumscribed neuroma, was first described by Reed et al21 in 1972. It is a benign and solitary, firm, dome-shaped, flesh-colored papule that occurs in middle-aged adults, predominately near mucocutaneous junctions of the face. Other locations include the oral mucosa, eyelid, nasal fossa, shoulder, arm, hand, foot, and glans penis.22,23 Histopathologically, palisaded encapsulated neuroma demonstrates a solitary, well-circumscribed, partially encapsulated, intradermal nodule composed of interweaving fascicles of spindle cells with prominent clefts (Figure 3). Rarely, palisaded encapsulated neuroma may have a plexiform or multinodular architecture.24 Immunohistochemically, tumor cells stain positively for S-100 protein, type IV collagen, and vimentin. The capsule, composed of perineural cells, stains positive for epithelial membrane antigen. A neurofilament stain will highlight axons within the tumor.24,25 Currently, palisaded encapsulated neuroma does not have a well-established link to known neurocutaneous or inherited syndromes. Excision is curative with a low risk of recurrence.26 

Figure 3. Palisaded encapsulated neuroma. A partially encapsulated nodule composed of interweaving fascicles of spindle cells with prominent clefts can be seen (H&E, original magnification ×100).

Sclerotic fibromas (SFs) were first reported by Weary et al27 as multiple tumors involving the tongues of patients with Cowden syndrome. Sporadic or solitary SFs of the skin in patients without Cowden syndrome have been reported, and both multiple and solitary SFs present with similar pathologic changes.28-30 Clinically, the solitary variant manifests as a well-demarcated, flesh-colored to erythematous, waxy papule or nodule with no site or sex predilection.30,31 Histologically, SF demonstrates a well-demarcated, nonencapsulated dermal nodule composed of hypocellular and sclerotic collagen bundles with scattered spindled cells and prominent clefts resembling Vincent van Gogh's Starry Night or plywood (Figure 4). Immunohistochemically, the spindled cells strongly express CD34. Factor XIIIa and markers of melanocytic, neural, and muscular differentiation are negative. When rendering a diagnosis in a patient with multiple SFs, a comment regarding the possibility of Cowden syndrome should be mentioned.32 

Figure 4. Sclerotic fibroma. Sclerotic collagen bundles with scattered spindled cells and clefts resembling Vincent van Gogh’s Starry Night (H&E, original magnification ×100).

References
  1. Fetsch JF, Miettinen M. Sclerosing perineurioma: a clinicopathologic study of 19 cases of a distinctive soft tissue lesion with a predilection for the fingers and palms of young adults. Am J Surg Pathol. 1997;21:1433-1442. 
  2. Fox MD, Gleason BC, Thomas AB, et al. Extra-acral cutaneous/soft tissue sclerosing perineurioma: an under-recognized entity in the differential of CD34-positive cutaneous neoplasms. J Cutan Pathol. 2010;37:1053-1056. 
  3. Erstine EM, Ko JS, Rubin BP, et al. Broadening the anatomic landscape of sclerosing perineurioma: a series of 5 cases in nonacral sites. Am J Dermatopathol. 2017;39:679-681. 
  4. Senghore N, Cunliffe D, Watt-Smith S, et al. Extraneural perineurioma of the face: an unusual cutaneous presentation of an uncommon tumour. Br J Oral Maxillofac Surg. 2001;39:315-319. 
  5. Lazarus SS, Trombetta LD. Ultrastructural identification of a benign perineurial cell tumor. Cancer. 1978;41:1823-1829. 
  6. Macarenco RS, Cury-Martins J. Extra-acral cutaneous sclerosing perineurioma with CD34 fingerprint pattern. J Cutan Pathol. 2017;44:388-392. 
  7. Santos-Briz A, Godoy E, Canueto J, et al. Cutaneous intraneural perineurioma: a case report. Am J Dermatopathol. 2013;35:E45-E48. 
  8. Rubin AI, Yassaee M, Johnson W, et al. Multiple cutaneous sclerosing perineuriomas: an extensive presentation with involvement of the bilateral upper extremities. J Cutan Pathol. 2009;36(suppl 1):60-65. 
  9. Damman J, Biswas A. Fibrous papule: a histopathologic review. Am J Dermatopathol. 2018;40:551-560. 
  10. Macri A, Tanner LS. Cutaneous angiofibroma. StatPearls. https://www.statpearls.com/kb/viewarticle/17566/. Updated January 24, 2019. Accessed October 21, 2019.  
  11. Darling TN, Skarulis MC, Steinberg SM, et al. Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1. Arch Dermatol. 1997;133:853-857. 
  12. Schaffer JV, Gohara MA, McNiff JM, et al. Multiple facial angiofibromas: a cutaneous manifestation of Birt-Hogg-Dube syndrome. J Am Acad Dermatol. 2005;53:S108-S111. 
  13. Northrup H, Krueger DA; International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol. 2013;49:243-254. 
  14. Bansal C, Stewart D, Li A, et al. Histologic variants of fibrous papule. J Cutan Pathol. 2005;32:424-428. 
  15. Harris GR, Shea CR, Horenstein MG, et al. Desmoplastic (sclerotic) nevus: an underrecognized entity that resembles dermatofibroma and desmoplastic melanoma. Am J Surg Pathol. 1999;23:786-794. 
  16. Ferrara G, Brasiello M, Annese P, et al. Desmoplastic nevus: clinicopathologic keynotes. Am J Dermatopathol. 2009;31:718-722. 
  17. Sherrill AM, Crespo G, Prakash AV, et al. Desmoplastic nevus: an entity distinct from Spitz nevus and blue nevus. Am J Dermatopathol. 2011;33:35-39. 
  18. Kucher C, Zhang PJ, Pasha T, et al. Expression of Melan-A and Ki-67 in desmoplastic melanoma and desmoplastic nevi. Am J Dermatopathol. 2004;26:452-457. 
  19. Sidiropoulos M, Sholl LM, Obregon R, et al. Desmoplastic nevus of chronically sun-damaged skin: an entity to be distinguished from desmoplastic melanoma. Am J Dermatopathol. 2014;36:629-634. 
  20. Kiuru M, Patel RM, Busam KJ. Desmoplastic melanocytic nevi with lymphocytic aggregates. J Cutan Pathol. 2012;39:940-944. 
  21. Reed RJ, Fine RM, Meltzer HD. Palisaded, encapsulated neuromas of the skin. Arch Dermatol. 1972;106:865-870. 
  22. Newman MD, Milgraum S. Palisaded encapsulated neuroma (PEN): an often misdiagnosed neural tumor. Dermatol Online J. 2008;14:12. 
  23. Beutler B, Cohen PR. Palisaded encapsulated neuroma of the trunk: a case report and review of palisaded encapsulated neuroma. Cureus. 2016;8:E726. 
  24. Jokinen CH, Ragsdale BD, Argenyi ZB. Expanding the clinicopathologic spectrum of palisaded encapsulated neuroma. J Cutan Pathol. 2010;37:43-48. 
  25. Argenyi ZB. Immunohistochemical characterization of palisaded, encapsulated neuroma. J Cutan Pathol. 1990;17:329-335. 
  26. Batra J, Ramesh V, Molpariya A, et al. Palisaded encapsulated neuroma: an unusual presentation. Indian Dermatol Online J. 2018;9:262-264. 
  27.  Weary PE, Gorlin RJ, Gentry WC Jr, et al. Multiple hamartoma syndrome (Cowden's disease). Arch Dermatol. 1972;106:682-690. 
  28. Mahmood MN, Salama ME, Chaffins M, et al. Solitary sclerotic fibroma of skin: a possible link with pleomorphic fibroma with immunophenotypic expression for O13 (CD99) and CD34. J Cutan Pathol. 2003;30:631-636. 
  29. Nakashima K, Yamada N, Adachi K, et al. Solitary sclerotic fibroma of the skin: morphological characterization of the 'plywood-like pattern'. J Cutan Pathol. 2008;35(suppl 1):74-79. 
  30. Rapini RP, Golitz LE. Sclerotic fibromas of the skin. J Am Acad Dermatol. 1989;20:266-271. 
  31. Abbas O, Ghosn S, Bahhady R, et al. Solitary sclerotic fibroma on the scalp of a young girl: reactive sclerosis pattern? J Dermatol. 2010;37:575-577. 
  32. Hanft VN, Shea CR, McNutt NS, et al. Expression of CD34 in sclerotic ("plywood") fibromas. Am J Dermatopathol. 2000;22:17-21.
Article PDF
Author and Disclosure Information

Dr. Wu is from the Department of Dermatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, China. Drs. Wu and Elston are from the Department of Dermatology and Dermatologic Surgery, and Dr. Skipper is from the Department of Pathology and Laboratory Medicine, all at the Medical University of South Carolina, Charleston.

The authors report no conflict of interest.

Correspondence: Dirk M. Elston, MD, Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, 135 Rutledge Ave, MSC 578, Charleston, SC 29425 (elstond@musc.edu).

Issue
Cutis - 104(5)
Publications
Topics
Page Number
268, 292-294
Sections
Author and Disclosure Information

Dr. Wu is from the Department of Dermatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, China. Drs. Wu and Elston are from the Department of Dermatology and Dermatologic Surgery, and Dr. Skipper is from the Department of Pathology and Laboratory Medicine, all at the Medical University of South Carolina, Charleston.

The authors report no conflict of interest.

Correspondence: Dirk M. Elston, MD, Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, 135 Rutledge Ave, MSC 578, Charleston, SC 29425 (elstond@musc.edu).

Author and Disclosure Information

Dr. Wu is from the Department of Dermatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, China. Drs. Wu and Elston are from the Department of Dermatology and Dermatologic Surgery, and Dr. Skipper is from the Department of Pathology and Laboratory Medicine, all at the Medical University of South Carolina, Charleston.

The authors report no conflict of interest.

Correspondence: Dirk M. Elston, MD, Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, 135 Rutledge Ave, MSC 578, Charleston, SC 29425 (elstond@musc.edu).

Article PDF
Article PDF
Related Articles

The Diagnosis: Sclerosing Perineurioma 

Sclerosing perineurioma, first described in 1997 by Fetsch and Miettinen,1 is a subtype of perineurioma with a strong predilection for the fingers and palms of young adults. Rare cases involving extra-acral sites including the forearm, elbow, axilla, back, neck, lower leg, thigh, knee, lips, nose, and mouth have been reported.2-4 Perineurioma is a relatively uncommon and benign peripheral nerve sheath tumor with exclusive perineurial differentiation.5 Perineurioma is divided into intraneural and extraneural types; the latter are further subclassified into soft tissue, sclerosing, reticular, and plexiform types. Other rare forms include the sclerosing, Pacinian corpuscle-like perineurioma, lipomatous perineurioma, perineurioma with xanthomatous areas, and perineurioma with granular cells.6,7  

Clinically, sclerosing perineurioma usually presents as a solitary lesion; however, rare cases of multiple lesions have been reported.8 Our patient presented with a solitary papule on the nose. Histopathologically, sclerosing perineurioma demonstrates slender spindle cells in a whorled growth pattern (onion skin) embedded in a hyalinized, lamellar, and dense collagenous stroma with intervening cleftlike spaces. Immunohistochemically, the spindle cells of our case stained positive for epithelial membrane antigen (quiz images). Other positive immunostains for perineurioma include claudin-1 and glucose transporter 1 (GLUT1). Perineurioma lacks expression of S-100 but can express CD34.2 As a benign tumor, the prognosis of sclerosing perineurioma is excellent. Complete local excision is considered curative.1  

Angiofibroma, also known as fibrous papule, is a common and benign lesion located primarily on or in close proximity to the nose.9 Angiofibromas can be associated with genodermatoses such as tuberous sclerosis, multiple endocrine neoplasia type 1, or Birt-Hogg-Dubé syndrome. When angiofibromas involve the penis, they are called pearly penile papules. Ungual angiofibroma, also known as Koenen tumor, occurs underneath the nail.10-12 Both facial angiofibromas (>3) and ungual angiofibromas (>2) are independent major criteria for tuberous sclerosis.13 Clinically, angiofibroma presents as a small, dome-shaped, pink papule arising on the lower portion of the nose or nearby area of the central face. Histopathologically, angiofibromas classically demonstrate increased dilated vessels and fibrosis in the dermis. Stellate, plump, spindle-shaped, and multinucleated cells can be seen in the collagenous stroma. The collagen fibers around hair follicles are arranged concentrically, resulting in an onion skin-like appearance. The epidermal rete ridges can be effaced (Figure 1). Increased numbers of single-unit melanocytes along the dermoepidermal junction can be seen in some cases. Immunohistochemically, a variable number of spindled and multinucleated cells in the dermis stain with factor XIIIa. There are at least 7 histologic variants of angiofibroma including hypercellular, pigmented, inflammatory, pleomorphic, clear cell, granular cell, and epithelioid.9,14 

Figure 1. Fibrous papule. Increased dilated vessels and fibrosis in the dermis with an onion skin–like appearance around hair follicles. Scattered stellate, spindled, and multinucleated cells can be seen (H&E, original magnification ×100).


Desmoplastic nevus (DN) is a benign melanocytic neoplasm characterized by predominantly spindle-shaped nevus cells embedded within a fibrotic stroma. Although it can resemble a Spitz nevus, it is recognized as a distinct entity.15-17 Clinically, DN presents as a small and flesh-colored, erythematous or slightly pigmented papule or nodule that usually occurs on the arms and legs of young adults. Histopathologically, DN demonstrates a dermal-based proliferation of spindled melanocytes embedded in a dense collagenous stroma with sparse or absent melanin deposition. The collagen bundles often show artifactual clefts and onion skin-like accentuation around vessels. Melanocytes may be epithelioid (Figure 2).16 Immunohistochemically, DN expresses melanocytic markers such as S-100, Melan-A, and human melanoma black 45, but epithelial membrane antigen is negative. Human melanoma black 45 demonstrates maturation with stronger staining in superficial portions of the lesion and diminution of staining with increasing dermal depth.18 Many other melanocytic tumors share histologic similarities to DN including blue nevus and desmoplastic melanoma.17,19,20  

Figure 2. Desmoplastic nevus. A proliferation of spindled and epithelioid melanocytes embedded in a dense collagenous stroma. Clefts within sclerotic collagen bundles can be seen (H&E, original magnification ×100).

Palisaded encapsulated neuroma, also referred to as solitary circumscribed neuroma, was first described by Reed et al21 in 1972. It is a benign and solitary, firm, dome-shaped, flesh-colored papule that occurs in middle-aged adults, predominately near mucocutaneous junctions of the face. Other locations include the oral mucosa, eyelid, nasal fossa, shoulder, arm, hand, foot, and glans penis.22,23 Histopathologically, palisaded encapsulated neuroma demonstrates a solitary, well-circumscribed, partially encapsulated, intradermal nodule composed of interweaving fascicles of spindle cells with prominent clefts (Figure 3). Rarely, palisaded encapsulated neuroma may have a plexiform or multinodular architecture.24 Immunohistochemically, tumor cells stain positively for S-100 protein, type IV collagen, and vimentin. The capsule, composed of perineural cells, stains positive for epithelial membrane antigen. A neurofilament stain will highlight axons within the tumor.24,25 Currently, palisaded encapsulated neuroma does not have a well-established link to known neurocutaneous or inherited syndromes. Excision is curative with a low risk of recurrence.26 

Figure 3. Palisaded encapsulated neuroma. A partially encapsulated nodule composed of interweaving fascicles of spindle cells with prominent clefts can be seen (H&E, original magnification ×100).

Sclerotic fibromas (SFs) were first reported by Weary et al27 as multiple tumors involving the tongues of patients with Cowden syndrome. Sporadic or solitary SFs of the skin in patients without Cowden syndrome have been reported, and both multiple and solitary SFs present with similar pathologic changes.28-30 Clinically, the solitary variant manifests as a well-demarcated, flesh-colored to erythematous, waxy papule or nodule with no site or sex predilection.30,31 Histologically, SF demonstrates a well-demarcated, nonencapsulated dermal nodule composed of hypocellular and sclerotic collagen bundles with scattered spindled cells and prominent clefts resembling Vincent van Gogh's Starry Night or plywood (Figure 4). Immunohistochemically, the spindled cells strongly express CD34. Factor XIIIa and markers of melanocytic, neural, and muscular differentiation are negative. When rendering a diagnosis in a patient with multiple SFs, a comment regarding the possibility of Cowden syndrome should be mentioned.32 

Figure 4. Sclerotic fibroma. Sclerotic collagen bundles with scattered spindled cells and clefts resembling Vincent van Gogh’s Starry Night (H&E, original magnification ×100).

The Diagnosis: Sclerosing Perineurioma 

Sclerosing perineurioma, first described in 1997 by Fetsch and Miettinen,1 is a subtype of perineurioma with a strong predilection for the fingers and palms of young adults. Rare cases involving extra-acral sites including the forearm, elbow, axilla, back, neck, lower leg, thigh, knee, lips, nose, and mouth have been reported.2-4 Perineurioma is a relatively uncommon and benign peripheral nerve sheath tumor with exclusive perineurial differentiation.5 Perineurioma is divided into intraneural and extraneural types; the latter are further subclassified into soft tissue, sclerosing, reticular, and plexiform types. Other rare forms include the sclerosing, Pacinian corpuscle-like perineurioma, lipomatous perineurioma, perineurioma with xanthomatous areas, and perineurioma with granular cells.6,7  

Clinically, sclerosing perineurioma usually presents as a solitary lesion; however, rare cases of multiple lesions have been reported.8 Our patient presented with a solitary papule on the nose. Histopathologically, sclerosing perineurioma demonstrates slender spindle cells in a whorled growth pattern (onion skin) embedded in a hyalinized, lamellar, and dense collagenous stroma with intervening cleftlike spaces. Immunohistochemically, the spindle cells of our case stained positive for epithelial membrane antigen (quiz images). Other positive immunostains for perineurioma include claudin-1 and glucose transporter 1 (GLUT1). Perineurioma lacks expression of S-100 but can express CD34.2 As a benign tumor, the prognosis of sclerosing perineurioma is excellent. Complete local excision is considered curative.1  

Angiofibroma, also known as fibrous papule, is a common and benign lesion located primarily on or in close proximity to the nose.9 Angiofibromas can be associated with genodermatoses such as tuberous sclerosis, multiple endocrine neoplasia type 1, or Birt-Hogg-Dubé syndrome. When angiofibromas involve the penis, they are called pearly penile papules. Ungual angiofibroma, also known as Koenen tumor, occurs underneath the nail.10-12 Both facial angiofibromas (>3) and ungual angiofibromas (>2) are independent major criteria for tuberous sclerosis.13 Clinically, angiofibroma presents as a small, dome-shaped, pink papule arising on the lower portion of the nose or nearby area of the central face. Histopathologically, angiofibromas classically demonstrate increased dilated vessels and fibrosis in the dermis. Stellate, plump, spindle-shaped, and multinucleated cells can be seen in the collagenous stroma. The collagen fibers around hair follicles are arranged concentrically, resulting in an onion skin-like appearance. The epidermal rete ridges can be effaced (Figure 1). Increased numbers of single-unit melanocytes along the dermoepidermal junction can be seen in some cases. Immunohistochemically, a variable number of spindled and multinucleated cells in the dermis stain with factor XIIIa. There are at least 7 histologic variants of angiofibroma including hypercellular, pigmented, inflammatory, pleomorphic, clear cell, granular cell, and epithelioid.9,14 

Figure 1. Fibrous papule. Increased dilated vessels and fibrosis in the dermis with an onion skin–like appearance around hair follicles. Scattered stellate, spindled, and multinucleated cells can be seen (H&E, original magnification ×100).


Desmoplastic nevus (DN) is a benign melanocytic neoplasm characterized by predominantly spindle-shaped nevus cells embedded within a fibrotic stroma. Although it can resemble a Spitz nevus, it is recognized as a distinct entity.15-17 Clinically, DN presents as a small and flesh-colored, erythematous or slightly pigmented papule or nodule that usually occurs on the arms and legs of young adults. Histopathologically, DN demonstrates a dermal-based proliferation of spindled melanocytes embedded in a dense collagenous stroma with sparse or absent melanin deposition. The collagen bundles often show artifactual clefts and onion skin-like accentuation around vessels. Melanocytes may be epithelioid (Figure 2).16 Immunohistochemically, DN expresses melanocytic markers such as S-100, Melan-A, and human melanoma black 45, but epithelial membrane antigen is negative. Human melanoma black 45 demonstrates maturation with stronger staining in superficial portions of the lesion and diminution of staining with increasing dermal depth.18 Many other melanocytic tumors share histologic similarities to DN including blue nevus and desmoplastic melanoma.17,19,20  

Figure 2. Desmoplastic nevus. A proliferation of spindled and epithelioid melanocytes embedded in a dense collagenous stroma. Clefts within sclerotic collagen bundles can be seen (H&E, original magnification ×100).

Palisaded encapsulated neuroma, also referred to as solitary circumscribed neuroma, was first described by Reed et al21 in 1972. It is a benign and solitary, firm, dome-shaped, flesh-colored papule that occurs in middle-aged adults, predominately near mucocutaneous junctions of the face. Other locations include the oral mucosa, eyelid, nasal fossa, shoulder, arm, hand, foot, and glans penis.22,23 Histopathologically, palisaded encapsulated neuroma demonstrates a solitary, well-circumscribed, partially encapsulated, intradermal nodule composed of interweaving fascicles of spindle cells with prominent clefts (Figure 3). Rarely, palisaded encapsulated neuroma may have a plexiform or multinodular architecture.24 Immunohistochemically, tumor cells stain positively for S-100 protein, type IV collagen, and vimentin. The capsule, composed of perineural cells, stains positive for epithelial membrane antigen. A neurofilament stain will highlight axons within the tumor.24,25 Currently, palisaded encapsulated neuroma does not have a well-established link to known neurocutaneous or inherited syndromes. Excision is curative with a low risk of recurrence.26 

Figure 3. Palisaded encapsulated neuroma. A partially encapsulated nodule composed of interweaving fascicles of spindle cells with prominent clefts can be seen (H&E, original magnification ×100).

Sclerotic fibromas (SFs) were first reported by Weary et al27 as multiple tumors involving the tongues of patients with Cowden syndrome. Sporadic or solitary SFs of the skin in patients without Cowden syndrome have been reported, and both multiple and solitary SFs present with similar pathologic changes.28-30 Clinically, the solitary variant manifests as a well-demarcated, flesh-colored to erythematous, waxy papule or nodule with no site or sex predilection.30,31 Histologically, SF demonstrates a well-demarcated, nonencapsulated dermal nodule composed of hypocellular and sclerotic collagen bundles with scattered spindled cells and prominent clefts resembling Vincent van Gogh's Starry Night or plywood (Figure 4). Immunohistochemically, the spindled cells strongly express CD34. Factor XIIIa and markers of melanocytic, neural, and muscular differentiation are negative. When rendering a diagnosis in a patient with multiple SFs, a comment regarding the possibility of Cowden syndrome should be mentioned.32 

Figure 4. Sclerotic fibroma. Sclerotic collagen bundles with scattered spindled cells and clefts resembling Vincent van Gogh’s Starry Night (H&E, original magnification ×100).

References
  1. Fetsch JF, Miettinen M. Sclerosing perineurioma: a clinicopathologic study of 19 cases of a distinctive soft tissue lesion with a predilection for the fingers and palms of young adults. Am J Surg Pathol. 1997;21:1433-1442. 
  2. Fox MD, Gleason BC, Thomas AB, et al. Extra-acral cutaneous/soft tissue sclerosing perineurioma: an under-recognized entity in the differential of CD34-positive cutaneous neoplasms. J Cutan Pathol. 2010;37:1053-1056. 
  3. Erstine EM, Ko JS, Rubin BP, et al. Broadening the anatomic landscape of sclerosing perineurioma: a series of 5 cases in nonacral sites. Am J Dermatopathol. 2017;39:679-681. 
  4. Senghore N, Cunliffe D, Watt-Smith S, et al. Extraneural perineurioma of the face: an unusual cutaneous presentation of an uncommon tumour. Br J Oral Maxillofac Surg. 2001;39:315-319. 
  5. Lazarus SS, Trombetta LD. Ultrastructural identification of a benign perineurial cell tumor. Cancer. 1978;41:1823-1829. 
  6. Macarenco RS, Cury-Martins J. Extra-acral cutaneous sclerosing perineurioma with CD34 fingerprint pattern. J Cutan Pathol. 2017;44:388-392. 
  7. Santos-Briz A, Godoy E, Canueto J, et al. Cutaneous intraneural perineurioma: a case report. Am J Dermatopathol. 2013;35:E45-E48. 
  8. Rubin AI, Yassaee M, Johnson W, et al. Multiple cutaneous sclerosing perineuriomas: an extensive presentation with involvement of the bilateral upper extremities. J Cutan Pathol. 2009;36(suppl 1):60-65. 
  9. Damman J, Biswas A. Fibrous papule: a histopathologic review. Am J Dermatopathol. 2018;40:551-560. 
  10. Macri A, Tanner LS. Cutaneous angiofibroma. StatPearls. https://www.statpearls.com/kb/viewarticle/17566/. Updated January 24, 2019. Accessed October 21, 2019.  
  11. Darling TN, Skarulis MC, Steinberg SM, et al. Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1. Arch Dermatol. 1997;133:853-857. 
  12. Schaffer JV, Gohara MA, McNiff JM, et al. Multiple facial angiofibromas: a cutaneous manifestation of Birt-Hogg-Dube syndrome. J Am Acad Dermatol. 2005;53:S108-S111. 
  13. Northrup H, Krueger DA; International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol. 2013;49:243-254. 
  14. Bansal C, Stewart D, Li A, et al. Histologic variants of fibrous papule. J Cutan Pathol. 2005;32:424-428. 
  15. Harris GR, Shea CR, Horenstein MG, et al. Desmoplastic (sclerotic) nevus: an underrecognized entity that resembles dermatofibroma and desmoplastic melanoma. Am J Surg Pathol. 1999;23:786-794. 
  16. Ferrara G, Brasiello M, Annese P, et al. Desmoplastic nevus: clinicopathologic keynotes. Am J Dermatopathol. 2009;31:718-722. 
  17. Sherrill AM, Crespo G, Prakash AV, et al. Desmoplastic nevus: an entity distinct from Spitz nevus and blue nevus. Am J Dermatopathol. 2011;33:35-39. 
  18. Kucher C, Zhang PJ, Pasha T, et al. Expression of Melan-A and Ki-67 in desmoplastic melanoma and desmoplastic nevi. Am J Dermatopathol. 2004;26:452-457. 
  19. Sidiropoulos M, Sholl LM, Obregon R, et al. Desmoplastic nevus of chronically sun-damaged skin: an entity to be distinguished from desmoplastic melanoma. Am J Dermatopathol. 2014;36:629-634. 
  20. Kiuru M, Patel RM, Busam KJ. Desmoplastic melanocytic nevi with lymphocytic aggregates. J Cutan Pathol. 2012;39:940-944. 
  21. Reed RJ, Fine RM, Meltzer HD. Palisaded, encapsulated neuromas of the skin. Arch Dermatol. 1972;106:865-870. 
  22. Newman MD, Milgraum S. Palisaded encapsulated neuroma (PEN): an often misdiagnosed neural tumor. Dermatol Online J. 2008;14:12. 
  23. Beutler B, Cohen PR. Palisaded encapsulated neuroma of the trunk: a case report and review of palisaded encapsulated neuroma. Cureus. 2016;8:E726. 
  24. Jokinen CH, Ragsdale BD, Argenyi ZB. Expanding the clinicopathologic spectrum of palisaded encapsulated neuroma. J Cutan Pathol. 2010;37:43-48. 
  25. Argenyi ZB. Immunohistochemical characterization of palisaded, encapsulated neuroma. J Cutan Pathol. 1990;17:329-335. 
  26. Batra J, Ramesh V, Molpariya A, et al. Palisaded encapsulated neuroma: an unusual presentation. Indian Dermatol Online J. 2018;9:262-264. 
  27.  Weary PE, Gorlin RJ, Gentry WC Jr, et al. Multiple hamartoma syndrome (Cowden's disease). Arch Dermatol. 1972;106:682-690. 
  28. Mahmood MN, Salama ME, Chaffins M, et al. Solitary sclerotic fibroma of skin: a possible link with pleomorphic fibroma with immunophenotypic expression for O13 (CD99) and CD34. J Cutan Pathol. 2003;30:631-636. 
  29. Nakashima K, Yamada N, Adachi K, et al. Solitary sclerotic fibroma of the skin: morphological characterization of the 'plywood-like pattern'. J Cutan Pathol. 2008;35(suppl 1):74-79. 
  30. Rapini RP, Golitz LE. Sclerotic fibromas of the skin. J Am Acad Dermatol. 1989;20:266-271. 
  31. Abbas O, Ghosn S, Bahhady R, et al. Solitary sclerotic fibroma on the scalp of a young girl: reactive sclerosis pattern? J Dermatol. 2010;37:575-577. 
  32. Hanft VN, Shea CR, McNutt NS, et al. Expression of CD34 in sclerotic ("plywood") fibromas. Am J Dermatopathol. 2000;22:17-21.
References
  1. Fetsch JF, Miettinen M. Sclerosing perineurioma: a clinicopathologic study of 19 cases of a distinctive soft tissue lesion with a predilection for the fingers and palms of young adults. Am J Surg Pathol. 1997;21:1433-1442. 
  2. Fox MD, Gleason BC, Thomas AB, et al. Extra-acral cutaneous/soft tissue sclerosing perineurioma: an under-recognized entity in the differential of CD34-positive cutaneous neoplasms. J Cutan Pathol. 2010;37:1053-1056. 
  3. Erstine EM, Ko JS, Rubin BP, et al. Broadening the anatomic landscape of sclerosing perineurioma: a series of 5 cases in nonacral sites. Am J Dermatopathol. 2017;39:679-681. 
  4. Senghore N, Cunliffe D, Watt-Smith S, et al. Extraneural perineurioma of the face: an unusual cutaneous presentation of an uncommon tumour. Br J Oral Maxillofac Surg. 2001;39:315-319. 
  5. Lazarus SS, Trombetta LD. Ultrastructural identification of a benign perineurial cell tumor. Cancer. 1978;41:1823-1829. 
  6. Macarenco RS, Cury-Martins J. Extra-acral cutaneous sclerosing perineurioma with CD34 fingerprint pattern. J Cutan Pathol. 2017;44:388-392. 
  7. Santos-Briz A, Godoy E, Canueto J, et al. Cutaneous intraneural perineurioma: a case report. Am J Dermatopathol. 2013;35:E45-E48. 
  8. Rubin AI, Yassaee M, Johnson W, et al. Multiple cutaneous sclerosing perineuriomas: an extensive presentation with involvement of the bilateral upper extremities. J Cutan Pathol. 2009;36(suppl 1):60-65. 
  9. Damman J, Biswas A. Fibrous papule: a histopathologic review. Am J Dermatopathol. 2018;40:551-560. 
  10. Macri A, Tanner LS. Cutaneous angiofibroma. StatPearls. https://www.statpearls.com/kb/viewarticle/17566/. Updated January 24, 2019. Accessed October 21, 2019.  
  11. Darling TN, Skarulis MC, Steinberg SM, et al. Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1. Arch Dermatol. 1997;133:853-857. 
  12. Schaffer JV, Gohara MA, McNiff JM, et al. Multiple facial angiofibromas: a cutaneous manifestation of Birt-Hogg-Dube syndrome. J Am Acad Dermatol. 2005;53:S108-S111. 
  13. Northrup H, Krueger DA; International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol. 2013;49:243-254. 
  14. Bansal C, Stewart D, Li A, et al. Histologic variants of fibrous papule. J Cutan Pathol. 2005;32:424-428. 
  15. Harris GR, Shea CR, Horenstein MG, et al. Desmoplastic (sclerotic) nevus: an underrecognized entity that resembles dermatofibroma and desmoplastic melanoma. Am J Surg Pathol. 1999;23:786-794. 
  16. Ferrara G, Brasiello M, Annese P, et al. Desmoplastic nevus: clinicopathologic keynotes. Am J Dermatopathol. 2009;31:718-722. 
  17. Sherrill AM, Crespo G, Prakash AV, et al. Desmoplastic nevus: an entity distinct from Spitz nevus and blue nevus. Am J Dermatopathol. 2011;33:35-39. 
  18. Kucher C, Zhang PJ, Pasha T, et al. Expression of Melan-A and Ki-67 in desmoplastic melanoma and desmoplastic nevi. Am J Dermatopathol. 2004;26:452-457. 
  19. Sidiropoulos M, Sholl LM, Obregon R, et al. Desmoplastic nevus of chronically sun-damaged skin: an entity to be distinguished from desmoplastic melanoma. Am J Dermatopathol. 2014;36:629-634. 
  20. Kiuru M, Patel RM, Busam KJ. Desmoplastic melanocytic nevi with lymphocytic aggregates. J Cutan Pathol. 2012;39:940-944. 
  21. Reed RJ, Fine RM, Meltzer HD. Palisaded, encapsulated neuromas of the skin. Arch Dermatol. 1972;106:865-870. 
  22. Newman MD, Milgraum S. Palisaded encapsulated neuroma (PEN): an often misdiagnosed neural tumor. Dermatol Online J. 2008;14:12. 
  23. Beutler B, Cohen PR. Palisaded encapsulated neuroma of the trunk: a case report and review of palisaded encapsulated neuroma. Cureus. 2016;8:E726. 
  24. Jokinen CH, Ragsdale BD, Argenyi ZB. Expanding the clinicopathologic spectrum of palisaded encapsulated neuroma. J Cutan Pathol. 2010;37:43-48. 
  25. Argenyi ZB. Immunohistochemical characterization of palisaded, encapsulated neuroma. J Cutan Pathol. 1990;17:329-335. 
  26. Batra J, Ramesh V, Molpariya A, et al. Palisaded encapsulated neuroma: an unusual presentation. Indian Dermatol Online J. 2018;9:262-264. 
  27.  Weary PE, Gorlin RJ, Gentry WC Jr, et al. Multiple hamartoma syndrome (Cowden's disease). Arch Dermatol. 1972;106:682-690. 
  28. Mahmood MN, Salama ME, Chaffins M, et al. Solitary sclerotic fibroma of skin: a possible link with pleomorphic fibroma with immunophenotypic expression for O13 (CD99) and CD34. J Cutan Pathol. 2003;30:631-636. 
  29. Nakashima K, Yamada N, Adachi K, et al. Solitary sclerotic fibroma of the skin: morphological characterization of the 'plywood-like pattern'. J Cutan Pathol. 2008;35(suppl 1):74-79. 
  30. Rapini RP, Golitz LE. Sclerotic fibromas of the skin. J Am Acad Dermatol. 1989;20:266-271. 
  31. Abbas O, Ghosn S, Bahhady R, et al. Solitary sclerotic fibroma on the scalp of a young girl: reactive sclerosis pattern? J Dermatol. 2010;37:575-577. 
  32. Hanft VN, Shea CR, McNutt NS, et al. Expression of CD34 in sclerotic ("plywood") fibromas. Am J Dermatopathol. 2000;22:17-21.
Issue
Cutis - 104(5)
Issue
Cutis - 104(5)
Page Number
268, 292-294
Page Number
268, 292-294
Publications
Publications
Topics
Article Type
Display Headline
Solitary Papule on the Nose
Display Headline
Solitary Papule on the Nose
Sections
Questionnaire Body

H&E, original magnification ×20.

H&E, original magnification ×100 (epithelial membrane antigen, original magnification ×200 [inset]).

A 25-year-old man presented with a flesh-colored papule on the left side of the nose of 2 years' duration. 

Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Fri, 11/08/2019 - 15:30
Un-Gate On Date
Fri, 11/08/2019 - 15:30
Use ProPublica
CFC Schedule Remove Status
Fri, 11/08/2019 - 15:30
Hide sidebar & use full width
render the right sidebar.
Article PDF Media

Erythematous Papules on the Scrotum, Trunk, and Extremities

Article Type
Changed
Thu, 10/17/2019 - 14:25
Display Headline
Erythematous Papules on the Scrotum, Trunk, and Extremities

The Diagnosis: Lichenoid and Granulomatous Dermatitis in the Setting of Secondary Syphilis  

Syphilis, an infectious disease that has risen in incidence and is most commonly reported in men who have sex with men, involves a vast array of clinical and histologic presentations.1 Clinically, secondary syphilis involves an erythematous maculopapular eruption on the face, trunk, palms, soles, or genital area.2 The characteristic histologic features for secondary syphilis include endothelial swelling, interstitial inflammatory array, irregular acanthosis, elongated rete ridges, and vacuolar interface dermatitis with lymphocytes and plasma cells.1 Syphilitic infection has been associated with lichenoid and granulomatous dermatitis, which is an inflammatory skin disease described by Magro and Crowson.3 Lichenoid and granulomatous dermatitis has been linked to various systemic disorders, including chronic hepatitis C, Crohn disease, rheumatoid arthritis, endocrinopathy, subacute cutaneous lupus erythematosus, secondary syphilis, prior herpes infection, tuberculoid leprosy, mycobacterial infection, and human immunodeficiency virus infection.3-7 For this patient, given histopathology findings, clinical presentation, and positive rapid plasma reagin serologies, a diagnosis of lichenoid and granulomatous dermatitis in the setting of a secondary syphilis infection was established. A comprehensive investigation should be conducted to consider secondary syphilis or other systemic diseases in patients with a histologic finding of lichenoid and granulomatous dermatitis. 

Histologically, lichenoid and granulomatous dermatitis cases show a bandlike infiltrate of lymphocytes with neighboring histiocytes along the dermoepidermal junction, accompanied by epithelial changes of dyskeratosis, vasculopathy, and colloid body formation, in addition to a dermal histiocytic component.3 Our patient's biopsy showed a lichenoid reaction pattern with vacuolar interface changes, dyskeratosis, plump endothelial cells, and small collections of plasma cells. Additionally, there was a granulomatous component in the dermis with histiocytes admixed with lymphocytes and plasma cells. The presence of spirochetes was confirmed with antitreponemal immunohistochemical stain (Figure 1). Quantitative rapid plasma reagin was 1:64 (reference range, <1:1) and Treponema pallidum antibody was reactive. 

Figure 1. Secondary syphilis. Treponema pallidum immunohistochemistry showed scattered spirochetes (original magnification ×600).

Interstitial granulomatous dermatitis has a variable clinical presentation, often with red-purple annular plaques, hyperpigmented papules, and nodules frequently in a linear arrangement and predominantly on the trunk, thighs, groin, or buttocks.8,9 On histopathology, there are histiocytes in the reticular dermis and/or a macrophage infiltrate in the mid to deep dermis with collections of degenerated collagen (Figure 2).8,10 An interstitial infiltrate of eosinophils and neutrophils also may be appreciated, but mucin generally is absent.8,11 This condition often coexists with rheumatic and systemic autoimmune diseases.8-10  

Figure 2. Interstitial granulomatous dermatitis. Thickened collagen bundles interlaced with histiocytes and lymphocytes. Little to no mucin is appreciated (H&E, original magnification ×200).

Interstitial granuloma annulare is a noninfectious granulomatous skin condition that often presents clinically as asymptomatic annular red-brown patches, usually on the extremities.11-13 On histopathology, an interstitial or palisaded inflammatory infiltrate with histiocytes and multinucleated giant cells may be seen along with collagen degeneration or collagen bundles without necrosis (Figure 3).9 Mucin often is associated with the histiocytes.11 Of note, our patient's skin biopsy shows interface dermatitis, differentiating it from both interstitial granuloma annulare and interstitial granulomatous dermatitis. 

Figure 3. Interstitial granuloma annulare. A busy dermis with increased histiocytes and lymphocytes arranged about vessels and between collagen bundles that are separated by increased mucin (H&E, original magnification ×200).

Postviral granulomatous reactions are the most frequently reported types of reactions to occur at the location of herpes zoster infection up to years after the initial disease. Wolf isotopic reaction encompasses skin reactions in the body region of formerly resolved skin disease, commonly herpesvirus infection.14,15 This manifestation may occur due to a hypersensitivity reaction from enduring viral proteins, resident memory T cells, or local neuroimmune imbalance from herpesvirus-induced injury to dermal sensory nerve fibers.14-17 Clinically, patients present with red-purple pruritic papules and plaques in a bandlike unilateral pattern, usually in the same region as the prior herpes infection and often accompanied by postherpetic neuralgia.16-19 Of note, our patient's clinical findings were more diffuse than the frequently localized and often linear distribution seen in postherpetic granulomatous reaction. On histopathology, granulomatous or lichenoid tissue reaction most commonly is appreciated.15 Specifically, interstitial granulomatous dermatitis with histiocytes, lymphocytes, and multinucleated giant cells showing elastophagocytosis and an inflammatory infiltrate with lymphocytes and plasma cells around vasculature, eccrine glands, and nerves can be noted (Figure 4).19  

Figure 4. Postviral granulomatous reaction. Histiocytes, lymphocytes, and multinucleated giant cells with thickened collagen bundles (H&E, original magnification ×200).

Lupus erythematosus is an autoimmune condition with a wide array of clinical features, including skin manifestations and systemic symptoms. Specifically, discoid lupus erythematosus presents with clearly outlined, red-pink macules or papules with scaling. Histologic features include keratotic follicular plugging, acanthosis, dermal mucin, thickening of the basement membrane zone, and dense lymphocytic infiltrate (Figure 5).20  

Figure 5. Discoid lupus erythematosus. Perifollicular and perivascular inflammatory infiltrate with vacuolization along the dermoepidermal junction and scattered dyskeratotic keratinocytes along the basal layer of the epidermis. There is focal follicular plugging and the basement membrane zone appears thickened (H&E, original magnification ×200).

References
  1. Flamm A, Parikh K, Xie Q, et al. Histologic features of secondary syphilis: a multicenter retrospective review. J Am Acad Dermatol. 2015;73:325-330. 
  2. Zeltser R, Kurban AK. Syphilis. Clin Dermatol. 2004;22:461-468. 
  3. Magro CM, Crowson AN. Lichenoid and granulomatous dermatitis. Int J Dermatol. 2000;39:12-33.  
  4. S Breza T Jr, Magro CM. Lichenoid and granulomatous dermatitis associated with atypical mycobacterium infections. J Cutan Pathol. 2006;33:512-515.  
  5. Granel B, Serratrice J, Rey J, et al. Chronic hepatitis C virus infection associated with a generalized granuloma annulare. J Am Acad Dermatol. 2000;43(5, pt 2):918-919.  
  6. Jorizzo JL, Gonzalez EB, Apisarnthanarax P, et al. Pigmented purpuric eruption in a patient with rheumatoid arthritis. Arch Intern Med. 1982;142:2184-2185.  
  7. Magro CM, Crowson AN, Regauer S. Granuloma annulare and necrobiosis lipoidica tissue reactions as a manifestation of systemic disease. Hum Pathol. 1996;27:50-56.  
  8. Błażewicz I, Szczerkowska-Dobosz A, Pęksa R, et al. Interstitial granulomatous dermatitis: a characteristic histological pattern with variable clinical manifestations. Postepy Dermatol Alergol. 2015;32:475-477.  
  9. Sezer E, Luzar B, Calonje E. Secondary syphilis with an interstitial granuloma annulare-like histopathologic pattern. J Cutan Pathol. 2011;38:439-442. 
  10. Peroni A, Colato C, Schena D, et al. Interstitial granulomatous dermatitis: a distinct entity with characteristic histological and clinical pattern. Br J Dermatol. 2012;166:775-783. 
  11. Sakiyama T, Hirai I, Konohana A, et al. Interstitial-type granuloma annulare associated with Sjögren syndrome. J Dtsch Dermatol Ges. 2014;12:415-416. 
  12. Spring P, Vernez M, Maniu CM, et al. Localized interstitial granuloma annulare induced by subcutaneous injections for desensitization. Dermatol Online J. 2013;19:18572. 
  13. Kluger N, Moguelet P, Chaslin-Ferbus D, et al. Generalized interstitial granuloma annulare induced by pegylated interferon-alpha. Dermatology. 2006;213:248-249. 
  14. Ruocco E, Baroni A, Cutrì FT, et al. Granuloma annulare in a site of healed herpes zoster: Wolf's isotopic response. J Eur Acad Dermatol Venereol. 2003;17:686-688.  
  15. Ise M, Tanese K, Adachi T, et al. Postherpetic Wolf's isotopic response: possible contribution of resident memory T cells to the pathogenesis of lichenoid reaction. Br J Dermatol. 2015;173:1331-1334.  
  16. Lora V, Cota C, Kanitakis J. Zosteriform lichen planus after herpes zoster: report of a new case of Wolf's isotopic phenomenon and literature review. Dermatol Online J. 2014;20. pii:13030/qt5vf99178. 
  17. Lin CH, Chen HC, Gao HW, et al. Wolf's post-herpetic isotopic response to tocilizumab for rheumatoid arthritis. Australas J Dermatol. 2018;59:E135-E137.  
  18. Melgar E, Henry J, Valois A, et al. Extra-facial Lever granuloma on a herpes zoster scar: Wolf's isotopic response. Ann Dermatol Venereol. 2018;145:354-358.  
  19. Ferenczi K, Rosenberg AS, McCalmont TH, et al. Herpes zoster granulomatous dermatitis: histopathologic findings in a case series. J Cutan Pathol. 2015;42:739-745.  
  20. Li Q, Wu H, Liao W, et al. A comprehensive review of immune-mediated dermatopathology in systemic lupus erythematosus. J Autoimmun. 2018;93:1-15. 
Article PDF
Author and Disclosure Information

Drs. Darji, Williams, and Hurley are from the Department of Dermatology, Saint Louis University School of Medicine, Missouri. Dr. Sufficool is from Cutaneous Pathology, Saint Louis.

The authors report no conflict of interest.

Correspondence: Kavita Darji, MD, Saint Louis University School of Medicine, Department of Dermatology, 1755 S Grand Blvd, Saint Louis, MO 63104 (kavita.darji@health.slu.edu).

Issue
Cutis - 104(4)
Publications
Topics
Page Number
211, 236-237
Sections
Author and Disclosure Information

Drs. Darji, Williams, and Hurley are from the Department of Dermatology, Saint Louis University School of Medicine, Missouri. Dr. Sufficool is from Cutaneous Pathology, Saint Louis.

The authors report no conflict of interest.

Correspondence: Kavita Darji, MD, Saint Louis University School of Medicine, Department of Dermatology, 1755 S Grand Blvd, Saint Louis, MO 63104 (kavita.darji@health.slu.edu).

Author and Disclosure Information

Drs. Darji, Williams, and Hurley are from the Department of Dermatology, Saint Louis University School of Medicine, Missouri. Dr. Sufficool is from Cutaneous Pathology, Saint Louis.

The authors report no conflict of interest.

Correspondence: Kavita Darji, MD, Saint Louis University School of Medicine, Department of Dermatology, 1755 S Grand Blvd, Saint Louis, MO 63104 (kavita.darji@health.slu.edu).

Article PDF
Article PDF
Related Articles

The Diagnosis: Lichenoid and Granulomatous Dermatitis in the Setting of Secondary Syphilis  

Syphilis, an infectious disease that has risen in incidence and is most commonly reported in men who have sex with men, involves a vast array of clinical and histologic presentations.1 Clinically, secondary syphilis involves an erythematous maculopapular eruption on the face, trunk, palms, soles, or genital area.2 The characteristic histologic features for secondary syphilis include endothelial swelling, interstitial inflammatory array, irregular acanthosis, elongated rete ridges, and vacuolar interface dermatitis with lymphocytes and plasma cells.1 Syphilitic infection has been associated with lichenoid and granulomatous dermatitis, which is an inflammatory skin disease described by Magro and Crowson.3 Lichenoid and granulomatous dermatitis has been linked to various systemic disorders, including chronic hepatitis C, Crohn disease, rheumatoid arthritis, endocrinopathy, subacute cutaneous lupus erythematosus, secondary syphilis, prior herpes infection, tuberculoid leprosy, mycobacterial infection, and human immunodeficiency virus infection.3-7 For this patient, given histopathology findings, clinical presentation, and positive rapid plasma reagin serologies, a diagnosis of lichenoid and granulomatous dermatitis in the setting of a secondary syphilis infection was established. A comprehensive investigation should be conducted to consider secondary syphilis or other systemic diseases in patients with a histologic finding of lichenoid and granulomatous dermatitis. 

Histologically, lichenoid and granulomatous dermatitis cases show a bandlike infiltrate of lymphocytes with neighboring histiocytes along the dermoepidermal junction, accompanied by epithelial changes of dyskeratosis, vasculopathy, and colloid body formation, in addition to a dermal histiocytic component.3 Our patient's biopsy showed a lichenoid reaction pattern with vacuolar interface changes, dyskeratosis, plump endothelial cells, and small collections of plasma cells. Additionally, there was a granulomatous component in the dermis with histiocytes admixed with lymphocytes and plasma cells. The presence of spirochetes was confirmed with antitreponemal immunohistochemical stain (Figure 1). Quantitative rapid plasma reagin was 1:64 (reference range, <1:1) and Treponema pallidum antibody was reactive. 

Figure 1. Secondary syphilis. Treponema pallidum immunohistochemistry showed scattered spirochetes (original magnification ×600).

Interstitial granulomatous dermatitis has a variable clinical presentation, often with red-purple annular plaques, hyperpigmented papules, and nodules frequently in a linear arrangement and predominantly on the trunk, thighs, groin, or buttocks.8,9 On histopathology, there are histiocytes in the reticular dermis and/or a macrophage infiltrate in the mid to deep dermis with collections of degenerated collagen (Figure 2).8,10 An interstitial infiltrate of eosinophils and neutrophils also may be appreciated, but mucin generally is absent.8,11 This condition often coexists with rheumatic and systemic autoimmune diseases.8-10  

Figure 2. Interstitial granulomatous dermatitis. Thickened collagen bundles interlaced with histiocytes and lymphocytes. Little to no mucin is appreciated (H&E, original magnification ×200).

Interstitial granuloma annulare is a noninfectious granulomatous skin condition that often presents clinically as asymptomatic annular red-brown patches, usually on the extremities.11-13 On histopathology, an interstitial or palisaded inflammatory infiltrate with histiocytes and multinucleated giant cells may be seen along with collagen degeneration or collagen bundles without necrosis (Figure 3).9 Mucin often is associated with the histiocytes.11 Of note, our patient's skin biopsy shows interface dermatitis, differentiating it from both interstitial granuloma annulare and interstitial granulomatous dermatitis. 

Figure 3. Interstitial granuloma annulare. A busy dermis with increased histiocytes and lymphocytes arranged about vessels and between collagen bundles that are separated by increased mucin (H&E, original magnification ×200).

Postviral granulomatous reactions are the most frequently reported types of reactions to occur at the location of herpes zoster infection up to years after the initial disease. Wolf isotopic reaction encompasses skin reactions in the body region of formerly resolved skin disease, commonly herpesvirus infection.14,15 This manifestation may occur due to a hypersensitivity reaction from enduring viral proteins, resident memory T cells, or local neuroimmune imbalance from herpesvirus-induced injury to dermal sensory nerve fibers.14-17 Clinically, patients present with red-purple pruritic papules and plaques in a bandlike unilateral pattern, usually in the same region as the prior herpes infection and often accompanied by postherpetic neuralgia.16-19 Of note, our patient's clinical findings were more diffuse than the frequently localized and often linear distribution seen in postherpetic granulomatous reaction. On histopathology, granulomatous or lichenoid tissue reaction most commonly is appreciated.15 Specifically, interstitial granulomatous dermatitis with histiocytes, lymphocytes, and multinucleated giant cells showing elastophagocytosis and an inflammatory infiltrate with lymphocytes and plasma cells around vasculature, eccrine glands, and nerves can be noted (Figure 4).19  

Figure 4. Postviral granulomatous reaction. Histiocytes, lymphocytes, and multinucleated giant cells with thickened collagen bundles (H&E, original magnification ×200).

Lupus erythematosus is an autoimmune condition with a wide array of clinical features, including skin manifestations and systemic symptoms. Specifically, discoid lupus erythematosus presents with clearly outlined, red-pink macules or papules with scaling. Histologic features include keratotic follicular plugging, acanthosis, dermal mucin, thickening of the basement membrane zone, and dense lymphocytic infiltrate (Figure 5).20  

Figure 5. Discoid lupus erythematosus. Perifollicular and perivascular inflammatory infiltrate with vacuolization along the dermoepidermal junction and scattered dyskeratotic keratinocytes along the basal layer of the epidermis. There is focal follicular plugging and the basement membrane zone appears thickened (H&E, original magnification ×200).

The Diagnosis: Lichenoid and Granulomatous Dermatitis in the Setting of Secondary Syphilis  

Syphilis, an infectious disease that has risen in incidence and is most commonly reported in men who have sex with men, involves a vast array of clinical and histologic presentations.1 Clinically, secondary syphilis involves an erythematous maculopapular eruption on the face, trunk, palms, soles, or genital area.2 The characteristic histologic features for secondary syphilis include endothelial swelling, interstitial inflammatory array, irregular acanthosis, elongated rete ridges, and vacuolar interface dermatitis with lymphocytes and plasma cells.1 Syphilitic infection has been associated with lichenoid and granulomatous dermatitis, which is an inflammatory skin disease described by Magro and Crowson.3 Lichenoid and granulomatous dermatitis has been linked to various systemic disorders, including chronic hepatitis C, Crohn disease, rheumatoid arthritis, endocrinopathy, subacute cutaneous lupus erythematosus, secondary syphilis, prior herpes infection, tuberculoid leprosy, mycobacterial infection, and human immunodeficiency virus infection.3-7 For this patient, given histopathology findings, clinical presentation, and positive rapid plasma reagin serologies, a diagnosis of lichenoid and granulomatous dermatitis in the setting of a secondary syphilis infection was established. A comprehensive investigation should be conducted to consider secondary syphilis or other systemic diseases in patients with a histologic finding of lichenoid and granulomatous dermatitis. 

Histologically, lichenoid and granulomatous dermatitis cases show a bandlike infiltrate of lymphocytes with neighboring histiocytes along the dermoepidermal junction, accompanied by epithelial changes of dyskeratosis, vasculopathy, and colloid body formation, in addition to a dermal histiocytic component.3 Our patient's biopsy showed a lichenoid reaction pattern with vacuolar interface changes, dyskeratosis, plump endothelial cells, and small collections of plasma cells. Additionally, there was a granulomatous component in the dermis with histiocytes admixed with lymphocytes and plasma cells. The presence of spirochetes was confirmed with antitreponemal immunohistochemical stain (Figure 1). Quantitative rapid plasma reagin was 1:64 (reference range, <1:1) and Treponema pallidum antibody was reactive. 

Figure 1. Secondary syphilis. Treponema pallidum immunohistochemistry showed scattered spirochetes (original magnification ×600).

Interstitial granulomatous dermatitis has a variable clinical presentation, often with red-purple annular plaques, hyperpigmented papules, and nodules frequently in a linear arrangement and predominantly on the trunk, thighs, groin, or buttocks.8,9 On histopathology, there are histiocytes in the reticular dermis and/or a macrophage infiltrate in the mid to deep dermis with collections of degenerated collagen (Figure 2).8,10 An interstitial infiltrate of eosinophils and neutrophils also may be appreciated, but mucin generally is absent.8,11 This condition often coexists with rheumatic and systemic autoimmune diseases.8-10  

Figure 2. Interstitial granulomatous dermatitis. Thickened collagen bundles interlaced with histiocytes and lymphocytes. Little to no mucin is appreciated (H&E, original magnification ×200).

Interstitial granuloma annulare is a noninfectious granulomatous skin condition that often presents clinically as asymptomatic annular red-brown patches, usually on the extremities.11-13 On histopathology, an interstitial or palisaded inflammatory infiltrate with histiocytes and multinucleated giant cells may be seen along with collagen degeneration or collagen bundles without necrosis (Figure 3).9 Mucin often is associated with the histiocytes.11 Of note, our patient's skin biopsy shows interface dermatitis, differentiating it from both interstitial granuloma annulare and interstitial granulomatous dermatitis. 

Figure 3. Interstitial granuloma annulare. A busy dermis with increased histiocytes and lymphocytes arranged about vessels and between collagen bundles that are separated by increased mucin (H&E, original magnification ×200).

Postviral granulomatous reactions are the most frequently reported types of reactions to occur at the location of herpes zoster infection up to years after the initial disease. Wolf isotopic reaction encompasses skin reactions in the body region of formerly resolved skin disease, commonly herpesvirus infection.14,15 This manifestation may occur due to a hypersensitivity reaction from enduring viral proteins, resident memory T cells, or local neuroimmune imbalance from herpesvirus-induced injury to dermal sensory nerve fibers.14-17 Clinically, patients present with red-purple pruritic papules and plaques in a bandlike unilateral pattern, usually in the same region as the prior herpes infection and often accompanied by postherpetic neuralgia.16-19 Of note, our patient's clinical findings were more diffuse than the frequently localized and often linear distribution seen in postherpetic granulomatous reaction. On histopathology, granulomatous or lichenoid tissue reaction most commonly is appreciated.15 Specifically, interstitial granulomatous dermatitis with histiocytes, lymphocytes, and multinucleated giant cells showing elastophagocytosis and an inflammatory infiltrate with lymphocytes and plasma cells around vasculature, eccrine glands, and nerves can be noted (Figure 4).19  

Figure 4. Postviral granulomatous reaction. Histiocytes, lymphocytes, and multinucleated giant cells with thickened collagen bundles (H&E, original magnification ×200).

Lupus erythematosus is an autoimmune condition with a wide array of clinical features, including skin manifestations and systemic symptoms. Specifically, discoid lupus erythematosus presents with clearly outlined, red-pink macules or papules with scaling. Histologic features include keratotic follicular plugging, acanthosis, dermal mucin, thickening of the basement membrane zone, and dense lymphocytic infiltrate (Figure 5).20  

Figure 5. Discoid lupus erythematosus. Perifollicular and perivascular inflammatory infiltrate with vacuolization along the dermoepidermal junction and scattered dyskeratotic keratinocytes along the basal layer of the epidermis. There is focal follicular plugging and the basement membrane zone appears thickened (H&E, original magnification ×200).

References
  1. Flamm A, Parikh K, Xie Q, et al. Histologic features of secondary syphilis: a multicenter retrospective review. J Am Acad Dermatol. 2015;73:325-330. 
  2. Zeltser R, Kurban AK. Syphilis. Clin Dermatol. 2004;22:461-468. 
  3. Magro CM, Crowson AN. Lichenoid and granulomatous dermatitis. Int J Dermatol. 2000;39:12-33.  
  4. S Breza T Jr, Magro CM. Lichenoid and granulomatous dermatitis associated with atypical mycobacterium infections. J Cutan Pathol. 2006;33:512-515.  
  5. Granel B, Serratrice J, Rey J, et al. Chronic hepatitis C virus infection associated with a generalized granuloma annulare. J Am Acad Dermatol. 2000;43(5, pt 2):918-919.  
  6. Jorizzo JL, Gonzalez EB, Apisarnthanarax P, et al. Pigmented purpuric eruption in a patient with rheumatoid arthritis. Arch Intern Med. 1982;142:2184-2185.  
  7. Magro CM, Crowson AN, Regauer S. Granuloma annulare and necrobiosis lipoidica tissue reactions as a manifestation of systemic disease. Hum Pathol. 1996;27:50-56.  
  8. Błażewicz I, Szczerkowska-Dobosz A, Pęksa R, et al. Interstitial granulomatous dermatitis: a characteristic histological pattern with variable clinical manifestations. Postepy Dermatol Alergol. 2015;32:475-477.  
  9. Sezer E, Luzar B, Calonje E. Secondary syphilis with an interstitial granuloma annulare-like histopathologic pattern. J Cutan Pathol. 2011;38:439-442. 
  10. Peroni A, Colato C, Schena D, et al. Interstitial granulomatous dermatitis: a distinct entity with characteristic histological and clinical pattern. Br J Dermatol. 2012;166:775-783. 
  11. Sakiyama T, Hirai I, Konohana A, et al. Interstitial-type granuloma annulare associated with Sjögren syndrome. J Dtsch Dermatol Ges. 2014;12:415-416. 
  12. Spring P, Vernez M, Maniu CM, et al. Localized interstitial granuloma annulare induced by subcutaneous injections for desensitization. Dermatol Online J. 2013;19:18572. 
  13. Kluger N, Moguelet P, Chaslin-Ferbus D, et al. Generalized interstitial granuloma annulare induced by pegylated interferon-alpha. Dermatology. 2006;213:248-249. 
  14. Ruocco E, Baroni A, Cutrì FT, et al. Granuloma annulare in a site of healed herpes zoster: Wolf's isotopic response. J Eur Acad Dermatol Venereol. 2003;17:686-688.  
  15. Ise M, Tanese K, Adachi T, et al. Postherpetic Wolf's isotopic response: possible contribution of resident memory T cells to the pathogenesis of lichenoid reaction. Br J Dermatol. 2015;173:1331-1334.  
  16. Lora V, Cota C, Kanitakis J. Zosteriform lichen planus after herpes zoster: report of a new case of Wolf's isotopic phenomenon and literature review. Dermatol Online J. 2014;20. pii:13030/qt5vf99178. 
  17. Lin CH, Chen HC, Gao HW, et al. Wolf's post-herpetic isotopic response to tocilizumab for rheumatoid arthritis. Australas J Dermatol. 2018;59:E135-E137.  
  18. Melgar E, Henry J, Valois A, et al. Extra-facial Lever granuloma on a herpes zoster scar: Wolf's isotopic response. Ann Dermatol Venereol. 2018;145:354-358.  
  19. Ferenczi K, Rosenberg AS, McCalmont TH, et al. Herpes zoster granulomatous dermatitis: histopathologic findings in a case series. J Cutan Pathol. 2015;42:739-745.  
  20. Li Q, Wu H, Liao W, et al. A comprehensive review of immune-mediated dermatopathology in systemic lupus erythematosus. J Autoimmun. 2018;93:1-15. 
References
  1. Flamm A, Parikh K, Xie Q, et al. Histologic features of secondary syphilis: a multicenter retrospective review. J Am Acad Dermatol. 2015;73:325-330. 
  2. Zeltser R, Kurban AK. Syphilis. Clin Dermatol. 2004;22:461-468. 
  3. Magro CM, Crowson AN. Lichenoid and granulomatous dermatitis. Int J Dermatol. 2000;39:12-33.  
  4. S Breza T Jr, Magro CM. Lichenoid and granulomatous dermatitis associated with atypical mycobacterium infections. J Cutan Pathol. 2006;33:512-515.  
  5. Granel B, Serratrice J, Rey J, et al. Chronic hepatitis C virus infection associated with a generalized granuloma annulare. J Am Acad Dermatol. 2000;43(5, pt 2):918-919.  
  6. Jorizzo JL, Gonzalez EB, Apisarnthanarax P, et al. Pigmented purpuric eruption in a patient with rheumatoid arthritis. Arch Intern Med. 1982;142:2184-2185.  
  7. Magro CM, Crowson AN, Regauer S. Granuloma annulare and necrobiosis lipoidica tissue reactions as a manifestation of systemic disease. Hum Pathol. 1996;27:50-56.  
  8. Błażewicz I, Szczerkowska-Dobosz A, Pęksa R, et al. Interstitial granulomatous dermatitis: a characteristic histological pattern with variable clinical manifestations. Postepy Dermatol Alergol. 2015;32:475-477.  
  9. Sezer E, Luzar B, Calonje E. Secondary syphilis with an interstitial granuloma annulare-like histopathologic pattern. J Cutan Pathol. 2011;38:439-442. 
  10. Peroni A, Colato C, Schena D, et al. Interstitial granulomatous dermatitis: a distinct entity with characteristic histological and clinical pattern. Br J Dermatol. 2012;166:775-783. 
  11. Sakiyama T, Hirai I, Konohana A, et al. Interstitial-type granuloma annulare associated with Sjögren syndrome. J Dtsch Dermatol Ges. 2014;12:415-416. 
  12. Spring P, Vernez M, Maniu CM, et al. Localized interstitial granuloma annulare induced by subcutaneous injections for desensitization. Dermatol Online J. 2013;19:18572. 
  13. Kluger N, Moguelet P, Chaslin-Ferbus D, et al. Generalized interstitial granuloma annulare induced by pegylated interferon-alpha. Dermatology. 2006;213:248-249. 
  14. Ruocco E, Baroni A, Cutrì FT, et al. Granuloma annulare in a site of healed herpes zoster: Wolf's isotopic response. J Eur Acad Dermatol Venereol. 2003;17:686-688.  
  15. Ise M, Tanese K, Adachi T, et al. Postherpetic Wolf's isotopic response: possible contribution of resident memory T cells to the pathogenesis of lichenoid reaction. Br J Dermatol. 2015;173:1331-1334.  
  16. Lora V, Cota C, Kanitakis J. Zosteriform lichen planus after herpes zoster: report of a new case of Wolf's isotopic phenomenon and literature review. Dermatol Online J. 2014;20. pii:13030/qt5vf99178. 
  17. Lin CH, Chen HC, Gao HW, et al. Wolf's post-herpetic isotopic response to tocilizumab for rheumatoid arthritis. Australas J Dermatol. 2018;59:E135-E137.  
  18. Melgar E, Henry J, Valois A, et al. Extra-facial Lever granuloma on a herpes zoster scar: Wolf's isotopic response. Ann Dermatol Venereol. 2018;145:354-358.  
  19. Ferenczi K, Rosenberg AS, McCalmont TH, et al. Herpes zoster granulomatous dermatitis: histopathologic findings in a case series. J Cutan Pathol. 2015;42:739-745.  
  20. Li Q, Wu H, Liao W, et al. A comprehensive review of immune-mediated dermatopathology in systemic lupus erythematosus. J Autoimmun. 2018;93:1-15. 
Issue
Cutis - 104(4)
Issue
Cutis - 104(4)
Page Number
211, 236-237
Page Number
211, 236-237
Publications
Publications
Topics
Article Type
Display Headline
Erythematous Papules on the Scrotum, Trunk, and Extremities
Display Headline
Erythematous Papules on the Scrotum, Trunk, and Extremities
Sections
Questionnaire Body

H&E, original magnification ×100 (inset, original magnification ×400).

A 54-year-old man presented with painful, nonpruritic, erythematous papules that began on the scrotum. The eruption progressed to involve the trunk, arms, and legs.

Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Mon, 10/07/2019 - 12:30
Un-Gate On Date
Mon, 10/07/2019 - 12:30
Use ProPublica
CFC Schedule Remove Status
Mon, 10/07/2019 - 12:30
Hide sidebar & use full width
render the right sidebar.
Article PDF Media

Solitary Papule on the Leg

Article Type
Changed
Wed, 09/11/2019 - 16:15
Display Headline
Solitary Papule on the Leg

The Diagnosis: Epithelioid Histiocytoma 

Epithelioid histiocytoma (EH), also known as epithelioid cell histiocytoma or epithelioid fibrous histiocytoma, is a rare benign fibrohistiocytic tumor first described in 1989.1 Epithelioid histiocytoma commonly presents in middle-aged adults with a slight predilection for males.2 The most frequently affected site is the lower extremity. The arms, trunk, head and neck, groin, and tongue also can be involved.3,4 It usually presents as a solitary asymptomatic papule or nodule, though cases with multiple lesions have been reported.5 Anaplastic lymphoma kinase rearrangement and overexpression have been confirmed and suggest that EH is distinct from conventional cutaneous fibrous histiocytoma.5  

Histologically, EH appears as an exophytic, symmetric, and well-demarcated dermal nodule with a classic epidermal collarette. Prominent vascularity with perivascular accentuation of the epithelioid tumor cells is common. Older lesions may be hyalinized and sclerotic. Epithelioid cells commonly account for more than 50% of the tumor and are characterized by eosinophilic cytoplasm, vesicular nuclei, and small eosinophilic nucleoli. A small population of lymphocytes and mast cells are variably present (quiz image, bottom).1-3,7 A predominantly spindle cell variant has been reported.8 Other histopathologic variants include granular cell,9 cellular,10 and EH with perineuriomalike growth.11 Immunohistochemical staining shows anaplastic lymphoma kinase positivity in most cases, and more than half of cases stain positive for factor XIIIa and epithelial membrane antigen. Tumor cells consistently are negative for desmin and cytokeratins.6,10,12 Excision is curative.8  

Polypoid Spitz nevus (PSN) is a benign nevus with a conspicuous polypoid or papillary exophytic architecture. The term was coined in 2000 by Fabrizi and Massi.13 Spitz nevus is a benign acquired melanocytic tumor that typically presents in children and adolescents and has a wide histologic spectrum.14 There is some debate on this entity, as some authors do not regard PSN as a distinct histologic variant; thus, it seems underreported in the literature.15 In a review of 349 cases of Spitz nevi, the authors found 7 cases of PSN.16 In another review of 74 cases of intradermal Spitz nevi, 14 cases of PSN were identified.14 This polypoid variant is easily mistaken for a polypoid melanoma because it can show cytologic atypia with large nuclei. Polypoid Spitz nevus usually lacks mitoses, notable pleomorphism, and sheetlike growth, unlike melanoma (Figure 1).13,14  

Figure 1. Polypoid Spitz nevus. A polypoid architecture with predominantly intradermal epithelioid and spindled melanocytes arranged as single units splaying between dermal collagen. The thick-walled vascular pattern is characteristic (H&E, original magnification ×40; inset, original magnification ×200).

Myopericytoma is an uncommon benign mesenchymal neoplasm that typically presents as a solitary, slowly enlarging and painless nodule with a predilection for the lower extremities, usually in adult males.17-20 Histologically, it consists of a well-circumscribed nodule with numerous thin-walled vessels and a proliferation of ovoid to spindled myopericytes exhibiting a concentric perivascular growth pattern (Figure 2). Myopericytoma usually is positive for smooth muscle actin and h-caldesmon but is negative or only focally positive for desmin. The prognosis is good with rare recurrence, despite incomplete excision.17,18 

Figure 2. Myopericytoma. A proliferation of concentric perivascular myopericytes around numerous thin-walled vessels. The cells are ovoid and plump spindled with eosinophilic cytoplasm (H&E, original magnification ×200).

Solitary reticulohistiocytoma is a rare benign form of non-Langerhans cell histiocytosis.21,22 Unlike its multicentric counterpart, solitary reticulohistiocytoma rarely is associated with systemic disease. It presents as a small, dome-shaped, painless papule or nodule that can affect any part of the body.22,23 Solitary reticulohistiocytoma characteristically demonstrates cells with a ground glass-like appearance and 2-toned cytoplasm. A mixed inflammatory infiltrate including neutrophils, eosinophils, and lymphocytes commonly is present (Figure 3). The epithelioid histiocytes are positive for vimentin and histiocytic markers including CD68 and CD163.22  

Figure 3. Solitary reticulohistiocytoma. A dermal epithelioid histiocytic proliferation of cells with a ground glass–like appearance and 2-toned cytoplasm. A background mixed inflammatory infiltrate is present (H&E, original magnification ×200).

Solitary fibrous tumor (SFT) is an uncommon mesenchymal fibroblastic neoplasm that can arise at almost any anatomic site.24 Cutaneous SFTs are more common in women, most often involve the head, and appear to behave in an indolent manner.25 Solitary fibrous tumors are translocation-associated neoplasms with a NAB2-STAT6 gene fusion.26 The classic histology of SFT is a spindled fibroblastic proliferation arranged in a "patternless pattern" with interspersed stag horn-like, thin-walled blood vessels (Figure 4). Tumor cells usually are positive for CD34, CD99, and Bcl-2.27 In addition, STAT6 immunoreactivity is useful in diagnosis of SFT.25

Figure 4. Solitary fibrous tumor. A dense, bland, spindled, fibroblastic proliferation with a “patternless pattern” and collagenized stroma with interspersed branching vessels (H&E, original magnification ×200).

References
  1. Jones EW, Cerio R, Smith NP. Epithelioid cell histiocytoma: a new entity. Br J Dermatol. 1989;120:185-195. 
  2. Singh Gomez C, Calonje E, Fletcher CD. Epithelioid benign fibrous histiocytoma of skin: clinico-pathological analysis of 20 cases of a poorly known variant. Histopathology. 1994;24:123-129. 
  3. Felty CC, Linos K. Epithelioid fibrous histiocytoma: a concise review [published online October 4, 2018]. Am J Dermatopathol. doi:10.1097/DAD.0000000000001272. 
  4. Rawal YB, Kalmar JR, Shumway B, et al. Presentation of an epithelioid cell histiocytoma on the ventral tongue. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;100:75-83. 
  5. Cangelosi JJ, Prieto VG, Baker GF, et al. Unusual presentation of multiple epithelioid cell histiocytomas. Am J Dermatopathol. 2008;30:373-376. 
  6. Doyle LA, Marino-Enriquez A, Fletcher CD, et al. ALK rearrangement and overexpression in epithelioid fibrous histiocytoma. Mod Pathol. 2015;28:904-912. 
  7. Silverman JS, Glusac EJ. Epithelioid cell histiocytoma--histogenetic and kinetics analysis of dermal microvascular unit dendritic cell subpopulations. J Cutan Pathol. 2003;30:415-422. 
  8. Murigu T, Bhatt N, Miller K, et al. Spindle cell-predominant epithelioid fibrous histiocytoma. Histopathology. 2018;72:1233-1236. 
  9. Rabkin MS, Vukmer T. Granular cell variant of epithelioid cell histiocytoma. Am J Dermatopathol. 2012;34:766-769. 
  10. Glusac EJ, Barr RJ, Everett MA, et al. Epithelioid cell histiocytoma. a report of 10 cases including a new cellular variant. Am J Surg Pathol. 1994;18:583-590. 
  11. Creytens D, Ferdinande L, Van Dorpe J. ALK Rearrangement and overexpression in an unusual cutaneous epithelioid tumor with a peculiar whorled "perineurioma-like" growth pattern: epithelioid fibrous histiocytoma. Appl Immunohistochem Mol Morphol. 2017;25:E46-E48. 
  12. Doyle LA, Fletcher CD. EMA positivity in epithelioid fibrous histiocytoma: a potential diagnostic pitfall. J Cutan Pathol. 2011;38:697-703. 
  13. Fabrizi G, Massi G. Polypoid Spitz naevus: the benign counterpart of polypoid malignant melanoma. Br J Dermatol. 2000;142:128-132. 
  14. Plaza JA, De Stefano D, Suster S, et al. Intradermal Spitz nevi: a rare subtype of Spitz nevi analyzed in a clinicopathologic study of 74 cases. Am J Dermatopathol. 2014;36:283-294; quiz 295-287. 
  15. Menezes FD, Mooi WJ. Spitz tumors of the skin. Surg Pathol Clin. 2017;10:281-298. 
  16. Requena C, Requena L, Kutzner H, et al. Spitz nevus: a clinicopathological study of 349 cases. Am J Dermatopathol. 2009;31:107-116. 
  17. Mentzel T, Dei Tos AP, Sapi Z, et al. Myopericytoma of skin and soft tissues: clinicopathologic and immunohistochemical study of 54 cases. Am J Surg Pathol. 2006;30:104-113. 
  18. Aung PP, Goldberg LJ, Mahalingam M, et al. Cutaneous myopericytoma: a report of 3 cases and review of the literature. Dermatopathology (Basel). 2015;2:9-14. 
  19. Morzycki A, Joukhadar N, Murphy A, et al. Digital myopericytoma: a case report and systematic literature review. J Hand Microsurg. 2017;9:32-36. 
  20. LeBlanc RE, Taube J. Myofibroma, myopericytoma, myoepithelioma, and myofibroblastoma of skin and soft tissue. Surg Pathol Clin. 2011;4:745-759. 
  21. Chisolm SS, Schulman JM, Fox LP. Adult xanthogranuloma, reticulohistiocytosis, and Rosai-Dorfman disease. Dermatol Clin. 2015;33:465-472; discussion 473. 
  22. Miettinen M, Fetsch JF. Reticulohistiocytoma (solitary epithelioid histiocytoma): a clinicopathologic and immunohistochemical study of 44 cases. Am J Surg Pathol. 2006;30:521-528. 
  23. Cohen PR, Lee RA. Adult-onset reticulohistiocytoma presenting as a solitary asymptomatic red knee nodule: report and review of clinical presentations and immunohistochemistry staining features of reticulohistiocytosis. Dermatol Online J. 2014. pii:doj_21725. 
  24. Soldano AC, Meehan SA. Cutaneous solitary fibrous tumor: a report of 2 cases and review of the literature. Am J Dermatopathol. 2008;30:54-58. 
  25. Feasel P, Al-Ibraheemi A, Fritchie K, et al. Superficial solitary fibrous tumor: a series of 26 cases. Am J Surg Pathol. 2018;42:778-785. 
  26. Thway K, Ng W, Noujaim J, et al. The current status of solitary fibrous tumor: diagnostic features, variants, and genetics. Int J Surg Pathol. 2016;24:281-292. 
  27. Erdag G, Qureshi HS, Patterson JW, et al. Solitary fibrous tumors of the skin: a clinicopathologic study of 10 cases and review of the literature. J Cutan Pathol. 2007;34:844-850.
Article PDF
Author and Disclosure Information

Dr. Wu is from the Department of Dermatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, China. Dr. Wu also is from and Drs. Skipper and Elston are from the Medical University of South Carolina, Charleston. Drs. Wu and Elston are from the Department of Dermatology and Dermatologic Surgery, and Dr. Skipper is from the Department of Pathology and Laboratory Medicine.

The authors report no conflict of interest.

Correspondence: Dirk M. Elston, MD, Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, 135 Rutledge Ave, MSC 578, Charleston, SC 29425 (elstond@musc.edu).

Issue
Cutis - 104(3)
Publications
Topics
Page Number
173, 187-188
Sections
Author and Disclosure Information

Dr. Wu is from the Department of Dermatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, China. Dr. Wu also is from and Drs. Skipper and Elston are from the Medical University of South Carolina, Charleston. Drs. Wu and Elston are from the Department of Dermatology and Dermatologic Surgery, and Dr. Skipper is from the Department of Pathology and Laboratory Medicine.

The authors report no conflict of interest.

Correspondence: Dirk M. Elston, MD, Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, 135 Rutledge Ave, MSC 578, Charleston, SC 29425 (elstond@musc.edu).

Author and Disclosure Information

Dr. Wu is from the Department of Dermatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, China. Dr. Wu also is from and Drs. Skipper and Elston are from the Medical University of South Carolina, Charleston. Drs. Wu and Elston are from the Department of Dermatology and Dermatologic Surgery, and Dr. Skipper is from the Department of Pathology and Laboratory Medicine.

The authors report no conflict of interest.

Correspondence: Dirk M. Elston, MD, Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, 135 Rutledge Ave, MSC 578, Charleston, SC 29425 (elstond@musc.edu).

Article PDF
Article PDF
Related Articles

The Diagnosis: Epithelioid Histiocytoma 

Epithelioid histiocytoma (EH), also known as epithelioid cell histiocytoma or epithelioid fibrous histiocytoma, is a rare benign fibrohistiocytic tumor first described in 1989.1 Epithelioid histiocytoma commonly presents in middle-aged adults with a slight predilection for males.2 The most frequently affected site is the lower extremity. The arms, trunk, head and neck, groin, and tongue also can be involved.3,4 It usually presents as a solitary asymptomatic papule or nodule, though cases with multiple lesions have been reported.5 Anaplastic lymphoma kinase rearrangement and overexpression have been confirmed and suggest that EH is distinct from conventional cutaneous fibrous histiocytoma.5  

Histologically, EH appears as an exophytic, symmetric, and well-demarcated dermal nodule with a classic epidermal collarette. Prominent vascularity with perivascular accentuation of the epithelioid tumor cells is common. Older lesions may be hyalinized and sclerotic. Epithelioid cells commonly account for more than 50% of the tumor and are characterized by eosinophilic cytoplasm, vesicular nuclei, and small eosinophilic nucleoli. A small population of lymphocytes and mast cells are variably present (quiz image, bottom).1-3,7 A predominantly spindle cell variant has been reported.8 Other histopathologic variants include granular cell,9 cellular,10 and EH with perineuriomalike growth.11 Immunohistochemical staining shows anaplastic lymphoma kinase positivity in most cases, and more than half of cases stain positive for factor XIIIa and epithelial membrane antigen. Tumor cells consistently are negative for desmin and cytokeratins.6,10,12 Excision is curative.8  

Polypoid Spitz nevus (PSN) is a benign nevus with a conspicuous polypoid or papillary exophytic architecture. The term was coined in 2000 by Fabrizi and Massi.13 Spitz nevus is a benign acquired melanocytic tumor that typically presents in children and adolescents and has a wide histologic spectrum.14 There is some debate on this entity, as some authors do not regard PSN as a distinct histologic variant; thus, it seems underreported in the literature.15 In a review of 349 cases of Spitz nevi, the authors found 7 cases of PSN.16 In another review of 74 cases of intradermal Spitz nevi, 14 cases of PSN were identified.14 This polypoid variant is easily mistaken for a polypoid melanoma because it can show cytologic atypia with large nuclei. Polypoid Spitz nevus usually lacks mitoses, notable pleomorphism, and sheetlike growth, unlike melanoma (Figure 1).13,14  

Figure 1. Polypoid Spitz nevus. A polypoid architecture with predominantly intradermal epithelioid and spindled melanocytes arranged as single units splaying between dermal collagen. The thick-walled vascular pattern is characteristic (H&E, original magnification ×40; inset, original magnification ×200).

Myopericytoma is an uncommon benign mesenchymal neoplasm that typically presents as a solitary, slowly enlarging and painless nodule with a predilection for the lower extremities, usually in adult males.17-20 Histologically, it consists of a well-circumscribed nodule with numerous thin-walled vessels and a proliferation of ovoid to spindled myopericytes exhibiting a concentric perivascular growth pattern (Figure 2). Myopericytoma usually is positive for smooth muscle actin and h-caldesmon but is negative or only focally positive for desmin. The prognosis is good with rare recurrence, despite incomplete excision.17,18 

Figure 2. Myopericytoma. A proliferation of concentric perivascular myopericytes around numerous thin-walled vessels. The cells are ovoid and plump spindled with eosinophilic cytoplasm (H&E, original magnification ×200).

Solitary reticulohistiocytoma is a rare benign form of non-Langerhans cell histiocytosis.21,22 Unlike its multicentric counterpart, solitary reticulohistiocytoma rarely is associated with systemic disease. It presents as a small, dome-shaped, painless papule or nodule that can affect any part of the body.22,23 Solitary reticulohistiocytoma characteristically demonstrates cells with a ground glass-like appearance and 2-toned cytoplasm. A mixed inflammatory infiltrate including neutrophils, eosinophils, and lymphocytes commonly is present (Figure 3). The epithelioid histiocytes are positive for vimentin and histiocytic markers including CD68 and CD163.22  

Figure 3. Solitary reticulohistiocytoma. A dermal epithelioid histiocytic proliferation of cells with a ground glass–like appearance and 2-toned cytoplasm. A background mixed inflammatory infiltrate is present (H&E, original magnification ×200).

Solitary fibrous tumor (SFT) is an uncommon mesenchymal fibroblastic neoplasm that can arise at almost any anatomic site.24 Cutaneous SFTs are more common in women, most often involve the head, and appear to behave in an indolent manner.25 Solitary fibrous tumors are translocation-associated neoplasms with a NAB2-STAT6 gene fusion.26 The classic histology of SFT is a spindled fibroblastic proliferation arranged in a "patternless pattern" with interspersed stag horn-like, thin-walled blood vessels (Figure 4). Tumor cells usually are positive for CD34, CD99, and Bcl-2.27 In addition, STAT6 immunoreactivity is useful in diagnosis of SFT.25

Figure 4. Solitary fibrous tumor. A dense, bland, spindled, fibroblastic proliferation with a “patternless pattern” and collagenized stroma with interspersed branching vessels (H&E, original magnification ×200).

The Diagnosis: Epithelioid Histiocytoma 

Epithelioid histiocytoma (EH), also known as epithelioid cell histiocytoma or epithelioid fibrous histiocytoma, is a rare benign fibrohistiocytic tumor first described in 1989.1 Epithelioid histiocytoma commonly presents in middle-aged adults with a slight predilection for males.2 The most frequently affected site is the lower extremity. The arms, trunk, head and neck, groin, and tongue also can be involved.3,4 It usually presents as a solitary asymptomatic papule or nodule, though cases with multiple lesions have been reported.5 Anaplastic lymphoma kinase rearrangement and overexpression have been confirmed and suggest that EH is distinct from conventional cutaneous fibrous histiocytoma.5  

Histologically, EH appears as an exophytic, symmetric, and well-demarcated dermal nodule with a classic epidermal collarette. Prominent vascularity with perivascular accentuation of the epithelioid tumor cells is common. Older lesions may be hyalinized and sclerotic. Epithelioid cells commonly account for more than 50% of the tumor and are characterized by eosinophilic cytoplasm, vesicular nuclei, and small eosinophilic nucleoli. A small population of lymphocytes and mast cells are variably present (quiz image, bottom).1-3,7 A predominantly spindle cell variant has been reported.8 Other histopathologic variants include granular cell,9 cellular,10 and EH with perineuriomalike growth.11 Immunohistochemical staining shows anaplastic lymphoma kinase positivity in most cases, and more than half of cases stain positive for factor XIIIa and epithelial membrane antigen. Tumor cells consistently are negative for desmin and cytokeratins.6,10,12 Excision is curative.8  

Polypoid Spitz nevus (PSN) is a benign nevus with a conspicuous polypoid or papillary exophytic architecture. The term was coined in 2000 by Fabrizi and Massi.13 Spitz nevus is a benign acquired melanocytic tumor that typically presents in children and adolescents and has a wide histologic spectrum.14 There is some debate on this entity, as some authors do not regard PSN as a distinct histologic variant; thus, it seems underreported in the literature.15 In a review of 349 cases of Spitz nevi, the authors found 7 cases of PSN.16 In another review of 74 cases of intradermal Spitz nevi, 14 cases of PSN were identified.14 This polypoid variant is easily mistaken for a polypoid melanoma because it can show cytologic atypia with large nuclei. Polypoid Spitz nevus usually lacks mitoses, notable pleomorphism, and sheetlike growth, unlike melanoma (Figure 1).13,14  

Figure 1. Polypoid Spitz nevus. A polypoid architecture with predominantly intradermal epithelioid and spindled melanocytes arranged as single units splaying between dermal collagen. The thick-walled vascular pattern is characteristic (H&E, original magnification ×40; inset, original magnification ×200).

Myopericytoma is an uncommon benign mesenchymal neoplasm that typically presents as a solitary, slowly enlarging and painless nodule with a predilection for the lower extremities, usually in adult males.17-20 Histologically, it consists of a well-circumscribed nodule with numerous thin-walled vessels and a proliferation of ovoid to spindled myopericytes exhibiting a concentric perivascular growth pattern (Figure 2). Myopericytoma usually is positive for smooth muscle actin and h-caldesmon but is negative or only focally positive for desmin. The prognosis is good with rare recurrence, despite incomplete excision.17,18 

Figure 2. Myopericytoma. A proliferation of concentric perivascular myopericytes around numerous thin-walled vessels. The cells are ovoid and plump spindled with eosinophilic cytoplasm (H&E, original magnification ×200).

Solitary reticulohistiocytoma is a rare benign form of non-Langerhans cell histiocytosis.21,22 Unlike its multicentric counterpart, solitary reticulohistiocytoma rarely is associated with systemic disease. It presents as a small, dome-shaped, painless papule or nodule that can affect any part of the body.22,23 Solitary reticulohistiocytoma characteristically demonstrates cells with a ground glass-like appearance and 2-toned cytoplasm. A mixed inflammatory infiltrate including neutrophils, eosinophils, and lymphocytes commonly is present (Figure 3). The epithelioid histiocytes are positive for vimentin and histiocytic markers including CD68 and CD163.22  

Figure 3. Solitary reticulohistiocytoma. A dermal epithelioid histiocytic proliferation of cells with a ground glass–like appearance and 2-toned cytoplasm. A background mixed inflammatory infiltrate is present (H&E, original magnification ×200).

Solitary fibrous tumor (SFT) is an uncommon mesenchymal fibroblastic neoplasm that can arise at almost any anatomic site.24 Cutaneous SFTs are more common in women, most often involve the head, and appear to behave in an indolent manner.25 Solitary fibrous tumors are translocation-associated neoplasms with a NAB2-STAT6 gene fusion.26 The classic histology of SFT is a spindled fibroblastic proliferation arranged in a "patternless pattern" with interspersed stag horn-like, thin-walled blood vessels (Figure 4). Tumor cells usually are positive for CD34, CD99, and Bcl-2.27 In addition, STAT6 immunoreactivity is useful in diagnosis of SFT.25

Figure 4. Solitary fibrous tumor. A dense, bland, spindled, fibroblastic proliferation with a “patternless pattern” and collagenized stroma with interspersed branching vessels (H&E, original magnification ×200).

References
  1. Jones EW, Cerio R, Smith NP. Epithelioid cell histiocytoma: a new entity. Br J Dermatol. 1989;120:185-195. 
  2. Singh Gomez C, Calonje E, Fletcher CD. Epithelioid benign fibrous histiocytoma of skin: clinico-pathological analysis of 20 cases of a poorly known variant. Histopathology. 1994;24:123-129. 
  3. Felty CC, Linos K. Epithelioid fibrous histiocytoma: a concise review [published online October 4, 2018]. Am J Dermatopathol. doi:10.1097/DAD.0000000000001272. 
  4. Rawal YB, Kalmar JR, Shumway B, et al. Presentation of an epithelioid cell histiocytoma on the ventral tongue. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;100:75-83. 
  5. Cangelosi JJ, Prieto VG, Baker GF, et al. Unusual presentation of multiple epithelioid cell histiocytomas. Am J Dermatopathol. 2008;30:373-376. 
  6. Doyle LA, Marino-Enriquez A, Fletcher CD, et al. ALK rearrangement and overexpression in epithelioid fibrous histiocytoma. Mod Pathol. 2015;28:904-912. 
  7. Silverman JS, Glusac EJ. Epithelioid cell histiocytoma--histogenetic and kinetics analysis of dermal microvascular unit dendritic cell subpopulations. J Cutan Pathol. 2003;30:415-422. 
  8. Murigu T, Bhatt N, Miller K, et al. Spindle cell-predominant epithelioid fibrous histiocytoma. Histopathology. 2018;72:1233-1236. 
  9. Rabkin MS, Vukmer T. Granular cell variant of epithelioid cell histiocytoma. Am J Dermatopathol. 2012;34:766-769. 
  10. Glusac EJ, Barr RJ, Everett MA, et al. Epithelioid cell histiocytoma. a report of 10 cases including a new cellular variant. Am J Surg Pathol. 1994;18:583-590. 
  11. Creytens D, Ferdinande L, Van Dorpe J. ALK Rearrangement and overexpression in an unusual cutaneous epithelioid tumor with a peculiar whorled "perineurioma-like" growth pattern: epithelioid fibrous histiocytoma. Appl Immunohistochem Mol Morphol. 2017;25:E46-E48. 
  12. Doyle LA, Fletcher CD. EMA positivity in epithelioid fibrous histiocytoma: a potential diagnostic pitfall. J Cutan Pathol. 2011;38:697-703. 
  13. Fabrizi G, Massi G. Polypoid Spitz naevus: the benign counterpart of polypoid malignant melanoma. Br J Dermatol. 2000;142:128-132. 
  14. Plaza JA, De Stefano D, Suster S, et al. Intradermal Spitz nevi: a rare subtype of Spitz nevi analyzed in a clinicopathologic study of 74 cases. Am J Dermatopathol. 2014;36:283-294; quiz 295-287. 
  15. Menezes FD, Mooi WJ. Spitz tumors of the skin. Surg Pathol Clin. 2017;10:281-298. 
  16. Requena C, Requena L, Kutzner H, et al. Spitz nevus: a clinicopathological study of 349 cases. Am J Dermatopathol. 2009;31:107-116. 
  17. Mentzel T, Dei Tos AP, Sapi Z, et al. Myopericytoma of skin and soft tissues: clinicopathologic and immunohistochemical study of 54 cases. Am J Surg Pathol. 2006;30:104-113. 
  18. Aung PP, Goldberg LJ, Mahalingam M, et al. Cutaneous myopericytoma: a report of 3 cases and review of the literature. Dermatopathology (Basel). 2015;2:9-14. 
  19. Morzycki A, Joukhadar N, Murphy A, et al. Digital myopericytoma: a case report and systematic literature review. J Hand Microsurg. 2017;9:32-36. 
  20. LeBlanc RE, Taube J. Myofibroma, myopericytoma, myoepithelioma, and myofibroblastoma of skin and soft tissue. Surg Pathol Clin. 2011;4:745-759. 
  21. Chisolm SS, Schulman JM, Fox LP. Adult xanthogranuloma, reticulohistiocytosis, and Rosai-Dorfman disease. Dermatol Clin. 2015;33:465-472; discussion 473. 
  22. Miettinen M, Fetsch JF. Reticulohistiocytoma (solitary epithelioid histiocytoma): a clinicopathologic and immunohistochemical study of 44 cases. Am J Surg Pathol. 2006;30:521-528. 
  23. Cohen PR, Lee RA. Adult-onset reticulohistiocytoma presenting as a solitary asymptomatic red knee nodule: report and review of clinical presentations and immunohistochemistry staining features of reticulohistiocytosis. Dermatol Online J. 2014. pii:doj_21725. 
  24. Soldano AC, Meehan SA. Cutaneous solitary fibrous tumor: a report of 2 cases and review of the literature. Am J Dermatopathol. 2008;30:54-58. 
  25. Feasel P, Al-Ibraheemi A, Fritchie K, et al. Superficial solitary fibrous tumor: a series of 26 cases. Am J Surg Pathol. 2018;42:778-785. 
  26. Thway K, Ng W, Noujaim J, et al. The current status of solitary fibrous tumor: diagnostic features, variants, and genetics. Int J Surg Pathol. 2016;24:281-292. 
  27. Erdag G, Qureshi HS, Patterson JW, et al. Solitary fibrous tumors of the skin: a clinicopathologic study of 10 cases and review of the literature. J Cutan Pathol. 2007;34:844-850.
References
  1. Jones EW, Cerio R, Smith NP. Epithelioid cell histiocytoma: a new entity. Br J Dermatol. 1989;120:185-195. 
  2. Singh Gomez C, Calonje E, Fletcher CD. Epithelioid benign fibrous histiocytoma of skin: clinico-pathological analysis of 20 cases of a poorly known variant. Histopathology. 1994;24:123-129. 
  3. Felty CC, Linos K. Epithelioid fibrous histiocytoma: a concise review [published online October 4, 2018]. Am J Dermatopathol. doi:10.1097/DAD.0000000000001272. 
  4. Rawal YB, Kalmar JR, Shumway B, et al. Presentation of an epithelioid cell histiocytoma on the ventral tongue. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;100:75-83. 
  5. Cangelosi JJ, Prieto VG, Baker GF, et al. Unusual presentation of multiple epithelioid cell histiocytomas. Am J Dermatopathol. 2008;30:373-376. 
  6. Doyle LA, Marino-Enriquez A, Fletcher CD, et al. ALK rearrangement and overexpression in epithelioid fibrous histiocytoma. Mod Pathol. 2015;28:904-912. 
  7. Silverman JS, Glusac EJ. Epithelioid cell histiocytoma--histogenetic and kinetics analysis of dermal microvascular unit dendritic cell subpopulations. J Cutan Pathol. 2003;30:415-422. 
  8. Murigu T, Bhatt N, Miller K, et al. Spindle cell-predominant epithelioid fibrous histiocytoma. Histopathology. 2018;72:1233-1236. 
  9. Rabkin MS, Vukmer T. Granular cell variant of epithelioid cell histiocytoma. Am J Dermatopathol. 2012;34:766-769. 
  10. Glusac EJ, Barr RJ, Everett MA, et al. Epithelioid cell histiocytoma. a report of 10 cases including a new cellular variant. Am J Surg Pathol. 1994;18:583-590. 
  11. Creytens D, Ferdinande L, Van Dorpe J. ALK Rearrangement and overexpression in an unusual cutaneous epithelioid tumor with a peculiar whorled "perineurioma-like" growth pattern: epithelioid fibrous histiocytoma. Appl Immunohistochem Mol Morphol. 2017;25:E46-E48. 
  12. Doyle LA, Fletcher CD. EMA positivity in epithelioid fibrous histiocytoma: a potential diagnostic pitfall. J Cutan Pathol. 2011;38:697-703. 
  13. Fabrizi G, Massi G. Polypoid Spitz naevus: the benign counterpart of polypoid malignant melanoma. Br J Dermatol. 2000;142:128-132. 
  14. Plaza JA, De Stefano D, Suster S, et al. Intradermal Spitz nevi: a rare subtype of Spitz nevi analyzed in a clinicopathologic study of 74 cases. Am J Dermatopathol. 2014;36:283-294; quiz 295-287. 
  15. Menezes FD, Mooi WJ. Spitz tumors of the skin. Surg Pathol Clin. 2017;10:281-298. 
  16. Requena C, Requena L, Kutzner H, et al. Spitz nevus: a clinicopathological study of 349 cases. Am J Dermatopathol. 2009;31:107-116. 
  17. Mentzel T, Dei Tos AP, Sapi Z, et al. Myopericytoma of skin and soft tissues: clinicopathologic and immunohistochemical study of 54 cases. Am J Surg Pathol. 2006;30:104-113. 
  18. Aung PP, Goldberg LJ, Mahalingam M, et al. Cutaneous myopericytoma: a report of 3 cases and review of the literature. Dermatopathology (Basel). 2015;2:9-14. 
  19. Morzycki A, Joukhadar N, Murphy A, et al. Digital myopericytoma: a case report and systematic literature review. J Hand Microsurg. 2017;9:32-36. 
  20. LeBlanc RE, Taube J. Myofibroma, myopericytoma, myoepithelioma, and myofibroblastoma of skin and soft tissue. Surg Pathol Clin. 2011;4:745-759. 
  21. Chisolm SS, Schulman JM, Fox LP. Adult xanthogranuloma, reticulohistiocytosis, and Rosai-Dorfman disease. Dermatol Clin. 2015;33:465-472; discussion 473. 
  22. Miettinen M, Fetsch JF. Reticulohistiocytoma (solitary epithelioid histiocytoma): a clinicopathologic and immunohistochemical study of 44 cases. Am J Surg Pathol. 2006;30:521-528. 
  23. Cohen PR, Lee RA. Adult-onset reticulohistiocytoma presenting as a solitary asymptomatic red knee nodule: report and review of clinical presentations and immunohistochemistry staining features of reticulohistiocytosis. Dermatol Online J. 2014. pii:doj_21725. 
  24. Soldano AC, Meehan SA. Cutaneous solitary fibrous tumor: a report of 2 cases and review of the literature. Am J Dermatopathol. 2008;30:54-58. 
  25. Feasel P, Al-Ibraheemi A, Fritchie K, et al. Superficial solitary fibrous tumor: a series of 26 cases. Am J Surg Pathol. 2018;42:778-785. 
  26. Thway K, Ng W, Noujaim J, et al. The current status of solitary fibrous tumor: diagnostic features, variants, and genetics. Int J Surg Pathol. 2016;24:281-292. 
  27. Erdag G, Qureshi HS, Patterson JW, et al. Solitary fibrous tumors of the skin: a clinicopathologic study of 10 cases and review of the literature. J Cutan Pathol. 2007;34:844-850.
Issue
Cutis - 104(3)
Issue
Cutis - 104(3)
Page Number
173, 187-188
Page Number
173, 187-188
Publications
Publications
Topics
Article Type
Display Headline
Solitary Papule on the Leg
Display Headline
Solitary Papule on the Leg
Sections
Questionnaire Body

H&E, original magnifications ×40 (top) and ×200 (bottom).

A 28-year-old man presented with a growing asymptomatic papule on the right leg. 

Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Wed, 09/11/2019 - 11:30
Un-Gate On Date
Wed, 09/11/2019 - 11:30
Use ProPublica
CFC Schedule Remove Status
Wed, 09/11/2019 - 11:30
Hide sidebar & use full width
render the right sidebar.
Article PDF Media

Pigmented Mass on the Shoulder

Article Type
Changed
Mon, 08/19/2019 - 11:52
Display Headline
Pigmented Mass on the Shoulder

The Diagnosis: Pigmented Dermatofibrosarcoma Protuberans  

Pigmented dermatofibrosarcoma protuberans (PDFSP), also known as Bednar tumor, is an uncommon variant of dermatofibrosarcoma protuberans (DFSP). Pigmented dermatofibrosarcoma protuberans constitutes 1% to 5% of all DFSP cases and most commonly is seen in nonwhite adults in the fourth decade of life, with occasional cases seen in pediatric patients, including some congenital cases. Typical sites of involvement include the shoulders, trunk, arms, legs, head, and neck.1,2 It also has been reported at sites of prior immunization, trauma, and insect bites.3  

Histopathologic examination of our patient's shoulder nodule revealed an infiltrative neoplasm in the dermis and subcutaneous tissue composed of spindled cells with a storiform pattern and foci of scattered elongated dendritic pigmented cells. A narrow grenz zone separated the tumor from the epidermis, and characteristic honeycomb infiltration by tumor cells was noted in the subcutaneous fat. The nuclei were bland and monomorphous with areas of neuroid differentiation containing whorls and nerve cord-like structures (quiz image). The tumor cells were diffusely CD34 and vimentin positive, while S-100, SOX-10, neurofilament, smooth muscle actin, desmin, epithelial membrane antigen, and cytokeratins were negative. The immunophenotype excluded the possibility of neurogenic, pericytic, myofibroblastic, and myoid differentiation.  

Wang and Yang4 previously reported a case of PDFSP with prominent meningothelial-like whorls focally resembling extracranial meningioma; however, the tumor cells were CD34 positive and epithelial membrane antigen negative, weighing against a diagnosis of meningioma. Most cases of PDFSP demonstrate the COL1A1-PDGFB (collagen type I α; 1/platelet-derived growth factor B-chain) fusion protein caused by the translocation t(17;22)(q22;q13), as in classic DFSP.5  

Cellular blue nevus (CBN) is a benign melanocytic neoplasm that can present at any age and often occurs on the buttocks and in the sacrococcygeal region. Clinically, CBN presents as a firm, bluish black to bluish gray, dome-shaped nodule. The size varies from a few millimeters to several centimeters.6,7 Histologically, CBN is located completely in the dermis, extending along the adnexae into the subcutaneous tissue with a dumbbell-shaped outline (Figure 1).6-8 The tumor demonstrates oval epithelioid melanocytes with vesicular nuclei and prominent nucleoli. Immunohistochemically, tumor cells stain positively for melanocytic markers such as S-100, SOX-10, MART-1, and human melanoma black 45. CD34 expression rarely is reported in a subset of CBN.9  

Figure 1. Cellular blue nevus. Cellular areas extending to the deep subcutaneous tissue with a blunt outline. The spindled oval melanocytes show clear or pigmented cytoplasm (H&E, original magnification ×40 [inset, original magnification ×200]).

Pigmented neurofibroma is a rare variant of neurofibroma that produces melanin pigment and has a strong association with neurofibromatosis.10 It occurs most frequently in dark-skinned populations (Fitzpatrick skin types IV-VI). The most common location is the head and neck region.11,12 Histologically, pigmented neurofibroma resembles a diffuse neurofibroma admixed with melanin-producing cells (Figure 2).12 Immunostaining shows positivity for S-100 in both pigmented and Schwann cells; however, the pigmented cells stain positively for human melanoma black 45, Melan-A, and tyrosinase.10 CD34 can be fingerprint positive in neurofibroma, but a distinction from DFSP can be made by S-100 and SOX-10 immunostaining.13 

Figure 2. Pigmented neurofibroma. Diffuse haphazard spindle cells with S-shaped nuclei embedded in a loose pale stroma deep in the adipose tissue, admixed with melanin-producing cells and scattered mast cells (H&E, original magnification ×200).

Desmoplastic melanoma (DM) is an uncommon variant of malignant melanoma and has a higher tendency for persistent local growth and less frequent metastases than other variants of melanoma. It has a predilection for chronically sun-exposed areas such as the head and neck and occurs later in life. Clinically, DM appears as nonspecific, often amelanotic nodules or plaques or as scarlike lesions.14 Histologically, DM can be classified as mixed or pure based on the degree of desmoplasia and cellularity. A paucicellular proliferation of malignant spindled melanocytes within a densely fibrotic stroma with lymphoid nodules in the dermis is characteristic (Figure 3); perineural involvement is common.14,15 The most reliable confirmative stains are S-100 and SOX-10.16 

Figure 3. Desmoplastic melanoma. Diffusely infiltrative growth of spindled melanocytes within a fibrotic stroma expanding into the subcutaneous tissue. Nodular lymphoid aggregates are present (H&E, original magnification ×100).

Cutaneous meningioma is a rare tumor and could be subtyped into 3 groups. Type I is primary cutaneous meningioma and usually is present at birth on the scalp and paravertebral regions with a relatively good prognosis. Type II is ectopic soft-tissue meningioma that extends into the skin from around the sensory organs on the face. Type III is local invasion or true metastasis from a central nervous system meningioma. Types II and III develop later in life and the prognosis is poor.17,18 Clinically, lesions present as firm subcutaneous nodules or swellings. Cutaneous meningioma has several histopathologic variants. The classic presentation reveals concentric wrapping of tumor cells with round-oval nuclei containing delicate chromatin. Psammoma bodies are a common finding (Figure 4). Immunohistochemically, tumor cells are diffusely positive for epithelial membrane antigen and vimentin.18,19 

Figure 4. Cutaneous meningioma. Tumor cells concentrically wrapping in whorls. The cells demonstrate round-oval nuclei, and psammoma bodies of lamellate calcification are easily found (H&E, original magnification ×200).

References
  1. Amonkar GP, Rupani A, Shah A, et al. Bednar tumor: an uncommon entity. Dermatopathology (Basel). 2016;3:36-38. 
  2. El Hachem M, Diociaiuti A, Latella E, et al. Congenital myxoid and pigmented dermatofibrosarcoma protuberans: a case report. Pediatr Dermatol. 2013;30:E74-E77. 
  3. Anon-Requena MJ, Pico-Valimana M, Munoz-Arias G. Bednar tumor (pigmented dermatofibrosarcoma protuberans). Actas Dermosifiliogr. 2016;107:618-620. 
  4. Wang J, Yang W. Pigmented dermatofibrosarcoma protuberans with prominent meningothelial-like whorls. J Cutan Pathol. 2008;35(suppl 1):65-69. 
  5. Zardawi IM, Kattampallil J, Rode J. An unusual pigmented skin tumour. Bednar tumour, dorsum of left foot (pigmented dermatofibrosarcoma protuberans). Pathology. 2004;36:358-361. 
  6. Sugianto JZ, Ralston JS, Metcalf JS, et al. Blue nevus and "malignant blue nevus": a concise review. Semin Diagn Pathol. 2016;33:219-224. 
  7. Zembowicz A. Blue nevi and related tumors. Clin Lab Med. 2017;37:401-415. 
  8. Zembowicz A, Granter SR, McKee PH, et al. Amelanotic cellular blue nevus: a hypopigmented variant of the cellular blue nevus: clinicopathologic analysis of 20 cases. Am J Surg Pathol. 2002;26:1493-1500. 
  9. Smith K, Germain M, Williams J, et al. CD34-positive cellular blue nevi. J Cutan Pathol. 2001;28:145-150. 
  10. Inaba M, Yamamoto T, Minami R, et al. Pigmented neurofibroma: report of two cases and literature review. Pathol Int. 2001;51:565-569. 
  11. Fetsch JF, Michal M, Miettinen M. Pigmented (melanotic) neurofibroma: a clinicopathologic and immunohistochemical analysis of 19 lesions from 17 patients. Am J Surg Pathol. 2000;24:331-343. 
  12. Motoi T, Ishida T, Kawato A, et al. Pigmented neurofibroma: review of Japanese patients with an analysis of melanogenesis demonstrating coexpression of c-met protooncogene and microphthalmia-associated transcription factor. Hum Pathol. 2005;36:871-877. 
  13. Yeh I, McCalmont TH. Distinguishing neurofibroma from desmoplastic melanoma: the value of the CD34 fingerprint. J Cutan Pathol. 2011;38:625-630. 
  14. Chen LL, Jaimes N, Barker CA, et al. Desmoplastic melanoma: a review. J Am Acad Dermatol. 2013;68:825-833. 
  15. Busam KJ. Desmoplastic melanoma. Clin Lab Med. 2011;31:321-330. 
  16. Schleich C, Ferringer T. Desmoplastic melanoma. Cutis. 2015;96:306, 313-314, 335. 
  17. Lopez DA, Silvers DN, Helwig EB. Cutaneous meningiomas--a clinicopathologic study. Cancer. 1974;34:728-744. 
  18. Miedema JR, Zedek D. Cutaneous meningioma. Arch Pathol Lab Med. 2012;136:208-211. 
  19. Bhanusali DG, Heath C, Gur D, et al. Metastatic meningioma of the scalp. Cutis. 2018;101:386-389.
Article PDF
Author and Disclosure Information

Drs. Q. Wu, Y. Wu, and Ju are from the Department of Dermatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. Dr. Yang is from the Department of Pathology, St. Vincent Evansville Medical Center, Indiana. Dr. Elston is from the Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, Charleston.

The authors report no conflict of interest.

Correspondence: Qiang Ju, MD, Department of Dermatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Pujian Rd 160, Shanghai 200127, China (Qiangju401@sina.com).

Issue
Cutis - 104(2)
Publications
Topics
Page Number
102, 106-107
Sections
Author and Disclosure Information

Drs. Q. Wu, Y. Wu, and Ju are from the Department of Dermatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. Dr. Yang is from the Department of Pathology, St. Vincent Evansville Medical Center, Indiana. Dr. Elston is from the Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, Charleston.

The authors report no conflict of interest.

Correspondence: Qiang Ju, MD, Department of Dermatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Pujian Rd 160, Shanghai 200127, China (Qiangju401@sina.com).

Author and Disclosure Information

Drs. Q. Wu, Y. Wu, and Ju are from the Department of Dermatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. Dr. Yang is from the Department of Pathology, St. Vincent Evansville Medical Center, Indiana. Dr. Elston is from the Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, Charleston.

The authors report no conflict of interest.

Correspondence: Qiang Ju, MD, Department of Dermatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Pujian Rd 160, Shanghai 200127, China (Qiangju401@sina.com).

Article PDF
Article PDF
Related Articles

The Diagnosis: Pigmented Dermatofibrosarcoma Protuberans  

Pigmented dermatofibrosarcoma protuberans (PDFSP), also known as Bednar tumor, is an uncommon variant of dermatofibrosarcoma protuberans (DFSP). Pigmented dermatofibrosarcoma protuberans constitutes 1% to 5% of all DFSP cases and most commonly is seen in nonwhite adults in the fourth decade of life, with occasional cases seen in pediatric patients, including some congenital cases. Typical sites of involvement include the shoulders, trunk, arms, legs, head, and neck.1,2 It also has been reported at sites of prior immunization, trauma, and insect bites.3  

Histopathologic examination of our patient's shoulder nodule revealed an infiltrative neoplasm in the dermis and subcutaneous tissue composed of spindled cells with a storiform pattern and foci of scattered elongated dendritic pigmented cells. A narrow grenz zone separated the tumor from the epidermis, and characteristic honeycomb infiltration by tumor cells was noted in the subcutaneous fat. The nuclei were bland and monomorphous with areas of neuroid differentiation containing whorls and nerve cord-like structures (quiz image). The tumor cells were diffusely CD34 and vimentin positive, while S-100, SOX-10, neurofilament, smooth muscle actin, desmin, epithelial membrane antigen, and cytokeratins were negative. The immunophenotype excluded the possibility of neurogenic, pericytic, myofibroblastic, and myoid differentiation.  

Wang and Yang4 previously reported a case of PDFSP with prominent meningothelial-like whorls focally resembling extracranial meningioma; however, the tumor cells were CD34 positive and epithelial membrane antigen negative, weighing against a diagnosis of meningioma. Most cases of PDFSP demonstrate the COL1A1-PDGFB (collagen type I α; 1/platelet-derived growth factor B-chain) fusion protein caused by the translocation t(17;22)(q22;q13), as in classic DFSP.5  

Cellular blue nevus (CBN) is a benign melanocytic neoplasm that can present at any age and often occurs on the buttocks and in the sacrococcygeal region. Clinically, CBN presents as a firm, bluish black to bluish gray, dome-shaped nodule. The size varies from a few millimeters to several centimeters.6,7 Histologically, CBN is located completely in the dermis, extending along the adnexae into the subcutaneous tissue with a dumbbell-shaped outline (Figure 1).6-8 The tumor demonstrates oval epithelioid melanocytes with vesicular nuclei and prominent nucleoli. Immunohistochemically, tumor cells stain positively for melanocytic markers such as S-100, SOX-10, MART-1, and human melanoma black 45. CD34 expression rarely is reported in a subset of CBN.9  

Figure 1. Cellular blue nevus. Cellular areas extending to the deep subcutaneous tissue with a blunt outline. The spindled oval melanocytes show clear or pigmented cytoplasm (H&E, original magnification ×40 [inset, original magnification ×200]).

Pigmented neurofibroma is a rare variant of neurofibroma that produces melanin pigment and has a strong association with neurofibromatosis.10 It occurs most frequently in dark-skinned populations (Fitzpatrick skin types IV-VI). The most common location is the head and neck region.11,12 Histologically, pigmented neurofibroma resembles a diffuse neurofibroma admixed with melanin-producing cells (Figure 2).12 Immunostaining shows positivity for S-100 in both pigmented and Schwann cells; however, the pigmented cells stain positively for human melanoma black 45, Melan-A, and tyrosinase.10 CD34 can be fingerprint positive in neurofibroma, but a distinction from DFSP can be made by S-100 and SOX-10 immunostaining.13 

Figure 2. Pigmented neurofibroma. Diffuse haphazard spindle cells with S-shaped nuclei embedded in a loose pale stroma deep in the adipose tissue, admixed with melanin-producing cells and scattered mast cells (H&E, original magnification ×200).

Desmoplastic melanoma (DM) is an uncommon variant of malignant melanoma and has a higher tendency for persistent local growth and less frequent metastases than other variants of melanoma. It has a predilection for chronically sun-exposed areas such as the head and neck and occurs later in life. Clinically, DM appears as nonspecific, often amelanotic nodules or plaques or as scarlike lesions.14 Histologically, DM can be classified as mixed or pure based on the degree of desmoplasia and cellularity. A paucicellular proliferation of malignant spindled melanocytes within a densely fibrotic stroma with lymphoid nodules in the dermis is characteristic (Figure 3); perineural involvement is common.14,15 The most reliable confirmative stains are S-100 and SOX-10.16 

Figure 3. Desmoplastic melanoma. Diffusely infiltrative growth of spindled melanocytes within a fibrotic stroma expanding into the subcutaneous tissue. Nodular lymphoid aggregates are present (H&E, original magnification ×100).

Cutaneous meningioma is a rare tumor and could be subtyped into 3 groups. Type I is primary cutaneous meningioma and usually is present at birth on the scalp and paravertebral regions with a relatively good prognosis. Type II is ectopic soft-tissue meningioma that extends into the skin from around the sensory organs on the face. Type III is local invasion or true metastasis from a central nervous system meningioma. Types II and III develop later in life and the prognosis is poor.17,18 Clinically, lesions present as firm subcutaneous nodules or swellings. Cutaneous meningioma has several histopathologic variants. The classic presentation reveals concentric wrapping of tumor cells with round-oval nuclei containing delicate chromatin. Psammoma bodies are a common finding (Figure 4). Immunohistochemically, tumor cells are diffusely positive for epithelial membrane antigen and vimentin.18,19 

Figure 4. Cutaneous meningioma. Tumor cells concentrically wrapping in whorls. The cells demonstrate round-oval nuclei, and psammoma bodies of lamellate calcification are easily found (H&E, original magnification ×200).

The Diagnosis: Pigmented Dermatofibrosarcoma Protuberans  

Pigmented dermatofibrosarcoma protuberans (PDFSP), also known as Bednar tumor, is an uncommon variant of dermatofibrosarcoma protuberans (DFSP). Pigmented dermatofibrosarcoma protuberans constitutes 1% to 5% of all DFSP cases and most commonly is seen in nonwhite adults in the fourth decade of life, with occasional cases seen in pediatric patients, including some congenital cases. Typical sites of involvement include the shoulders, trunk, arms, legs, head, and neck.1,2 It also has been reported at sites of prior immunization, trauma, and insect bites.3  

Histopathologic examination of our patient's shoulder nodule revealed an infiltrative neoplasm in the dermis and subcutaneous tissue composed of spindled cells with a storiform pattern and foci of scattered elongated dendritic pigmented cells. A narrow grenz zone separated the tumor from the epidermis, and characteristic honeycomb infiltration by tumor cells was noted in the subcutaneous fat. The nuclei were bland and monomorphous with areas of neuroid differentiation containing whorls and nerve cord-like structures (quiz image). The tumor cells were diffusely CD34 and vimentin positive, while S-100, SOX-10, neurofilament, smooth muscle actin, desmin, epithelial membrane antigen, and cytokeratins were negative. The immunophenotype excluded the possibility of neurogenic, pericytic, myofibroblastic, and myoid differentiation.  

Wang and Yang4 previously reported a case of PDFSP with prominent meningothelial-like whorls focally resembling extracranial meningioma; however, the tumor cells were CD34 positive and epithelial membrane antigen negative, weighing against a diagnosis of meningioma. Most cases of PDFSP demonstrate the COL1A1-PDGFB (collagen type I α; 1/platelet-derived growth factor B-chain) fusion protein caused by the translocation t(17;22)(q22;q13), as in classic DFSP.5  

Cellular blue nevus (CBN) is a benign melanocytic neoplasm that can present at any age and often occurs on the buttocks and in the sacrococcygeal region. Clinically, CBN presents as a firm, bluish black to bluish gray, dome-shaped nodule. The size varies from a few millimeters to several centimeters.6,7 Histologically, CBN is located completely in the dermis, extending along the adnexae into the subcutaneous tissue with a dumbbell-shaped outline (Figure 1).6-8 The tumor demonstrates oval epithelioid melanocytes with vesicular nuclei and prominent nucleoli. Immunohistochemically, tumor cells stain positively for melanocytic markers such as S-100, SOX-10, MART-1, and human melanoma black 45. CD34 expression rarely is reported in a subset of CBN.9  

Figure 1. Cellular blue nevus. Cellular areas extending to the deep subcutaneous tissue with a blunt outline. The spindled oval melanocytes show clear or pigmented cytoplasm (H&E, original magnification ×40 [inset, original magnification ×200]).

Pigmented neurofibroma is a rare variant of neurofibroma that produces melanin pigment and has a strong association with neurofibromatosis.10 It occurs most frequently in dark-skinned populations (Fitzpatrick skin types IV-VI). The most common location is the head and neck region.11,12 Histologically, pigmented neurofibroma resembles a diffuse neurofibroma admixed with melanin-producing cells (Figure 2).12 Immunostaining shows positivity for S-100 in both pigmented and Schwann cells; however, the pigmented cells stain positively for human melanoma black 45, Melan-A, and tyrosinase.10 CD34 can be fingerprint positive in neurofibroma, but a distinction from DFSP can be made by S-100 and SOX-10 immunostaining.13 

Figure 2. Pigmented neurofibroma. Diffuse haphazard spindle cells with S-shaped nuclei embedded in a loose pale stroma deep in the adipose tissue, admixed with melanin-producing cells and scattered mast cells (H&E, original magnification ×200).

Desmoplastic melanoma (DM) is an uncommon variant of malignant melanoma and has a higher tendency for persistent local growth and less frequent metastases than other variants of melanoma. It has a predilection for chronically sun-exposed areas such as the head and neck and occurs later in life. Clinically, DM appears as nonspecific, often amelanotic nodules or plaques or as scarlike lesions.14 Histologically, DM can be classified as mixed or pure based on the degree of desmoplasia and cellularity. A paucicellular proliferation of malignant spindled melanocytes within a densely fibrotic stroma with lymphoid nodules in the dermis is characteristic (Figure 3); perineural involvement is common.14,15 The most reliable confirmative stains are S-100 and SOX-10.16 

Figure 3. Desmoplastic melanoma. Diffusely infiltrative growth of spindled melanocytes within a fibrotic stroma expanding into the subcutaneous tissue. Nodular lymphoid aggregates are present (H&E, original magnification ×100).

Cutaneous meningioma is a rare tumor and could be subtyped into 3 groups. Type I is primary cutaneous meningioma and usually is present at birth on the scalp and paravertebral regions with a relatively good prognosis. Type II is ectopic soft-tissue meningioma that extends into the skin from around the sensory organs on the face. Type III is local invasion or true metastasis from a central nervous system meningioma. Types II and III develop later in life and the prognosis is poor.17,18 Clinically, lesions present as firm subcutaneous nodules or swellings. Cutaneous meningioma has several histopathologic variants. The classic presentation reveals concentric wrapping of tumor cells with round-oval nuclei containing delicate chromatin. Psammoma bodies are a common finding (Figure 4). Immunohistochemically, tumor cells are diffusely positive for epithelial membrane antigen and vimentin.18,19 

Figure 4. Cutaneous meningioma. Tumor cells concentrically wrapping in whorls. The cells demonstrate round-oval nuclei, and psammoma bodies of lamellate calcification are easily found (H&E, original magnification ×200).

References
  1. Amonkar GP, Rupani A, Shah A, et al. Bednar tumor: an uncommon entity. Dermatopathology (Basel). 2016;3:36-38. 
  2. El Hachem M, Diociaiuti A, Latella E, et al. Congenital myxoid and pigmented dermatofibrosarcoma protuberans: a case report. Pediatr Dermatol. 2013;30:E74-E77. 
  3. Anon-Requena MJ, Pico-Valimana M, Munoz-Arias G. Bednar tumor (pigmented dermatofibrosarcoma protuberans). Actas Dermosifiliogr. 2016;107:618-620. 
  4. Wang J, Yang W. Pigmented dermatofibrosarcoma protuberans with prominent meningothelial-like whorls. J Cutan Pathol. 2008;35(suppl 1):65-69. 
  5. Zardawi IM, Kattampallil J, Rode J. An unusual pigmented skin tumour. Bednar tumour, dorsum of left foot (pigmented dermatofibrosarcoma protuberans). Pathology. 2004;36:358-361. 
  6. Sugianto JZ, Ralston JS, Metcalf JS, et al. Blue nevus and "malignant blue nevus": a concise review. Semin Diagn Pathol. 2016;33:219-224. 
  7. Zembowicz A. Blue nevi and related tumors. Clin Lab Med. 2017;37:401-415. 
  8. Zembowicz A, Granter SR, McKee PH, et al. Amelanotic cellular blue nevus: a hypopigmented variant of the cellular blue nevus: clinicopathologic analysis of 20 cases. Am J Surg Pathol. 2002;26:1493-1500. 
  9. Smith K, Germain M, Williams J, et al. CD34-positive cellular blue nevi. J Cutan Pathol. 2001;28:145-150. 
  10. Inaba M, Yamamoto T, Minami R, et al. Pigmented neurofibroma: report of two cases and literature review. Pathol Int. 2001;51:565-569. 
  11. Fetsch JF, Michal M, Miettinen M. Pigmented (melanotic) neurofibroma: a clinicopathologic and immunohistochemical analysis of 19 lesions from 17 patients. Am J Surg Pathol. 2000;24:331-343. 
  12. Motoi T, Ishida T, Kawato A, et al. Pigmented neurofibroma: review of Japanese patients with an analysis of melanogenesis demonstrating coexpression of c-met protooncogene and microphthalmia-associated transcription factor. Hum Pathol. 2005;36:871-877. 
  13. Yeh I, McCalmont TH. Distinguishing neurofibroma from desmoplastic melanoma: the value of the CD34 fingerprint. J Cutan Pathol. 2011;38:625-630. 
  14. Chen LL, Jaimes N, Barker CA, et al. Desmoplastic melanoma: a review. J Am Acad Dermatol. 2013;68:825-833. 
  15. Busam KJ. Desmoplastic melanoma. Clin Lab Med. 2011;31:321-330. 
  16. Schleich C, Ferringer T. Desmoplastic melanoma. Cutis. 2015;96:306, 313-314, 335. 
  17. Lopez DA, Silvers DN, Helwig EB. Cutaneous meningiomas--a clinicopathologic study. Cancer. 1974;34:728-744. 
  18. Miedema JR, Zedek D. Cutaneous meningioma. Arch Pathol Lab Med. 2012;136:208-211. 
  19. Bhanusali DG, Heath C, Gur D, et al. Metastatic meningioma of the scalp. Cutis. 2018;101:386-389.
References
  1. Amonkar GP, Rupani A, Shah A, et al. Bednar tumor: an uncommon entity. Dermatopathology (Basel). 2016;3:36-38. 
  2. El Hachem M, Diociaiuti A, Latella E, et al. Congenital myxoid and pigmented dermatofibrosarcoma protuberans: a case report. Pediatr Dermatol. 2013;30:E74-E77. 
  3. Anon-Requena MJ, Pico-Valimana M, Munoz-Arias G. Bednar tumor (pigmented dermatofibrosarcoma protuberans). Actas Dermosifiliogr. 2016;107:618-620. 
  4. Wang J, Yang W. Pigmented dermatofibrosarcoma protuberans with prominent meningothelial-like whorls. J Cutan Pathol. 2008;35(suppl 1):65-69. 
  5. Zardawi IM, Kattampallil J, Rode J. An unusual pigmented skin tumour. Bednar tumour, dorsum of left foot (pigmented dermatofibrosarcoma protuberans). Pathology. 2004;36:358-361. 
  6. Sugianto JZ, Ralston JS, Metcalf JS, et al. Blue nevus and "malignant blue nevus": a concise review. Semin Diagn Pathol. 2016;33:219-224. 
  7. Zembowicz A. Blue nevi and related tumors. Clin Lab Med. 2017;37:401-415. 
  8. Zembowicz A, Granter SR, McKee PH, et al. Amelanotic cellular blue nevus: a hypopigmented variant of the cellular blue nevus: clinicopathologic analysis of 20 cases. Am J Surg Pathol. 2002;26:1493-1500. 
  9. Smith K, Germain M, Williams J, et al. CD34-positive cellular blue nevi. J Cutan Pathol. 2001;28:145-150. 
  10. Inaba M, Yamamoto T, Minami R, et al. Pigmented neurofibroma: report of two cases and literature review. Pathol Int. 2001;51:565-569. 
  11. Fetsch JF, Michal M, Miettinen M. Pigmented (melanotic) neurofibroma: a clinicopathologic and immunohistochemical analysis of 19 lesions from 17 patients. Am J Surg Pathol. 2000;24:331-343. 
  12. Motoi T, Ishida T, Kawato A, et al. Pigmented neurofibroma: review of Japanese patients with an analysis of melanogenesis demonstrating coexpression of c-met protooncogene and microphthalmia-associated transcription factor. Hum Pathol. 2005;36:871-877. 
  13. Yeh I, McCalmont TH. Distinguishing neurofibroma from desmoplastic melanoma: the value of the CD34 fingerprint. J Cutan Pathol. 2011;38:625-630. 
  14. Chen LL, Jaimes N, Barker CA, et al. Desmoplastic melanoma: a review. J Am Acad Dermatol. 2013;68:825-833. 
  15. Busam KJ. Desmoplastic melanoma. Clin Lab Med. 2011;31:321-330. 
  16. Schleich C, Ferringer T. Desmoplastic melanoma. Cutis. 2015;96:306, 313-314, 335. 
  17. Lopez DA, Silvers DN, Helwig EB. Cutaneous meningiomas--a clinicopathologic study. Cancer. 1974;34:728-744. 
  18. Miedema JR, Zedek D. Cutaneous meningioma. Arch Pathol Lab Med. 2012;136:208-211. 
  19. Bhanusali DG, Heath C, Gur D, et al. Metastatic meningioma of the scalp. Cutis. 2018;101:386-389.
Issue
Cutis - 104(2)
Issue
Cutis - 104(2)
Page Number
102, 106-107
Page Number
102, 106-107
Publications
Publications
Topics
Article Type
Display Headline
Pigmented Mass on the Shoulder
Display Headline
Pigmented Mass on the Shoulder
Sections
Questionnaire Body

A 37-year-old woman presented with an asymptomatic, indurated, pigmented, subcutaneous nodule on the right shoulder of more than 3 years' duration. The lesion had gradually increased in size with no associated symptoms. The patient had a history of endometrial adenocarcinoma and papillary thyroid carcinoma, which had been treated by hysterectomy-oophorectomy and right thyroidectomy, respectively. She had no other notable systemic abnormalities, and there was no family history of genetic disease or cancer. Physical examination demonstrated a 1.2×1.8-cm nontender, pigmented, subcutaneous nodule with a rough surface and indistinct borders. An excisional biopsy was performed.

Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Wed, 08/14/2019 - 16:00
Un-Gate On Date
Wed, 08/14/2019 - 16:00
Use ProPublica
CFC Schedule Remove Status
Wed, 08/14/2019 - 16:00
Hide sidebar & use full width
render the right sidebar.
Article PDF Media

Ill-Defined Macule on the Abdomen

Article Type
Changed
Thu, 07/18/2019 - 11:31
Display Headline
Ill-Defined Macule on the Abdomen

The Diagnosis: Microvenular Hemangioma  

Microvenular hemangioma is an acquired benign vascular neoplasm that was described by Hunt et al1 in 1991, though Bantel et al2 reported a similar entity termed micropapillary angioma in 1989. Microvenular hemangioma typically presents as a solitary, slowly enlarging, red to violaceous, asymptomatic papule, plaque, or nodule measuring 5 to 20 mm in diameter. It usually is located on the trunk, arms, or legs of young adults without any gender predilection. Microvenular hemangioma is rare.3 The etiology has not been elucidated, though a relationship with hormonal factors such as pregnancy or hormonal contraceptives has been described.2  

Histopathologically, microvenular hemangioma has a characteristic morphology. It is comprised of a well-circumscribed collection of thin-walled blood vessels with narrow lumens (quiz image).4 The blood vessels tend to infiltrate the superficial and deep dermis and are surrounded by a collagenous or desmoplastic stroma. The endothelial cells are normal in size without atypia, mitotic figures, or pleomorphism. A mild lymphoplasmacytic inflammatory infiltrate sometimes is present. Microvenular hemangioma expresses many vascular markers confirming its endothelial origin, including CD34, CD31, WT1, factor VIII-related antigen, and von Willebrand factor.3 Moreover, WT1 staining suggests the lesion is a vascular proliferative growth, as it usually is negative in vascular malformations due to errors of endothelial development.5 In addition, it lacks expression of podoplanin (D2-40), which also supports a vascular as opposed to a lymphatic origin.4  

Cutaneous angiosarcoma is a rare and highly aggressive malignant neoplasm of the vascular endothelium with a predilection for the skin and superficial soft tissue. Clinical presentation is variable, as it can arise sporadically, commonly on the scalp and face of elderly patients, in areas of chronic radiation therapy, or in association with chronic lymphedema (Stewart-Treves syndrome).6 Sporadic neoplasms appear clinically as purpuric macules, plaques, or nodules and are more common in elderly men than women. They are aggressive tumors that tend to recur and metastasize despite aggressive therapy and therefore carry a poor prognosis.7 Histopathologically, well-differentiated tumors are characterized by irregular dissecting vessels lined with crowded inconspicuous endothelial cells (Figure 1). Cutaneous angiosarcoma is poorly circumscribed with marked cytologic atypia, and the vessels can take on a sinusoidal growth pattern.

Figure 1. Cutaneous angiosarcoma. Dermal proliferation of irregular dissecting vessels lined with crowded inconspicuous endothelial cells (H&E, original magnification ×200).

Kaposi sarcoma (KS) is a virally induced lymphoangioproliferative disease, with human herpesvirus 8 as the implicated agent. There are 4 principal clinical variants of KS: epidemic or AIDS-associated KS, endemic or African KS, KS due to iatrogenic immunosuppression, and Mediterranean or classic KS.9 Cutaneous lesions vary from pink patches to dark purple plaques or nodules that commonly occur on the lower legs10; however, the clinical appearance of KS varies depending on the clinical variant and stage. Histopathologically, early lesions of KS exhibit a superficial dermal proliferation of small angulated and jagged vessels that tend to separate into collagen bundles and are surrounded by a lymphoplasmacytic perivascular infiltrate. These native vascular structures often are surrounded by more ectatic neoplastic channels with plump endothelial cells, known as the promontory sign (Figure 2).11 With more advanced lesions, the proliferation of slitlike vessels becomes more cellular and extends deeper into the dermis and subcutis. Although the histopathologic features vary with the stage of the lesion, they do not notably vary between clinical subtypes. 

Figure 2. Kaposi sarcoma. Angulated and jagged vessels surrounded by a lymphoplasmacytic perivascular infiltrate and ectatic neoplastic channels, known as the promontory sign (H&E, original magnification ×200).

Targetoid hemosiderotic hemangioma, also known as hobnail hemangioma, is a small, benign, vascular tumor that usually affects the trunk, arms, and legs in young to middle-aged adults without a gender predilection. Clinically, it appears as a small, solitary, red to purple papule or macule that typically is surrounded by a pale thin area and a peripheral ecchymotic ring, creating a targetoid appearance, thus the term targetoid hemosiderotic hemangioma.12 Histopathologically, there is a prominent dermal vascular proliferation. In the papillary dermis, there are dilated superficial vessels lined with a single layer of endothelial cells characterized by a plump, hobnail-like appearance that protrude into the lumen (Figure 3). In the deeper dermis, the vascular spaces are angulated and slitlike and appear to dissect through collagen bundles. Hemosiderin, thrombi, extravasated erythrocytes, and a lymphocytic infiltrate also are often seen.13  

Figure 3. Targetoid hemosiderotic hemangioma. Dilated superficial vessels lined by plump, hobnail-like endothelial cells that protrude into the lumen (H&E, original magnification ×200).

Tufted angioma is a rare benign vascular lesion that usually presents as an acquired lesion in children and young adults, though it may be congenital. It is commonly localized to the skin and subcutaneous tissues. Clinically, the lesions appear as red to purple patches and plaques that typically are located on the neck or trunk. More than 50% of cases present during the first year of life and slowly spread to involve large areas before stabilizing in size.14 Partial spontaneous regression may occur, but complete regression is rare.15 Lesions usually are asymptomatic but may be painful during periods of platelet trapping (Kasabach-Merritt phenomenon), which may develop in congenital cases. Tufted angioma is named for its characteristic histopathologic appearance, which consists of multiple discrete lobules or tufts of tightly packed capillaries in a cannonball-like appearance throughout the dermis and subcutis (Figure 4).14,15  

Figure 4. Tufted angioma. Discrete lobules or tufts of tightly packed capillaries in a cannonball-like appearance throughout the dermis (H&E, original magnification ×200 [inset, original magnification ×40]).

References
  1. Hunt SJ, Santa Cruz DJ, Barr RJ. Microvenular hemangioma. J Cutan Pathol. 1991;18:235-240.  
  2. Bantel E, Grosshans E, Ortonne JP. Understanding microcapillary angioma, observations in pregnant patients and in females treated with hormonal contraceptives [in German]. Z Hautkr. 1989;64:1071-1074. 
  3. Mansur AT, Demirci GT, Ozbal Koc E, et al. An unusual lesion on the nose: microvenular hemangioma. Dermatol Pract Concept. 2018;8:7-11. 
  4. Napekoski KM, Fernandez AP, Billings SD. Microvenular hemangioma: a clinicopathologic review of 13 cases. J Cutan Pathol. 2014;41:816-822. 
  5. Trinidade F, Tellechea O, Torrelo A, et al. Wilms tumor 1 expression in vascular neoplasms and vascular malformations. Am J Dermatopathol. 2011;33:569-572.  
  6. Shustef E, Kazlouskaya V, Prieto VG, et al. Cutaneous angiosarcoma: a current update. J Clin Pathol. 2017;70:917-925. 
  7. Morgan M, Swann M, Somach S, et al. Cutaneous angiosarcoma: a case series with prognostic correlation. J Am Acad Dermatol. 2004;50:867-874. 
  8. Shon W, Billings SD. Cutaneous malignant vascular neoplasms. Clin Lab Med. 2017;37:633-646. 
  9. Régnier-Rosencher E, Guillot B, Dupin N. Treatments for classic Kaposi sarcoma: a systematic review of the literature. J Am Acad Dermatol. 2013;68:313-331.  
  10. Tappero JW, Conant MA, Wolfe SF, et al. Kaposi's sarcoma: epidemiology, pathogenesis, histology, clinical spectrum, staging criteria and therapy. J Am Acad Dermatol. 1993;28:371-395.  
  11. Grayson W, Pantanowitz L. Histological variants of cutaneous Kaposi sarcoma. Diagn Pathol. 2008;3:31. 
  12. Mentzel T, Partanen TA, Kutzner H. Hobnail hemangioma ("targetoid hemosiderotic hemangioma"): clinicopathologic and immunohistochemical analysis of 62 cases. J Cutan Pathol. 1999;26:279-286. 
  13. Morales-Callaghan AM, Martinez-Garcia G, Aragoneses-Fraile H, et al. Targetoid hemosiderotic hemangioma: clinical and dermoscopical findings. J Eur Acad Dermatol Venereol. 2007;21:267-269. 
  14. Kamath GH, Bhat RM, Kumar S. Tufted angioma. Int J Dermatol. 2005;44:1045-1047. 
  15. Prasuna A, Rao P. A tufted angioma. Indian Dermatol Online J. 2015;6:266-268. 
     
Article PDF
Author and Disclosure Information

Dr. Dorfman is from Lehigh Valley Health Network, Allentown, Pennsylvania. Drs. Lountzis and Ermolovich are from Advanced Dermatology Associates, LTD, Allentown.

The authors report no conflict of interest.

Correspondence: Claire O. Dorfman, DO, 1259 S Cedar Crest Blvd, Ste 100, Allentown, PA 18103 (claireot@pcom.edu)

Issue
Cutis - 104(1)
Publications
Topics
Page Number
53, 68-69
Sections
Author and Disclosure Information

Dr. Dorfman is from Lehigh Valley Health Network, Allentown, Pennsylvania. Drs. Lountzis and Ermolovich are from Advanced Dermatology Associates, LTD, Allentown.

The authors report no conflict of interest.

Correspondence: Claire O. Dorfman, DO, 1259 S Cedar Crest Blvd, Ste 100, Allentown, PA 18103 (claireot@pcom.edu)

Author and Disclosure Information

Dr. Dorfman is from Lehigh Valley Health Network, Allentown, Pennsylvania. Drs. Lountzis and Ermolovich are from Advanced Dermatology Associates, LTD, Allentown.

The authors report no conflict of interest.

Correspondence: Claire O. Dorfman, DO, 1259 S Cedar Crest Blvd, Ste 100, Allentown, PA 18103 (claireot@pcom.edu)

Article PDF
Article PDF
Related Articles

The Diagnosis: Microvenular Hemangioma  

Microvenular hemangioma is an acquired benign vascular neoplasm that was described by Hunt et al1 in 1991, though Bantel et al2 reported a similar entity termed micropapillary angioma in 1989. Microvenular hemangioma typically presents as a solitary, slowly enlarging, red to violaceous, asymptomatic papule, plaque, or nodule measuring 5 to 20 mm in diameter. It usually is located on the trunk, arms, or legs of young adults without any gender predilection. Microvenular hemangioma is rare.3 The etiology has not been elucidated, though a relationship with hormonal factors such as pregnancy or hormonal contraceptives has been described.2  

Histopathologically, microvenular hemangioma has a characteristic morphology. It is comprised of a well-circumscribed collection of thin-walled blood vessels with narrow lumens (quiz image).4 The blood vessels tend to infiltrate the superficial and deep dermis and are surrounded by a collagenous or desmoplastic stroma. The endothelial cells are normal in size without atypia, mitotic figures, or pleomorphism. A mild lymphoplasmacytic inflammatory infiltrate sometimes is present. Microvenular hemangioma expresses many vascular markers confirming its endothelial origin, including CD34, CD31, WT1, factor VIII-related antigen, and von Willebrand factor.3 Moreover, WT1 staining suggests the lesion is a vascular proliferative growth, as it usually is negative in vascular malformations due to errors of endothelial development.5 In addition, it lacks expression of podoplanin (D2-40), which also supports a vascular as opposed to a lymphatic origin.4  

Cutaneous angiosarcoma is a rare and highly aggressive malignant neoplasm of the vascular endothelium with a predilection for the skin and superficial soft tissue. Clinical presentation is variable, as it can arise sporadically, commonly on the scalp and face of elderly patients, in areas of chronic radiation therapy, or in association with chronic lymphedema (Stewart-Treves syndrome).6 Sporadic neoplasms appear clinically as purpuric macules, plaques, or nodules and are more common in elderly men than women. They are aggressive tumors that tend to recur and metastasize despite aggressive therapy and therefore carry a poor prognosis.7 Histopathologically, well-differentiated tumors are characterized by irregular dissecting vessels lined with crowded inconspicuous endothelial cells (Figure 1). Cutaneous angiosarcoma is poorly circumscribed with marked cytologic atypia, and the vessels can take on a sinusoidal growth pattern.

Figure 1. Cutaneous angiosarcoma. Dermal proliferation of irregular dissecting vessels lined with crowded inconspicuous endothelial cells (H&E, original magnification ×200).

Kaposi sarcoma (KS) is a virally induced lymphoangioproliferative disease, with human herpesvirus 8 as the implicated agent. There are 4 principal clinical variants of KS: epidemic or AIDS-associated KS, endemic or African KS, KS due to iatrogenic immunosuppression, and Mediterranean or classic KS.9 Cutaneous lesions vary from pink patches to dark purple plaques or nodules that commonly occur on the lower legs10; however, the clinical appearance of KS varies depending on the clinical variant and stage. Histopathologically, early lesions of KS exhibit a superficial dermal proliferation of small angulated and jagged vessels that tend to separate into collagen bundles and are surrounded by a lymphoplasmacytic perivascular infiltrate. These native vascular structures often are surrounded by more ectatic neoplastic channels with plump endothelial cells, known as the promontory sign (Figure 2).11 With more advanced lesions, the proliferation of slitlike vessels becomes more cellular and extends deeper into the dermis and subcutis. Although the histopathologic features vary with the stage of the lesion, they do not notably vary between clinical subtypes. 

Figure 2. Kaposi sarcoma. Angulated and jagged vessels surrounded by a lymphoplasmacytic perivascular infiltrate and ectatic neoplastic channels, known as the promontory sign (H&E, original magnification ×200).

Targetoid hemosiderotic hemangioma, also known as hobnail hemangioma, is a small, benign, vascular tumor that usually affects the trunk, arms, and legs in young to middle-aged adults without a gender predilection. Clinically, it appears as a small, solitary, red to purple papule or macule that typically is surrounded by a pale thin area and a peripheral ecchymotic ring, creating a targetoid appearance, thus the term targetoid hemosiderotic hemangioma.12 Histopathologically, there is a prominent dermal vascular proliferation. In the papillary dermis, there are dilated superficial vessels lined with a single layer of endothelial cells characterized by a plump, hobnail-like appearance that protrude into the lumen (Figure 3). In the deeper dermis, the vascular spaces are angulated and slitlike and appear to dissect through collagen bundles. Hemosiderin, thrombi, extravasated erythrocytes, and a lymphocytic infiltrate also are often seen.13  

Figure 3. Targetoid hemosiderotic hemangioma. Dilated superficial vessels lined by plump, hobnail-like endothelial cells that protrude into the lumen (H&E, original magnification ×200).

Tufted angioma is a rare benign vascular lesion that usually presents as an acquired lesion in children and young adults, though it may be congenital. It is commonly localized to the skin and subcutaneous tissues. Clinically, the lesions appear as red to purple patches and plaques that typically are located on the neck or trunk. More than 50% of cases present during the first year of life and slowly spread to involve large areas before stabilizing in size.14 Partial spontaneous regression may occur, but complete regression is rare.15 Lesions usually are asymptomatic but may be painful during periods of platelet trapping (Kasabach-Merritt phenomenon), which may develop in congenital cases. Tufted angioma is named for its characteristic histopathologic appearance, which consists of multiple discrete lobules or tufts of tightly packed capillaries in a cannonball-like appearance throughout the dermis and subcutis (Figure 4).14,15  

Figure 4. Tufted angioma. Discrete lobules or tufts of tightly packed capillaries in a cannonball-like appearance throughout the dermis (H&E, original magnification ×200 [inset, original magnification ×40]).

The Diagnosis: Microvenular Hemangioma  

Microvenular hemangioma is an acquired benign vascular neoplasm that was described by Hunt et al1 in 1991, though Bantel et al2 reported a similar entity termed micropapillary angioma in 1989. Microvenular hemangioma typically presents as a solitary, slowly enlarging, red to violaceous, asymptomatic papule, plaque, or nodule measuring 5 to 20 mm in diameter. It usually is located on the trunk, arms, or legs of young adults without any gender predilection. Microvenular hemangioma is rare.3 The etiology has not been elucidated, though a relationship with hormonal factors such as pregnancy or hormonal contraceptives has been described.2  

Histopathologically, microvenular hemangioma has a characteristic morphology. It is comprised of a well-circumscribed collection of thin-walled blood vessels with narrow lumens (quiz image).4 The blood vessels tend to infiltrate the superficial and deep dermis and are surrounded by a collagenous or desmoplastic stroma. The endothelial cells are normal in size without atypia, mitotic figures, or pleomorphism. A mild lymphoplasmacytic inflammatory infiltrate sometimes is present. Microvenular hemangioma expresses many vascular markers confirming its endothelial origin, including CD34, CD31, WT1, factor VIII-related antigen, and von Willebrand factor.3 Moreover, WT1 staining suggests the lesion is a vascular proliferative growth, as it usually is negative in vascular malformations due to errors of endothelial development.5 In addition, it lacks expression of podoplanin (D2-40), which also supports a vascular as opposed to a lymphatic origin.4  

Cutaneous angiosarcoma is a rare and highly aggressive malignant neoplasm of the vascular endothelium with a predilection for the skin and superficial soft tissue. Clinical presentation is variable, as it can arise sporadically, commonly on the scalp and face of elderly patients, in areas of chronic radiation therapy, or in association with chronic lymphedema (Stewart-Treves syndrome).6 Sporadic neoplasms appear clinically as purpuric macules, plaques, or nodules and are more common in elderly men than women. They are aggressive tumors that tend to recur and metastasize despite aggressive therapy and therefore carry a poor prognosis.7 Histopathologically, well-differentiated tumors are characterized by irregular dissecting vessels lined with crowded inconspicuous endothelial cells (Figure 1). Cutaneous angiosarcoma is poorly circumscribed with marked cytologic atypia, and the vessels can take on a sinusoidal growth pattern.

Figure 1. Cutaneous angiosarcoma. Dermal proliferation of irregular dissecting vessels lined with crowded inconspicuous endothelial cells (H&E, original magnification ×200).

Kaposi sarcoma (KS) is a virally induced lymphoangioproliferative disease, with human herpesvirus 8 as the implicated agent. There are 4 principal clinical variants of KS: epidemic or AIDS-associated KS, endemic or African KS, KS due to iatrogenic immunosuppression, and Mediterranean or classic KS.9 Cutaneous lesions vary from pink patches to dark purple plaques or nodules that commonly occur on the lower legs10; however, the clinical appearance of KS varies depending on the clinical variant and stage. Histopathologically, early lesions of KS exhibit a superficial dermal proliferation of small angulated and jagged vessels that tend to separate into collagen bundles and are surrounded by a lymphoplasmacytic perivascular infiltrate. These native vascular structures often are surrounded by more ectatic neoplastic channels with plump endothelial cells, known as the promontory sign (Figure 2).11 With more advanced lesions, the proliferation of slitlike vessels becomes more cellular and extends deeper into the dermis and subcutis. Although the histopathologic features vary with the stage of the lesion, they do not notably vary between clinical subtypes. 

Figure 2. Kaposi sarcoma. Angulated and jagged vessels surrounded by a lymphoplasmacytic perivascular infiltrate and ectatic neoplastic channels, known as the promontory sign (H&E, original magnification ×200).

Targetoid hemosiderotic hemangioma, also known as hobnail hemangioma, is a small, benign, vascular tumor that usually affects the trunk, arms, and legs in young to middle-aged adults without a gender predilection. Clinically, it appears as a small, solitary, red to purple papule or macule that typically is surrounded by a pale thin area and a peripheral ecchymotic ring, creating a targetoid appearance, thus the term targetoid hemosiderotic hemangioma.12 Histopathologically, there is a prominent dermal vascular proliferation. In the papillary dermis, there are dilated superficial vessels lined with a single layer of endothelial cells characterized by a plump, hobnail-like appearance that protrude into the lumen (Figure 3). In the deeper dermis, the vascular spaces are angulated and slitlike and appear to dissect through collagen bundles. Hemosiderin, thrombi, extravasated erythrocytes, and a lymphocytic infiltrate also are often seen.13  

Figure 3. Targetoid hemosiderotic hemangioma. Dilated superficial vessels lined by plump, hobnail-like endothelial cells that protrude into the lumen (H&E, original magnification ×200).

Tufted angioma is a rare benign vascular lesion that usually presents as an acquired lesion in children and young adults, though it may be congenital. It is commonly localized to the skin and subcutaneous tissues. Clinically, the lesions appear as red to purple patches and plaques that typically are located on the neck or trunk. More than 50% of cases present during the first year of life and slowly spread to involve large areas before stabilizing in size.14 Partial spontaneous regression may occur, but complete regression is rare.15 Lesions usually are asymptomatic but may be painful during periods of platelet trapping (Kasabach-Merritt phenomenon), which may develop in congenital cases. Tufted angioma is named for its characteristic histopathologic appearance, which consists of multiple discrete lobules or tufts of tightly packed capillaries in a cannonball-like appearance throughout the dermis and subcutis (Figure 4).14,15  

Figure 4. Tufted angioma. Discrete lobules or tufts of tightly packed capillaries in a cannonball-like appearance throughout the dermis (H&E, original magnification ×200 [inset, original magnification ×40]).

References
  1. Hunt SJ, Santa Cruz DJ, Barr RJ. Microvenular hemangioma. J Cutan Pathol. 1991;18:235-240.  
  2. Bantel E, Grosshans E, Ortonne JP. Understanding microcapillary angioma, observations in pregnant patients and in females treated with hormonal contraceptives [in German]. Z Hautkr. 1989;64:1071-1074. 
  3. Mansur AT, Demirci GT, Ozbal Koc E, et al. An unusual lesion on the nose: microvenular hemangioma. Dermatol Pract Concept. 2018;8:7-11. 
  4. Napekoski KM, Fernandez AP, Billings SD. Microvenular hemangioma: a clinicopathologic review of 13 cases. J Cutan Pathol. 2014;41:816-822. 
  5. Trinidade F, Tellechea O, Torrelo A, et al. Wilms tumor 1 expression in vascular neoplasms and vascular malformations. Am J Dermatopathol. 2011;33:569-572.  
  6. Shustef E, Kazlouskaya V, Prieto VG, et al. Cutaneous angiosarcoma: a current update. J Clin Pathol. 2017;70:917-925. 
  7. Morgan M, Swann M, Somach S, et al. Cutaneous angiosarcoma: a case series with prognostic correlation. J Am Acad Dermatol. 2004;50:867-874. 
  8. Shon W, Billings SD. Cutaneous malignant vascular neoplasms. Clin Lab Med. 2017;37:633-646. 
  9. Régnier-Rosencher E, Guillot B, Dupin N. Treatments for classic Kaposi sarcoma: a systematic review of the literature. J Am Acad Dermatol. 2013;68:313-331.  
  10. Tappero JW, Conant MA, Wolfe SF, et al. Kaposi's sarcoma: epidemiology, pathogenesis, histology, clinical spectrum, staging criteria and therapy. J Am Acad Dermatol. 1993;28:371-395.  
  11. Grayson W, Pantanowitz L. Histological variants of cutaneous Kaposi sarcoma. Diagn Pathol. 2008;3:31. 
  12. Mentzel T, Partanen TA, Kutzner H. Hobnail hemangioma ("targetoid hemosiderotic hemangioma"): clinicopathologic and immunohistochemical analysis of 62 cases. J Cutan Pathol. 1999;26:279-286. 
  13. Morales-Callaghan AM, Martinez-Garcia G, Aragoneses-Fraile H, et al. Targetoid hemosiderotic hemangioma: clinical and dermoscopical findings. J Eur Acad Dermatol Venereol. 2007;21:267-269. 
  14. Kamath GH, Bhat RM, Kumar S. Tufted angioma. Int J Dermatol. 2005;44:1045-1047. 
  15. Prasuna A, Rao P. A tufted angioma. Indian Dermatol Online J. 2015;6:266-268. 
     
References
  1. Hunt SJ, Santa Cruz DJ, Barr RJ. Microvenular hemangioma. J Cutan Pathol. 1991;18:235-240.  
  2. Bantel E, Grosshans E, Ortonne JP. Understanding microcapillary angioma, observations in pregnant patients and in females treated with hormonal contraceptives [in German]. Z Hautkr. 1989;64:1071-1074. 
  3. Mansur AT, Demirci GT, Ozbal Koc E, et al. An unusual lesion on the nose: microvenular hemangioma. Dermatol Pract Concept. 2018;8:7-11. 
  4. Napekoski KM, Fernandez AP, Billings SD. Microvenular hemangioma: a clinicopathologic review of 13 cases. J Cutan Pathol. 2014;41:816-822. 
  5. Trinidade F, Tellechea O, Torrelo A, et al. Wilms tumor 1 expression in vascular neoplasms and vascular malformations. Am J Dermatopathol. 2011;33:569-572.  
  6. Shustef E, Kazlouskaya V, Prieto VG, et al. Cutaneous angiosarcoma: a current update. J Clin Pathol. 2017;70:917-925. 
  7. Morgan M, Swann M, Somach S, et al. Cutaneous angiosarcoma: a case series with prognostic correlation. J Am Acad Dermatol. 2004;50:867-874. 
  8. Shon W, Billings SD. Cutaneous malignant vascular neoplasms. Clin Lab Med. 2017;37:633-646. 
  9. Régnier-Rosencher E, Guillot B, Dupin N. Treatments for classic Kaposi sarcoma: a systematic review of the literature. J Am Acad Dermatol. 2013;68:313-331.  
  10. Tappero JW, Conant MA, Wolfe SF, et al. Kaposi's sarcoma: epidemiology, pathogenesis, histology, clinical spectrum, staging criteria and therapy. J Am Acad Dermatol. 1993;28:371-395.  
  11. Grayson W, Pantanowitz L. Histological variants of cutaneous Kaposi sarcoma. Diagn Pathol. 2008;3:31. 
  12. Mentzel T, Partanen TA, Kutzner H. Hobnail hemangioma ("targetoid hemosiderotic hemangioma"): clinicopathologic and immunohistochemical analysis of 62 cases. J Cutan Pathol. 1999;26:279-286. 
  13. Morales-Callaghan AM, Martinez-Garcia G, Aragoneses-Fraile H, et al. Targetoid hemosiderotic hemangioma: clinical and dermoscopical findings. J Eur Acad Dermatol Venereol. 2007;21:267-269. 
  14. Kamath GH, Bhat RM, Kumar S. Tufted angioma. Int J Dermatol. 2005;44:1045-1047. 
  15. Prasuna A, Rao P. A tufted angioma. Indian Dermatol Online J. 2015;6:266-268. 
     
Issue
Cutis - 104(1)
Issue
Cutis - 104(1)
Page Number
53, 68-69
Page Number
53, 68-69
Publications
Publications
Topics
Article Type
Display Headline
Ill-Defined Macule on the Abdomen
Display Headline
Ill-Defined Macule on the Abdomen
Sections
Questionnaire Body

H&E, original magnification ×200 (inset, original magnification ×40).

A 38-year-old woman presented with an asymptomatic lesion on the abdomen. On physical examination, there was a 5×2-mm, solitary, ill-defined pink macule on the right side of the abdomen. The patient denied recent change in size or color of the lesion, prior trauma, or a personal or family history of similar lesions. Due to the uncertain diagnostic appearance, a punch biopsy was performed.

Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Thu, 07/11/2019 - 14:15
Un-Gate On Date
Thu, 07/11/2019 - 14:15
Use ProPublica
CFC Schedule Remove Status
Thu, 07/11/2019 - 14:15
Hide sidebar & use full width
render the right sidebar.
Article PDF Media

Enlarging Nodule on the Thigh

Article Type
Changed
Mon, 05/13/2019 - 16:10
Display Headline
Enlarging Nodule on the Thigh

The Diagnosis: Metastatic Adenocarcinoma of the Colon 

Cutaneous adenocarcinomas are uncommon, whether they present as a primary lesion or metastatic disease. In our patient, the histologic findings and immunohistochemical staining pattern were consistent with metastatic adenocarcinoma of the colon, an uncommon clinical presentation.  

Colonic adenocarcinoma can cause cutaneous metastasis in 3% of cases. The most common sites of metastases include the abdomen, chest, and back.1 On histologic examination, hematoxylin and eosin (H&E)-stained sections of cutaneous metastatic adenocarcinoma illustrate a malignant gland-forming neoplasm in the dermis with luminal mucin and necrotic debris (quiz image). The glands are lined by tall columnar epithelial cells with hyperchromatic nuclei. Alternatively, poorly differentiated morphology can be seen with fewer glands and more infiltrating nests of tumor cells.2 Immunohistochemically, colonic adenocarcinoma typically is negative for cytokeratin (CK) 7 and positive for CK20 and caudal type homeobox transcription factor 2 (CDX-2).3  

Primary cutaneous mucinous carcinoma is characterized by islands of neoplastic cells floating in pools of mucin (Figure 1). It may be indistinguishable from metastatic mucinous carcinomas of the colon or breast. Immunohistochemistry can be helpful in differentiating metastatic breast vs colon carcinoma. Cytokeratin 7, GATA binding protein 3, gross cystic disease fluid protein 15, and estrogen receptor will be positive in carcinomas of the breast and will be negative in colonic adenocarcinomas.4-6 Furthermore, lesional cells in metastatic adenocarcinoma of the colon are positive for CDX-2 and CK20, while those in metastatic carcinoma of the breast are negative.2 Immunohistochemistry also can differentiate primary cutaneous carcinoma from metastatic adenocarcinoma. When used in combination, p63 and podoplanin (D2-40) offer a highly sensitive and specific indicator of a primary cutaneous neoplasm, as both demonstrate either focal or diffuse positivity in this setting. In contrast, these stains typically are negative in metastatic adenocarcinomas of the skin.7 

Figure 1. Primary cutaneous mucinous carcinoma. Pools of mucin are present within the dermis with islands of malignant tumor cells, ample cytoplasm, and nuclear pleomorphism (H&E, original magnification ×100).

Endometriosis affects 1% to 2% of all reproductive-age females, of which extrapelvic manifestations account for only 0.5% to 1.0% of cases.8 Histologically, extrapelvic endometriosis is characterized by the triad of endometrial-type glands, endometrial stroma, and hemorrhage or hemosiderin deposition (Figure 2). The glands can enlarge and demonstrate architectural distortion with partial lack of polarity. These features initially can be concerning for adenocarcinoma, but on closer examination, nuclear morphology is regular and mitoses are absent.8,9 The diagnosis usually can be rendered with H&E alone; however, immunohistochemical stains for CD10 and estrogen receptor can highlight the endometrial stroma.10 Furthermore, endometrial glands will stain positive for paired box gene 8 (PAX8), a marker that is not expressed within the gastrointestinal tract and associated malignancies.11  

Figure 2. Endometriosis. An endometrial-type stroma is composed of bland-appearing spindle cells within the dermis with small interspersed capillaries and extravasated red blood cells. The glands are lined by columnar epithelial cells with regular, basally oriented nuclei and abundant
cytoplasm (H&E, original magnification ×100).

Primary cutaneous angiosarcoma may mimic adenocarcinoma, as the endothelial-lined vessels can be confused as malignant glands (Figure 3). Angiosarcoma often is seen in 1 of 3 clinical presentations: the head and neck of elderly patients, postradiation treatment, and chronic lymphedema.12,13 Regardless of the location, the disease carries a poor prognosis, with a 5-year survival rate of 12% following initial diagnosis.13 Angiosarcoma is characterized by malignant endothelial cells dissecting through the dermis. Although the histology can be deceptively bland in some cases, the neoplasm most commonly demonstrates notable atypia with a multilayered endothelium and occasional intravascular atypical cells ("fish in the creek appearance").13,14 There can be frequent mitoses, and the atypical cells may show intracytoplasmic lumina containing red blood cells. The lesional cells are positive for endothelial markers such as erythroblast transformation specific related gene (ERG), CD31, CD34, and friend leukemia integration factor 1 (FLI-1).15,16  

Figure 3. Primary cutaneous angiosarcoma. Large, atypical, pleomorphic cells line endothelial spaces and invade into the surrounding stroma. Occasionally, the vessels within angiosarcoma can mimic a gland-forming neoplasm (H&E, original magnification ×200).

Breast cancer also can cause cutaneous metastases in approximately 20% of cases, with the most common presenting site being the anterior chest wall.17 Macroscopically, these lesions appear most commonly as painless nodules but also as telangiectatic, erysipeloid, fibrotic, and alopecic lesions.17-19 The histologic findings from H&E-stained sections of a cutaneous metastasis of breast cancer are variable and depend on the specific tumor subtype (eg, ductal, lobular, mucinous). However, the classic histologic presentation is that of nests and cords of malignant epithelial cells with variable gland formation. Often, tumor cells infiltrate in a single-file fashion (Figure 4).17 Although inflammatory breast carcinoma is a strictly clinical diagnosis, the presence of tumor cells in the lymphovascular spaces is a histologic clue to this diagnosis. Immunohistochemically, GATA binding protein 3 is helpful in identifying both hormone receptor-positive and -negative breast cancer subtypes that have metastasized.20 

Figure 4. Metastatic breast carcinoma. Nests and cords of malignant epithelial cells are present within the dermis. Occasional tumor cells infiltrate in a single-file fashion (H&E, original magnification ×100).

Within the histologic differential diagnoses, the most useful tool to diagnose metastatic adenocarcinoma of the colon often is a thorough clinical history. In the absence of a clinical history of adenocarcinoma, immunohistochemistry can be a useful adjunct to aid in the correct characterization and classification of a malignant gland-forming tumor.2,3,6 

References
  1. Lookingbill DP, Spangler N, Helm KF. Cutaneous metastases in patients with metastatic carcinoma: a retrospective study of 4020 patients. J Am Acad Dermatol. 1993;29:228-236. 
  2. Kumar V, Robbins SL. Robbins Basic Pathology. 8th ed. Philadelphia, PA: Saunders/Elsevier; 2007. 
  3. Taliano RJ, LeGolvan M, Resnick MB. Immunohistochemistry of colorectal carcinoma: current practice and evolving applications. Hum Pathol. 2013;44:151-163. 
  4. Kamalpour L, Brindise RT, Nodzenski M, et al. Primary cutaneous mucinous carcinoma: a systematic review and meta-analysis of outcomes after surgery. JAMA Dermatol. 2014;150:380-384.  
  5. Roshan MH, Tambo A, Pace NP. The role of testosterone in colorectal carcinoma: pathomechanisms and open questions. EPMA J. 2016;7:22. 
  6. Mazoujian G, Pinkus GS, Davis S, et al. Immunohistochemistry of a gross cystic disease fluid protein (GCDFP-15) of the breast. a marker of apocrine epithelium and breast carcinomas with apocrine features. Am J Pathol. 1983;110:105-112. 
  7. Plaza JA, Ortega PF, Stockman DL, et al. Value of p63 and podoplanin (D2-40) immunoreactivity in the distinction between primary cutaneous tumors and adenocarcinomas metastatic to the skin: a clinicopathologic and immunohistochemical study of 79 cases. J Cutan Pathol. 2010;37:403-410. 
  8. Machairiotis N, Stylianaki A, Dryllis G, et al. Extrapelvic endometriosis: a rare entity or an under diagnosed condition? Diagn Pathol. 2013;8:194. 
  9. Chen H, Luo Q, Liu S, et al. Rectal mucosal endometriosis primarily misinterpreted as adenocarcinoma: a case report and review of literature. Int J Clin Exp Pathol. 2015;8:5902-5907. 
  10. Terada S, Miyata Y, Nakazawa H, et al. Immunohistochemical analysis of an ectopic endometriosis in the uterine round ligament. Diagn Pathol. 2006;1:27.  
  11. Yemelyanova A, Gown AM, Wu LS, et al. PAX8 expression in uterine adenocarcinomas and mesonephric proliferations. Int J Gynecol Pathol. 2014;33:492-499. 
  12. Farid M, Ong WS, Lee MJ, et al. Cutaneous versus non-cutaneous angiosarcoma: clinicopathologic features and treatment outcomes in 60 patients at a single Asian cancer centre. Oncology. 2013;85:182-190.  
  13. Requena C, Sendra E, Llombart B, et al. Cutaneous angiosarcoma: clinical and pathology study of 16 cases. Actas Dermosifiliogr. 2017;108:457-465. 
  14. Schmidt AP, Tjarks BJ, Lynch DW. Gone fishing: a unique histologic pattern in cutaneous angiosarcoma. Cutis. 2018;101:270-272. 
  15. Sullivan HC, Edgar MA, Cohen C, et al. The utility of ERG, CD31 and CD34 in the cytological diagnosis of angiosarcoma: an analysis of 25 cases. J Clin Pathol. 2015;68:44-50. 
  16. Rossi S, Orvieto E, Furlanetto A, et al. Utility of the immunohistochemical detection of FLI-1 expression in round cell and vascular neoplasm using a monoclonal antibody. Mod Pathol. 2004;17:547-552.  
  17. Tan AR. Cutaneous manifestations of breast cancer. Semin Oncol. 2016;43:331-334.  
  18. Schwartz RA, Wiederkehr M, Lambert WC. Secondary mucinous carcinoma of the skin: metastatic breast cancer. Dermatol Surg. 2004;30(2, pt 1):234-235. 
  19. Mallon E, Dawber RP. Alopecia neoplastica without alopecia: a unique presentation of breast carcinoma scalp metastasis. J Am Acad Dermatol. 1994;31(2, pt 2):319-321.  
  20. Braxton DR, Cohen C, Siddiqui MT. Utility of GATA3 immunohistochemistry for diagnosis of metastatic breast carcinoma in cytology specimens. Diagn Cytopathol. 2015;43:271-277.
Article PDF
Author and Disclosure Information

Mr. Valiga is from Drexel University College of Medicine, Philadelphia, Pennsylvania. Drs. Grandhi and Tjarks are from the Department of Dermatology, Geisinger Medical Center, Danville, Pennsylvania.

The authors report no conflict of interest.

Correspondence: Alexander A. Valiga, BS, Drexel University College of Medicine, 2900 W Queen Ln, Philadelphia, PA 19129 (avaliga331@gmail.com).

Issue
Cutis - 103(5)
Publications
Topics
Page Number
268, 282-283
Sections
Author and Disclosure Information

Mr. Valiga is from Drexel University College of Medicine, Philadelphia, Pennsylvania. Drs. Grandhi and Tjarks are from the Department of Dermatology, Geisinger Medical Center, Danville, Pennsylvania.

The authors report no conflict of interest.

Correspondence: Alexander A. Valiga, BS, Drexel University College of Medicine, 2900 W Queen Ln, Philadelphia, PA 19129 (avaliga331@gmail.com).

Author and Disclosure Information

Mr. Valiga is from Drexel University College of Medicine, Philadelphia, Pennsylvania. Drs. Grandhi and Tjarks are from the Department of Dermatology, Geisinger Medical Center, Danville, Pennsylvania.

The authors report no conflict of interest.

Correspondence: Alexander A. Valiga, BS, Drexel University College of Medicine, 2900 W Queen Ln, Philadelphia, PA 19129 (avaliga331@gmail.com).

Article PDF
Article PDF
Related Articles

The Diagnosis: Metastatic Adenocarcinoma of the Colon 

Cutaneous adenocarcinomas are uncommon, whether they present as a primary lesion or metastatic disease. In our patient, the histologic findings and immunohistochemical staining pattern were consistent with metastatic adenocarcinoma of the colon, an uncommon clinical presentation.  

Colonic adenocarcinoma can cause cutaneous metastasis in 3% of cases. The most common sites of metastases include the abdomen, chest, and back.1 On histologic examination, hematoxylin and eosin (H&E)-stained sections of cutaneous metastatic adenocarcinoma illustrate a malignant gland-forming neoplasm in the dermis with luminal mucin and necrotic debris (quiz image). The glands are lined by tall columnar epithelial cells with hyperchromatic nuclei. Alternatively, poorly differentiated morphology can be seen with fewer glands and more infiltrating nests of tumor cells.2 Immunohistochemically, colonic adenocarcinoma typically is negative for cytokeratin (CK) 7 and positive for CK20 and caudal type homeobox transcription factor 2 (CDX-2).3  

Primary cutaneous mucinous carcinoma is characterized by islands of neoplastic cells floating in pools of mucin (Figure 1). It may be indistinguishable from metastatic mucinous carcinomas of the colon or breast. Immunohistochemistry can be helpful in differentiating metastatic breast vs colon carcinoma. Cytokeratin 7, GATA binding protein 3, gross cystic disease fluid protein 15, and estrogen receptor will be positive in carcinomas of the breast and will be negative in colonic adenocarcinomas.4-6 Furthermore, lesional cells in metastatic adenocarcinoma of the colon are positive for CDX-2 and CK20, while those in metastatic carcinoma of the breast are negative.2 Immunohistochemistry also can differentiate primary cutaneous carcinoma from metastatic adenocarcinoma. When used in combination, p63 and podoplanin (D2-40) offer a highly sensitive and specific indicator of a primary cutaneous neoplasm, as both demonstrate either focal or diffuse positivity in this setting. In contrast, these stains typically are negative in metastatic adenocarcinomas of the skin.7 

Figure 1. Primary cutaneous mucinous carcinoma. Pools of mucin are present within the dermis with islands of malignant tumor cells, ample cytoplasm, and nuclear pleomorphism (H&E, original magnification ×100).

Endometriosis affects 1% to 2% of all reproductive-age females, of which extrapelvic manifestations account for only 0.5% to 1.0% of cases.8 Histologically, extrapelvic endometriosis is characterized by the triad of endometrial-type glands, endometrial stroma, and hemorrhage or hemosiderin deposition (Figure 2). The glands can enlarge and demonstrate architectural distortion with partial lack of polarity. These features initially can be concerning for adenocarcinoma, but on closer examination, nuclear morphology is regular and mitoses are absent.8,9 The diagnosis usually can be rendered with H&E alone; however, immunohistochemical stains for CD10 and estrogen receptor can highlight the endometrial stroma.10 Furthermore, endometrial glands will stain positive for paired box gene 8 (PAX8), a marker that is not expressed within the gastrointestinal tract and associated malignancies.11  

Figure 2. Endometriosis. An endometrial-type stroma is composed of bland-appearing spindle cells within the dermis with small interspersed capillaries and extravasated red blood cells. The glands are lined by columnar epithelial cells with regular, basally oriented nuclei and abundant
cytoplasm (H&E, original magnification ×100).

Primary cutaneous angiosarcoma may mimic adenocarcinoma, as the endothelial-lined vessels can be confused as malignant glands (Figure 3). Angiosarcoma often is seen in 1 of 3 clinical presentations: the head and neck of elderly patients, postradiation treatment, and chronic lymphedema.12,13 Regardless of the location, the disease carries a poor prognosis, with a 5-year survival rate of 12% following initial diagnosis.13 Angiosarcoma is characterized by malignant endothelial cells dissecting through the dermis. Although the histology can be deceptively bland in some cases, the neoplasm most commonly demonstrates notable atypia with a multilayered endothelium and occasional intravascular atypical cells ("fish in the creek appearance").13,14 There can be frequent mitoses, and the atypical cells may show intracytoplasmic lumina containing red blood cells. The lesional cells are positive for endothelial markers such as erythroblast transformation specific related gene (ERG), CD31, CD34, and friend leukemia integration factor 1 (FLI-1).15,16  

Figure 3. Primary cutaneous angiosarcoma. Large, atypical, pleomorphic cells line endothelial spaces and invade into the surrounding stroma. Occasionally, the vessels within angiosarcoma can mimic a gland-forming neoplasm (H&E, original magnification ×200).

Breast cancer also can cause cutaneous metastases in approximately 20% of cases, with the most common presenting site being the anterior chest wall.17 Macroscopically, these lesions appear most commonly as painless nodules but also as telangiectatic, erysipeloid, fibrotic, and alopecic lesions.17-19 The histologic findings from H&E-stained sections of a cutaneous metastasis of breast cancer are variable and depend on the specific tumor subtype (eg, ductal, lobular, mucinous). However, the classic histologic presentation is that of nests and cords of malignant epithelial cells with variable gland formation. Often, tumor cells infiltrate in a single-file fashion (Figure 4).17 Although inflammatory breast carcinoma is a strictly clinical diagnosis, the presence of tumor cells in the lymphovascular spaces is a histologic clue to this diagnosis. Immunohistochemically, GATA binding protein 3 is helpful in identifying both hormone receptor-positive and -negative breast cancer subtypes that have metastasized.20 

Figure 4. Metastatic breast carcinoma. Nests and cords of malignant epithelial cells are present within the dermis. Occasional tumor cells infiltrate in a single-file fashion (H&E, original magnification ×100).

Within the histologic differential diagnoses, the most useful tool to diagnose metastatic adenocarcinoma of the colon often is a thorough clinical history. In the absence of a clinical history of adenocarcinoma, immunohistochemistry can be a useful adjunct to aid in the correct characterization and classification of a malignant gland-forming tumor.2,3,6 

The Diagnosis: Metastatic Adenocarcinoma of the Colon 

Cutaneous adenocarcinomas are uncommon, whether they present as a primary lesion or metastatic disease. In our patient, the histologic findings and immunohistochemical staining pattern were consistent with metastatic adenocarcinoma of the colon, an uncommon clinical presentation.  

Colonic adenocarcinoma can cause cutaneous metastasis in 3% of cases. The most common sites of metastases include the abdomen, chest, and back.1 On histologic examination, hematoxylin and eosin (H&E)-stained sections of cutaneous metastatic adenocarcinoma illustrate a malignant gland-forming neoplasm in the dermis with luminal mucin and necrotic debris (quiz image). The glands are lined by tall columnar epithelial cells with hyperchromatic nuclei. Alternatively, poorly differentiated morphology can be seen with fewer glands and more infiltrating nests of tumor cells.2 Immunohistochemically, colonic adenocarcinoma typically is negative for cytokeratin (CK) 7 and positive for CK20 and caudal type homeobox transcription factor 2 (CDX-2).3  

Primary cutaneous mucinous carcinoma is characterized by islands of neoplastic cells floating in pools of mucin (Figure 1). It may be indistinguishable from metastatic mucinous carcinomas of the colon or breast. Immunohistochemistry can be helpful in differentiating metastatic breast vs colon carcinoma. Cytokeratin 7, GATA binding protein 3, gross cystic disease fluid protein 15, and estrogen receptor will be positive in carcinomas of the breast and will be negative in colonic adenocarcinomas.4-6 Furthermore, lesional cells in metastatic adenocarcinoma of the colon are positive for CDX-2 and CK20, while those in metastatic carcinoma of the breast are negative.2 Immunohistochemistry also can differentiate primary cutaneous carcinoma from metastatic adenocarcinoma. When used in combination, p63 and podoplanin (D2-40) offer a highly sensitive and specific indicator of a primary cutaneous neoplasm, as both demonstrate either focal or diffuse positivity in this setting. In contrast, these stains typically are negative in metastatic adenocarcinomas of the skin.7 

Figure 1. Primary cutaneous mucinous carcinoma. Pools of mucin are present within the dermis with islands of malignant tumor cells, ample cytoplasm, and nuclear pleomorphism (H&E, original magnification ×100).

Endometriosis affects 1% to 2% of all reproductive-age females, of which extrapelvic manifestations account for only 0.5% to 1.0% of cases.8 Histologically, extrapelvic endometriosis is characterized by the triad of endometrial-type glands, endometrial stroma, and hemorrhage or hemosiderin deposition (Figure 2). The glands can enlarge and demonstrate architectural distortion with partial lack of polarity. These features initially can be concerning for adenocarcinoma, but on closer examination, nuclear morphology is regular and mitoses are absent.8,9 The diagnosis usually can be rendered with H&E alone; however, immunohistochemical stains for CD10 and estrogen receptor can highlight the endometrial stroma.10 Furthermore, endometrial glands will stain positive for paired box gene 8 (PAX8), a marker that is not expressed within the gastrointestinal tract and associated malignancies.11  

Figure 2. Endometriosis. An endometrial-type stroma is composed of bland-appearing spindle cells within the dermis with small interspersed capillaries and extravasated red blood cells. The glands are lined by columnar epithelial cells with regular, basally oriented nuclei and abundant
cytoplasm (H&E, original magnification ×100).

Primary cutaneous angiosarcoma may mimic adenocarcinoma, as the endothelial-lined vessels can be confused as malignant glands (Figure 3). Angiosarcoma often is seen in 1 of 3 clinical presentations: the head and neck of elderly patients, postradiation treatment, and chronic lymphedema.12,13 Regardless of the location, the disease carries a poor prognosis, with a 5-year survival rate of 12% following initial diagnosis.13 Angiosarcoma is characterized by malignant endothelial cells dissecting through the dermis. Although the histology can be deceptively bland in some cases, the neoplasm most commonly demonstrates notable atypia with a multilayered endothelium and occasional intravascular atypical cells ("fish in the creek appearance").13,14 There can be frequent mitoses, and the atypical cells may show intracytoplasmic lumina containing red blood cells. The lesional cells are positive for endothelial markers such as erythroblast transformation specific related gene (ERG), CD31, CD34, and friend leukemia integration factor 1 (FLI-1).15,16  

Figure 3. Primary cutaneous angiosarcoma. Large, atypical, pleomorphic cells line endothelial spaces and invade into the surrounding stroma. Occasionally, the vessels within angiosarcoma can mimic a gland-forming neoplasm (H&E, original magnification ×200).

Breast cancer also can cause cutaneous metastases in approximately 20% of cases, with the most common presenting site being the anterior chest wall.17 Macroscopically, these lesions appear most commonly as painless nodules but also as telangiectatic, erysipeloid, fibrotic, and alopecic lesions.17-19 The histologic findings from H&E-stained sections of a cutaneous metastasis of breast cancer are variable and depend on the specific tumor subtype (eg, ductal, lobular, mucinous). However, the classic histologic presentation is that of nests and cords of malignant epithelial cells with variable gland formation. Often, tumor cells infiltrate in a single-file fashion (Figure 4).17 Although inflammatory breast carcinoma is a strictly clinical diagnosis, the presence of tumor cells in the lymphovascular spaces is a histologic clue to this diagnosis. Immunohistochemically, GATA binding protein 3 is helpful in identifying both hormone receptor-positive and -negative breast cancer subtypes that have metastasized.20 

Figure 4. Metastatic breast carcinoma. Nests and cords of malignant epithelial cells are present within the dermis. Occasional tumor cells infiltrate in a single-file fashion (H&E, original magnification ×100).

Within the histologic differential diagnoses, the most useful tool to diagnose metastatic adenocarcinoma of the colon often is a thorough clinical history. In the absence of a clinical history of adenocarcinoma, immunohistochemistry can be a useful adjunct to aid in the correct characterization and classification of a malignant gland-forming tumor.2,3,6 

References
  1. Lookingbill DP, Spangler N, Helm KF. Cutaneous metastases in patients with metastatic carcinoma: a retrospective study of 4020 patients. J Am Acad Dermatol. 1993;29:228-236. 
  2. Kumar V, Robbins SL. Robbins Basic Pathology. 8th ed. Philadelphia, PA: Saunders/Elsevier; 2007. 
  3. Taliano RJ, LeGolvan M, Resnick MB. Immunohistochemistry of colorectal carcinoma: current practice and evolving applications. Hum Pathol. 2013;44:151-163. 
  4. Kamalpour L, Brindise RT, Nodzenski M, et al. Primary cutaneous mucinous carcinoma: a systematic review and meta-analysis of outcomes after surgery. JAMA Dermatol. 2014;150:380-384.  
  5. Roshan MH, Tambo A, Pace NP. The role of testosterone in colorectal carcinoma: pathomechanisms and open questions. EPMA J. 2016;7:22. 
  6. Mazoujian G, Pinkus GS, Davis S, et al. Immunohistochemistry of a gross cystic disease fluid protein (GCDFP-15) of the breast. a marker of apocrine epithelium and breast carcinomas with apocrine features. Am J Pathol. 1983;110:105-112. 
  7. Plaza JA, Ortega PF, Stockman DL, et al. Value of p63 and podoplanin (D2-40) immunoreactivity in the distinction between primary cutaneous tumors and adenocarcinomas metastatic to the skin: a clinicopathologic and immunohistochemical study of 79 cases. J Cutan Pathol. 2010;37:403-410. 
  8. Machairiotis N, Stylianaki A, Dryllis G, et al. Extrapelvic endometriosis: a rare entity or an under diagnosed condition? Diagn Pathol. 2013;8:194. 
  9. Chen H, Luo Q, Liu S, et al. Rectal mucosal endometriosis primarily misinterpreted as adenocarcinoma: a case report and review of literature. Int J Clin Exp Pathol. 2015;8:5902-5907. 
  10. Terada S, Miyata Y, Nakazawa H, et al. Immunohistochemical analysis of an ectopic endometriosis in the uterine round ligament. Diagn Pathol. 2006;1:27.  
  11. Yemelyanova A, Gown AM, Wu LS, et al. PAX8 expression in uterine adenocarcinomas and mesonephric proliferations. Int J Gynecol Pathol. 2014;33:492-499. 
  12. Farid M, Ong WS, Lee MJ, et al. Cutaneous versus non-cutaneous angiosarcoma: clinicopathologic features and treatment outcomes in 60 patients at a single Asian cancer centre. Oncology. 2013;85:182-190.  
  13. Requena C, Sendra E, Llombart B, et al. Cutaneous angiosarcoma: clinical and pathology study of 16 cases. Actas Dermosifiliogr. 2017;108:457-465. 
  14. Schmidt AP, Tjarks BJ, Lynch DW. Gone fishing: a unique histologic pattern in cutaneous angiosarcoma. Cutis. 2018;101:270-272. 
  15. Sullivan HC, Edgar MA, Cohen C, et al. The utility of ERG, CD31 and CD34 in the cytological diagnosis of angiosarcoma: an analysis of 25 cases. J Clin Pathol. 2015;68:44-50. 
  16. Rossi S, Orvieto E, Furlanetto A, et al. Utility of the immunohistochemical detection of FLI-1 expression in round cell and vascular neoplasm using a monoclonal antibody. Mod Pathol. 2004;17:547-552.  
  17. Tan AR. Cutaneous manifestations of breast cancer. Semin Oncol. 2016;43:331-334.  
  18. Schwartz RA, Wiederkehr M, Lambert WC. Secondary mucinous carcinoma of the skin: metastatic breast cancer. Dermatol Surg. 2004;30(2, pt 1):234-235. 
  19. Mallon E, Dawber RP. Alopecia neoplastica without alopecia: a unique presentation of breast carcinoma scalp metastasis. J Am Acad Dermatol. 1994;31(2, pt 2):319-321.  
  20. Braxton DR, Cohen C, Siddiqui MT. Utility of GATA3 immunohistochemistry for diagnosis of metastatic breast carcinoma in cytology specimens. Diagn Cytopathol. 2015;43:271-277.
References
  1. Lookingbill DP, Spangler N, Helm KF. Cutaneous metastases in patients with metastatic carcinoma: a retrospective study of 4020 patients. J Am Acad Dermatol. 1993;29:228-236. 
  2. Kumar V, Robbins SL. Robbins Basic Pathology. 8th ed. Philadelphia, PA: Saunders/Elsevier; 2007. 
  3. Taliano RJ, LeGolvan M, Resnick MB. Immunohistochemistry of colorectal carcinoma: current practice and evolving applications. Hum Pathol. 2013;44:151-163. 
  4. Kamalpour L, Brindise RT, Nodzenski M, et al. Primary cutaneous mucinous carcinoma: a systematic review and meta-analysis of outcomes after surgery. JAMA Dermatol. 2014;150:380-384.  
  5. Roshan MH, Tambo A, Pace NP. The role of testosterone in colorectal carcinoma: pathomechanisms and open questions. EPMA J. 2016;7:22. 
  6. Mazoujian G, Pinkus GS, Davis S, et al. Immunohistochemistry of a gross cystic disease fluid protein (GCDFP-15) of the breast. a marker of apocrine epithelium and breast carcinomas with apocrine features. Am J Pathol. 1983;110:105-112. 
  7. Plaza JA, Ortega PF, Stockman DL, et al. Value of p63 and podoplanin (D2-40) immunoreactivity in the distinction between primary cutaneous tumors and adenocarcinomas metastatic to the skin: a clinicopathologic and immunohistochemical study of 79 cases. J Cutan Pathol. 2010;37:403-410. 
  8. Machairiotis N, Stylianaki A, Dryllis G, et al. Extrapelvic endometriosis: a rare entity or an under diagnosed condition? Diagn Pathol. 2013;8:194. 
  9. Chen H, Luo Q, Liu S, et al. Rectal mucosal endometriosis primarily misinterpreted as adenocarcinoma: a case report and review of literature. Int J Clin Exp Pathol. 2015;8:5902-5907. 
  10. Terada S, Miyata Y, Nakazawa H, et al. Immunohistochemical analysis of an ectopic endometriosis in the uterine round ligament. Diagn Pathol. 2006;1:27.  
  11. Yemelyanova A, Gown AM, Wu LS, et al. PAX8 expression in uterine adenocarcinomas and mesonephric proliferations. Int J Gynecol Pathol. 2014;33:492-499. 
  12. Farid M, Ong WS, Lee MJ, et al. Cutaneous versus non-cutaneous angiosarcoma: clinicopathologic features and treatment outcomes in 60 patients at a single Asian cancer centre. Oncology. 2013;85:182-190.  
  13. Requena C, Sendra E, Llombart B, et al. Cutaneous angiosarcoma: clinical and pathology study of 16 cases. Actas Dermosifiliogr. 2017;108:457-465. 
  14. Schmidt AP, Tjarks BJ, Lynch DW. Gone fishing: a unique histologic pattern in cutaneous angiosarcoma. Cutis. 2018;101:270-272. 
  15. Sullivan HC, Edgar MA, Cohen C, et al. The utility of ERG, CD31 and CD34 in the cytological diagnosis of angiosarcoma: an analysis of 25 cases. J Clin Pathol. 2015;68:44-50. 
  16. Rossi S, Orvieto E, Furlanetto A, et al. Utility of the immunohistochemical detection of FLI-1 expression in round cell and vascular neoplasm using a monoclonal antibody. Mod Pathol. 2004;17:547-552.  
  17. Tan AR. Cutaneous manifestations of breast cancer. Semin Oncol. 2016;43:331-334.  
  18. Schwartz RA, Wiederkehr M, Lambert WC. Secondary mucinous carcinoma of the skin: metastatic breast cancer. Dermatol Surg. 2004;30(2, pt 1):234-235. 
  19. Mallon E, Dawber RP. Alopecia neoplastica without alopecia: a unique presentation of breast carcinoma scalp metastasis. J Am Acad Dermatol. 1994;31(2, pt 2):319-321.  
  20. Braxton DR, Cohen C, Siddiqui MT. Utility of GATA3 immunohistochemistry for diagnosis of metastatic breast carcinoma in cytology specimens. Diagn Cytopathol. 2015;43:271-277.
Issue
Cutis - 103(5)
Issue
Cutis - 103(5)
Page Number
268, 282-283
Page Number
268, 282-283
Publications
Publications
Topics
Article Type
Display Headline
Enlarging Nodule on the Thigh
Display Headline
Enlarging Nodule on the Thigh
Sections
Questionnaire Body

H&E, original magnification ×40.

A 68-year-old patient presented with an enlarging flesh-colored nodule on the thigh that was positive for cytokeratin 20 and negative for cytokeratin 7.

Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Wed, 05/08/2019 - 10:00
Un-Gate On Date
Wed, 05/08/2019 - 10:00
Use ProPublica
CFC Schedule Remove Status
Wed, 05/08/2019 - 10:00
Hide sidebar & use full width
render the right sidebar.
Article PDF Media

Unilateral Facial Papules and Plaques

Article Type
Changed
Fri, 05/17/2019 - 11:28
Display Headline
Unilateral Facial Papules and Plaques

The Diagnosis: Unilateral Dermatomal Trichoepithelioma  

Adnexal lesions presenting with a linear and/or dermatomal pattern rarely have been reported. Bolognia et al1 performed a comprehensive review of Blaschko lines and skin conditions that follow such a pattern. The authors found that adnexal-related lesions included linear nevus comedonicus, linear basal cell nevus with comedones (linear basaloid follicular hamartoma), unilateral nevoid basal cell carcinoma (BCC), linear trichoepithelioma, linear trichodiscoma, linear hamartoma of the follicular infundibulum, nevus sebaceous, syringocystadenoma papilliferum, porokeratotic eccrine ostial and dermal duct nevus, linear eccrine poroma, linear spiradenoma, linear syringoma, and linear eccrine syringofibroadenoma.1  

Trichoepithelioma is a hair follicle-related neoplastic lesion presenting most commonly as the autosomal-dominant multiple familial type with lesions mainly centered on the face. Initial genetic studies associated the disease with loss of heterozygosity in the 9p21 region and further studies identified mutations in the CYLD (cylindromatosis [turban tumor syndrome]) gene on chromosome 16q12-q13.2,3 Unilateral, linear, and dermatomal forms of trichoepithelioma rarely are reported. In 1986, Geffner et al4 reported a case of linear and dermatomal trichoepithelioma in a 10-year-old girl. In addition to discrete solitary lesions affecting the face, she developed lesions on the left shoulder, left side of the trunk, and left lower leg following dermatomal distribution. In 2006, 2 cases of dermatomal trichoepitheliomas affecting the face in children, as in our case, were reported.5,6 Another case involving the neck was reported in 2016.7 Although classic multiple familial trichoepithelioma can be part of conditions such as Brooke-Spiegler8 and Rombo syndromes,9 no syndromal association has been reported thus far with the unilateral, linear, or dermatomal variants.  

Our case showed typical histopathologic features of trichoepithelioma, including discrete islands of basaloid cells in the dermis set in a conspicuous fibroblastic stroma. Focal connection with the epidermis was present. Most of the islands showed peripheral palisading and horn cysts lined by eosinophilic cells. The fibroblastic component was tightly adherent to the epithelial component, and only stromal clefts were detected. Papillary mesenchymal bodies also were detected as oval aggregates of fibroblastic cells invaginating into epithelial islands to form hair papillae. 

Histopathologically, the 2 most important differential diagnoses of trichoepithelioma include BCC and basaloid follicular hamartoma. In differentiating BCC from trichoepithelioma, the presence of dense fibroblastic stroma and papillary mesenchymal bodies characterize trichoepithelioma, while a fibromucinous stroma with mucinous retraction artifacts and clefting between the basaloid islands and the stroma characterize BCC (Figure 1).10 Immunohistochemical studies using antibodies against Bcl-2, CD34, CD10, androgen receptor, Ki-67, cytokeratin 19, and PHLDA1 (pleckstrin homologylike domain family A member 1) have reportedly been utilized to differentiate trichoepithelioma from BCC.11,12 Basaloid follicular hamartoma is characterized by thin anastomosing strands and branching cords of undifferentiated basaloid cells that replace or associate hair follicles in a latticelike pattern (Figure 2). The strands usually are vertically oriented perpendicular to the epidermis. Peripheral palisading is possible, and the basaloid strands are surrounded with cellular connective tissue stroma.13 Tumor islands in eccrine poroma show broad connections with the epidermis and are composed of poroid cells that show evident ductal differentiation with eosinophilic cuticles (Figure 3).14 Spiradenoma is characterized by capsulated deep-seated tumorous nodules not connected with the epidermis and composed of light and dark cells with ductal differentiation and vascular stroma (Figure 4). Scattered lymphocytes within the tumor lobules and in the stroma also are seen. Eosinophilic hyaline globules rarely can be present.15 

Figure 1. Basal cell carcinoma. Basaloid islands with peripheral palisading and peritumoral mucinous retraction artifacts (H&E, original magnification ×100).

Figure 2. Basaloid follicular hamartoma. Strands of immature basaloid cells replacing and associating follicular structures in a latticelike pattern (H&E, original magnification ×40).

Figure 3. Eccrine poroma. Tumor island composed of poroid cells with evident ductal differentiation with eosinophilic cuticles (H&E, original magnification ×100).

Figure 4. Spiradenoma. Light and dark cells with evident ductal differentiation and lymphocytic infiltrate within the tumor (H&E, original magnification ×400).

Many pathologists consider trichoepithelioma as the superficial variant of trichoblastoma. According to the recent World Health Organization classification of benign tumors with follicular differentiation, trichoepithelioma is considered synonymous with trichoblastoma.16 

Trichoepitheliomas are benign tumors, and therapy is mainly directed at removal for cosmetic purposes. Several methods of removal are available including electrocautery, laser therapy, and surgery. Awareness of the possible dermatomal distribution of hair follicle and other adnexal-related conditions is important, and such lesions should be thought of in the differential diagnosis of unilateral and/or dermatomal lesions.

References
  1. Bolognia JL, Orlow SJ, Glick SA. Lines of Blaschko. J Am Acad Dermatol. 1994;31(2, pt 1):157-190.
  2. Harada H, Hashimoto K, Ko MS. The gene for multiple familial trichoepithelioma maps to chromosome 9p21. J Invest Dermatol. 1996;107:41-43.
  3. Zheng G, Hu L, Huang W, et al. CYLD mutation causes multiple familial trichoepithelioma in three Chinese families. Hum Mutat. 2004;23:400.
  4. Geffner RE, Goslen JB, Santa Cruz DJ. Linear and dermatomal trichoepitheliomas. J Am Acad Dermatol. 1986;14(5, pt 2):927-930.
  5. Chang YC, Colome-Grimmer M, Kelly E. Multiple trichoepitheliomas in the lines of Blaschko. Pediatr Dermatol. 2006;23:149-151.
  6. Strauss RM, Merchant WJ, Stainforth JM, et al. Unilateral naevoid trichoepitheliomas on the face of a child. Clin Exp Dermatol. 2006;6:778-780.
  7. Laska AJ, Belli RA, Kobayashi TT. Linear trichoepithelioma on the neck of a 15-year-old girl. Dermatol Online J. 2016;22. pii:13030/qt87b6h4q8.
  8. Rasmussen JE. A syndrome of trichoepitheliomas, milia and cylindroma. Arch Dermatol. 1975;111:610-614.
  9. Michaelson G, Olsson E, Westermark P. The Rombo syndrome. Acta Derm Venereol. 1981;61:497-503.
  10. Brooke JD, Fitzpatrick JE, Golitz LE. Papillary mesenchymal bodies: a histologic finding useful in differentiating trichoepitheliomas from basal cell carcinomas. J Am Acad Dermatol. 1989;21(3, pt 1):523-528.
  11. Mostafa NA, Assaf M, Elhakim S, et al. Diagnostic accuracy of immunohistochemical markers in differentiation between basal cell carcinoma and trichoepithelioma in small biopsy specimens. J Cutan Pathol. 2018;45:807-816.
  12. Poniecka AW, Alexis JB. An immunohistochemical study of basal cell carcinoma and trichoepithelioma. Am J Dermatopathol. 1999;21:332-336.
  13. Abdel-Halim MRE, Fawzy M, Saleh M, et al. Linear unilateral basal cell nevus with comedones (linear nevoid basaloid follicular hamartoma): a case report. J Egypt Womens Dermatol Soc. 2016;13:46-48.
  14. Hyman AB, Brownstein MH. Eccrine poroma: analysis of 45 new cases. Dermatologica. 1969;138:28-38.
  15. Mambo NC. Eccrine spiradenoma: clinical and pathologic study of 49 tumors. J Cutan Pathol. 1983;10:312-320.
  16. Kutzner H, Kaddu S, Kanitakis J, et al. Trichoblastoma. In: Elder D, Massi D, Scolyer RA, et al, eds. WHO Classification of Skin Tumours. 4th ed. Lyon, France: IARC; 2018.
Article PDF
Author and Disclosure Information

From the Dermatopathology Unit, Dermatology Department, Cairo University, Kasr Al Aini Hospital, Egypt.

The authors report no conflict of interest.

Correspondence: Mona R.E. Abdel-Halim, MD, Dermatology Department, Cairo University, Kasr Al Aini Hospital, Kasr Al Aini St, 11562 Cairo, Egypt (abdelhalimmona@gmail.com).

Issue
Cutis - 103(4)
Publications
Topics
Page Number
198, 201-202
Sections
Author and Disclosure Information

From the Dermatopathology Unit, Dermatology Department, Cairo University, Kasr Al Aini Hospital, Egypt.

The authors report no conflict of interest.

Correspondence: Mona R.E. Abdel-Halim, MD, Dermatology Department, Cairo University, Kasr Al Aini Hospital, Kasr Al Aini St, 11562 Cairo, Egypt (abdelhalimmona@gmail.com).

Author and Disclosure Information

From the Dermatopathology Unit, Dermatology Department, Cairo University, Kasr Al Aini Hospital, Egypt.

The authors report no conflict of interest.

Correspondence: Mona R.E. Abdel-Halim, MD, Dermatology Department, Cairo University, Kasr Al Aini Hospital, Kasr Al Aini St, 11562 Cairo, Egypt (abdelhalimmona@gmail.com).

Article PDF
Article PDF
Related Articles

The Diagnosis: Unilateral Dermatomal Trichoepithelioma  

Adnexal lesions presenting with a linear and/or dermatomal pattern rarely have been reported. Bolognia et al1 performed a comprehensive review of Blaschko lines and skin conditions that follow such a pattern. The authors found that adnexal-related lesions included linear nevus comedonicus, linear basal cell nevus with comedones (linear basaloid follicular hamartoma), unilateral nevoid basal cell carcinoma (BCC), linear trichoepithelioma, linear trichodiscoma, linear hamartoma of the follicular infundibulum, nevus sebaceous, syringocystadenoma papilliferum, porokeratotic eccrine ostial and dermal duct nevus, linear eccrine poroma, linear spiradenoma, linear syringoma, and linear eccrine syringofibroadenoma.1  

Trichoepithelioma is a hair follicle-related neoplastic lesion presenting most commonly as the autosomal-dominant multiple familial type with lesions mainly centered on the face. Initial genetic studies associated the disease with loss of heterozygosity in the 9p21 region and further studies identified mutations in the CYLD (cylindromatosis [turban tumor syndrome]) gene on chromosome 16q12-q13.2,3 Unilateral, linear, and dermatomal forms of trichoepithelioma rarely are reported. In 1986, Geffner et al4 reported a case of linear and dermatomal trichoepithelioma in a 10-year-old girl. In addition to discrete solitary lesions affecting the face, she developed lesions on the left shoulder, left side of the trunk, and left lower leg following dermatomal distribution. In 2006, 2 cases of dermatomal trichoepitheliomas affecting the face in children, as in our case, were reported.5,6 Another case involving the neck was reported in 2016.7 Although classic multiple familial trichoepithelioma can be part of conditions such as Brooke-Spiegler8 and Rombo syndromes,9 no syndromal association has been reported thus far with the unilateral, linear, or dermatomal variants.  

Our case showed typical histopathologic features of trichoepithelioma, including discrete islands of basaloid cells in the dermis set in a conspicuous fibroblastic stroma. Focal connection with the epidermis was present. Most of the islands showed peripheral palisading and horn cysts lined by eosinophilic cells. The fibroblastic component was tightly adherent to the epithelial component, and only stromal clefts were detected. Papillary mesenchymal bodies also were detected as oval aggregates of fibroblastic cells invaginating into epithelial islands to form hair papillae. 

Histopathologically, the 2 most important differential diagnoses of trichoepithelioma include BCC and basaloid follicular hamartoma. In differentiating BCC from trichoepithelioma, the presence of dense fibroblastic stroma and papillary mesenchymal bodies characterize trichoepithelioma, while a fibromucinous stroma with mucinous retraction artifacts and clefting between the basaloid islands and the stroma characterize BCC (Figure 1).10 Immunohistochemical studies using antibodies against Bcl-2, CD34, CD10, androgen receptor, Ki-67, cytokeratin 19, and PHLDA1 (pleckstrin homologylike domain family A member 1) have reportedly been utilized to differentiate trichoepithelioma from BCC.11,12 Basaloid follicular hamartoma is characterized by thin anastomosing strands and branching cords of undifferentiated basaloid cells that replace or associate hair follicles in a latticelike pattern (Figure 2). The strands usually are vertically oriented perpendicular to the epidermis. Peripheral palisading is possible, and the basaloid strands are surrounded with cellular connective tissue stroma.13 Tumor islands in eccrine poroma show broad connections with the epidermis and are composed of poroid cells that show evident ductal differentiation with eosinophilic cuticles (Figure 3).14 Spiradenoma is characterized by capsulated deep-seated tumorous nodules not connected with the epidermis and composed of light and dark cells with ductal differentiation and vascular stroma (Figure 4). Scattered lymphocytes within the tumor lobules and in the stroma also are seen. Eosinophilic hyaline globules rarely can be present.15 

Figure 1. Basal cell carcinoma. Basaloid islands with peripheral palisading and peritumoral mucinous retraction artifacts (H&E, original magnification ×100).

Figure 2. Basaloid follicular hamartoma. Strands of immature basaloid cells replacing and associating follicular structures in a latticelike pattern (H&E, original magnification ×40).

Figure 3. Eccrine poroma. Tumor island composed of poroid cells with evident ductal differentiation with eosinophilic cuticles (H&E, original magnification ×100).

Figure 4. Spiradenoma. Light and dark cells with evident ductal differentiation and lymphocytic infiltrate within the tumor (H&E, original magnification ×400).

Many pathologists consider trichoepithelioma as the superficial variant of trichoblastoma. According to the recent World Health Organization classification of benign tumors with follicular differentiation, trichoepithelioma is considered synonymous with trichoblastoma.16 

Trichoepitheliomas are benign tumors, and therapy is mainly directed at removal for cosmetic purposes. Several methods of removal are available including electrocautery, laser therapy, and surgery. Awareness of the possible dermatomal distribution of hair follicle and other adnexal-related conditions is important, and such lesions should be thought of in the differential diagnosis of unilateral and/or dermatomal lesions.

The Diagnosis: Unilateral Dermatomal Trichoepithelioma  

Adnexal lesions presenting with a linear and/or dermatomal pattern rarely have been reported. Bolognia et al1 performed a comprehensive review of Blaschko lines and skin conditions that follow such a pattern. The authors found that adnexal-related lesions included linear nevus comedonicus, linear basal cell nevus with comedones (linear basaloid follicular hamartoma), unilateral nevoid basal cell carcinoma (BCC), linear trichoepithelioma, linear trichodiscoma, linear hamartoma of the follicular infundibulum, nevus sebaceous, syringocystadenoma papilliferum, porokeratotic eccrine ostial and dermal duct nevus, linear eccrine poroma, linear spiradenoma, linear syringoma, and linear eccrine syringofibroadenoma.1  

Trichoepithelioma is a hair follicle-related neoplastic lesion presenting most commonly as the autosomal-dominant multiple familial type with lesions mainly centered on the face. Initial genetic studies associated the disease with loss of heterozygosity in the 9p21 region and further studies identified mutations in the CYLD (cylindromatosis [turban tumor syndrome]) gene on chromosome 16q12-q13.2,3 Unilateral, linear, and dermatomal forms of trichoepithelioma rarely are reported. In 1986, Geffner et al4 reported a case of linear and dermatomal trichoepithelioma in a 10-year-old girl. In addition to discrete solitary lesions affecting the face, she developed lesions on the left shoulder, left side of the trunk, and left lower leg following dermatomal distribution. In 2006, 2 cases of dermatomal trichoepitheliomas affecting the face in children, as in our case, were reported.5,6 Another case involving the neck was reported in 2016.7 Although classic multiple familial trichoepithelioma can be part of conditions such as Brooke-Spiegler8 and Rombo syndromes,9 no syndromal association has been reported thus far with the unilateral, linear, or dermatomal variants.  

Our case showed typical histopathologic features of trichoepithelioma, including discrete islands of basaloid cells in the dermis set in a conspicuous fibroblastic stroma. Focal connection with the epidermis was present. Most of the islands showed peripheral palisading and horn cysts lined by eosinophilic cells. The fibroblastic component was tightly adherent to the epithelial component, and only stromal clefts were detected. Papillary mesenchymal bodies also were detected as oval aggregates of fibroblastic cells invaginating into epithelial islands to form hair papillae. 

Histopathologically, the 2 most important differential diagnoses of trichoepithelioma include BCC and basaloid follicular hamartoma. In differentiating BCC from trichoepithelioma, the presence of dense fibroblastic stroma and papillary mesenchymal bodies characterize trichoepithelioma, while a fibromucinous stroma with mucinous retraction artifacts and clefting between the basaloid islands and the stroma characterize BCC (Figure 1).10 Immunohistochemical studies using antibodies against Bcl-2, CD34, CD10, androgen receptor, Ki-67, cytokeratin 19, and PHLDA1 (pleckstrin homologylike domain family A member 1) have reportedly been utilized to differentiate trichoepithelioma from BCC.11,12 Basaloid follicular hamartoma is characterized by thin anastomosing strands and branching cords of undifferentiated basaloid cells that replace or associate hair follicles in a latticelike pattern (Figure 2). The strands usually are vertically oriented perpendicular to the epidermis. Peripheral palisading is possible, and the basaloid strands are surrounded with cellular connective tissue stroma.13 Tumor islands in eccrine poroma show broad connections with the epidermis and are composed of poroid cells that show evident ductal differentiation with eosinophilic cuticles (Figure 3).14 Spiradenoma is characterized by capsulated deep-seated tumorous nodules not connected with the epidermis and composed of light and dark cells with ductal differentiation and vascular stroma (Figure 4). Scattered lymphocytes within the tumor lobules and in the stroma also are seen. Eosinophilic hyaline globules rarely can be present.15 

Figure 1. Basal cell carcinoma. Basaloid islands with peripheral palisading and peritumoral mucinous retraction artifacts (H&E, original magnification ×100).

Figure 2. Basaloid follicular hamartoma. Strands of immature basaloid cells replacing and associating follicular structures in a latticelike pattern (H&E, original magnification ×40).

Figure 3. Eccrine poroma. Tumor island composed of poroid cells with evident ductal differentiation with eosinophilic cuticles (H&E, original magnification ×100).

Figure 4. Spiradenoma. Light and dark cells with evident ductal differentiation and lymphocytic infiltrate within the tumor (H&E, original magnification ×400).

Many pathologists consider trichoepithelioma as the superficial variant of trichoblastoma. According to the recent World Health Organization classification of benign tumors with follicular differentiation, trichoepithelioma is considered synonymous with trichoblastoma.16 

Trichoepitheliomas are benign tumors, and therapy is mainly directed at removal for cosmetic purposes. Several methods of removal are available including electrocautery, laser therapy, and surgery. Awareness of the possible dermatomal distribution of hair follicle and other adnexal-related conditions is important, and such lesions should be thought of in the differential diagnosis of unilateral and/or dermatomal lesions.

References
  1. Bolognia JL, Orlow SJ, Glick SA. Lines of Blaschko. J Am Acad Dermatol. 1994;31(2, pt 1):157-190.
  2. Harada H, Hashimoto K, Ko MS. The gene for multiple familial trichoepithelioma maps to chromosome 9p21. J Invest Dermatol. 1996;107:41-43.
  3. Zheng G, Hu L, Huang W, et al. CYLD mutation causes multiple familial trichoepithelioma in three Chinese families. Hum Mutat. 2004;23:400.
  4. Geffner RE, Goslen JB, Santa Cruz DJ. Linear and dermatomal trichoepitheliomas. J Am Acad Dermatol. 1986;14(5, pt 2):927-930.
  5. Chang YC, Colome-Grimmer M, Kelly E. Multiple trichoepitheliomas in the lines of Blaschko. Pediatr Dermatol. 2006;23:149-151.
  6. Strauss RM, Merchant WJ, Stainforth JM, et al. Unilateral naevoid trichoepitheliomas on the face of a child. Clin Exp Dermatol. 2006;6:778-780.
  7. Laska AJ, Belli RA, Kobayashi TT. Linear trichoepithelioma on the neck of a 15-year-old girl. Dermatol Online J. 2016;22. pii:13030/qt87b6h4q8.
  8. Rasmussen JE. A syndrome of trichoepitheliomas, milia and cylindroma. Arch Dermatol. 1975;111:610-614.
  9. Michaelson G, Olsson E, Westermark P. The Rombo syndrome. Acta Derm Venereol. 1981;61:497-503.
  10. Brooke JD, Fitzpatrick JE, Golitz LE. Papillary mesenchymal bodies: a histologic finding useful in differentiating trichoepitheliomas from basal cell carcinomas. J Am Acad Dermatol. 1989;21(3, pt 1):523-528.
  11. Mostafa NA, Assaf M, Elhakim S, et al. Diagnostic accuracy of immunohistochemical markers in differentiation between basal cell carcinoma and trichoepithelioma in small biopsy specimens. J Cutan Pathol. 2018;45:807-816.
  12. Poniecka AW, Alexis JB. An immunohistochemical study of basal cell carcinoma and trichoepithelioma. Am J Dermatopathol. 1999;21:332-336.
  13. Abdel-Halim MRE, Fawzy M, Saleh M, et al. Linear unilateral basal cell nevus with comedones (linear nevoid basaloid follicular hamartoma): a case report. J Egypt Womens Dermatol Soc. 2016;13:46-48.
  14. Hyman AB, Brownstein MH. Eccrine poroma: analysis of 45 new cases. Dermatologica. 1969;138:28-38.
  15. Mambo NC. Eccrine spiradenoma: clinical and pathologic study of 49 tumors. J Cutan Pathol. 1983;10:312-320.
  16. Kutzner H, Kaddu S, Kanitakis J, et al. Trichoblastoma. In: Elder D, Massi D, Scolyer RA, et al, eds. WHO Classification of Skin Tumours. 4th ed. Lyon, France: IARC; 2018.
References
  1. Bolognia JL, Orlow SJ, Glick SA. Lines of Blaschko. J Am Acad Dermatol. 1994;31(2, pt 1):157-190.
  2. Harada H, Hashimoto K, Ko MS. The gene for multiple familial trichoepithelioma maps to chromosome 9p21. J Invest Dermatol. 1996;107:41-43.
  3. Zheng G, Hu L, Huang W, et al. CYLD mutation causes multiple familial trichoepithelioma in three Chinese families. Hum Mutat. 2004;23:400.
  4. Geffner RE, Goslen JB, Santa Cruz DJ. Linear and dermatomal trichoepitheliomas. J Am Acad Dermatol. 1986;14(5, pt 2):927-930.
  5. Chang YC, Colome-Grimmer M, Kelly E. Multiple trichoepitheliomas in the lines of Blaschko. Pediatr Dermatol. 2006;23:149-151.
  6. Strauss RM, Merchant WJ, Stainforth JM, et al. Unilateral naevoid trichoepitheliomas on the face of a child. Clin Exp Dermatol. 2006;6:778-780.
  7. Laska AJ, Belli RA, Kobayashi TT. Linear trichoepithelioma on the neck of a 15-year-old girl. Dermatol Online J. 2016;22. pii:13030/qt87b6h4q8.
  8. Rasmussen JE. A syndrome of trichoepitheliomas, milia and cylindroma. Arch Dermatol. 1975;111:610-614.
  9. Michaelson G, Olsson E, Westermark P. The Rombo syndrome. Acta Derm Venereol. 1981;61:497-503.
  10. Brooke JD, Fitzpatrick JE, Golitz LE. Papillary mesenchymal bodies: a histologic finding useful in differentiating trichoepitheliomas from basal cell carcinomas. J Am Acad Dermatol. 1989;21(3, pt 1):523-528.
  11. Mostafa NA, Assaf M, Elhakim S, et al. Diagnostic accuracy of immunohistochemical markers in differentiation between basal cell carcinoma and trichoepithelioma in small biopsy specimens. J Cutan Pathol. 2018;45:807-816.
  12. Poniecka AW, Alexis JB. An immunohistochemical study of basal cell carcinoma and trichoepithelioma. Am J Dermatopathol. 1999;21:332-336.
  13. Abdel-Halim MRE, Fawzy M, Saleh M, et al. Linear unilateral basal cell nevus with comedones (linear nevoid basaloid follicular hamartoma): a case report. J Egypt Womens Dermatol Soc. 2016;13:46-48.
  14. Hyman AB, Brownstein MH. Eccrine poroma: analysis of 45 new cases. Dermatologica. 1969;138:28-38.
  15. Mambo NC. Eccrine spiradenoma: clinical and pathologic study of 49 tumors. J Cutan Pathol. 1983;10:312-320.
  16. Kutzner H, Kaddu S, Kanitakis J, et al. Trichoblastoma. In: Elder D, Massi D, Scolyer RA, et al, eds. WHO Classification of Skin Tumours. 4th ed. Lyon, France: IARC; 2018.
Issue
Cutis - 103(4)
Issue
Cutis - 103(4)
Page Number
198, 201-202
Page Number
198, 201-202
Publications
Publications
Topics
Article Type
Display Headline
Unilateral Facial Papules and Plaques
Display Headline
Unilateral Facial Papules and Plaques
Sections
Questionnaire Body

H&E, original magnification ×25.

H&E, original magnification ×400.

A 9-year-old boy presented with a slowly progressive lesion of 5 years’ duration affecting only the left side of the face in a dermatomal pattern. The patient denied any symptoms and had no other anomalies or family history of similar lesions. On physical examination the lesion was found to span a 12×7-cm area of the lateral half of the left cheek and was composed of multiple variable-sized, pinkish to flesh-colored papules that coalesced in some areas to form small plaques. Few milialike cysts were present. One papule was biopsied.

Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Tue, 04/09/2019 - 10:30
Un-Gate On Date
Tue, 04/09/2019 - 10:30
Use ProPublica
CFC Schedule Remove Status
Tue, 04/09/2019 - 10:30
Hide sidebar & use full width
render the right sidebar.
Article PDF Media

Indurated Plaque on the Shoulder

Article Type
Changed
Tue, 03/12/2019 - 08:32
Display Headline
Indurated Plaque on the Shoulder

Herpes zoster (HZ) is a painful skin condition caused by reactivation of latent varicella-zoster virus (VZV) in dorsal root ganglion cells.1 Upon reactivation, VZV replicates in the dorsal root ganglion, which ultimately results in inflammation and necrosis of the neuron and intense neuralgia. Reactivation of latent VZV may occur spontaneously or may be induced by various factors including immunosuppression, stress, illness, and trauma. Prior to the development of skin lesions, many patients experience a prodrome of tingling, pain, or pruritus. Herpes zoster classically presents with grouped vesicles on an erythematous base in a unilateral dermatomal distribution; however, more than one adjacent dermatome may be involved, and the lesions can cross the midline. Furthermore, the development of vesicles may be preceded by the development of edematous papules or plaques.1

On histology, VZV closely resembles herpes simplex virus type 1 and herpes simplex virus type 2 infections.2 Classic histologic findings include ballooning degeneration of keratinocytes, acantholysis, nuclear molding, ground-glass nuclear inclusions, marginated chromatin, and multinucleated keratinocytes, as well as necrosis of follicles and sebaceous glands.2 Varicella-zoster virus polymerase chain reaction or immunostaining can be used to confirm the diagnosis.2

Classic mycosis fungoides (MF) presents with well-circumscribed erythematous patches in non–sun-exposed areas and eventually may progress to plaques and tumors.3 Patients with cutaneous T-cell lymphomas, such as MF, are at a higher risk for skin infections including HZ4,5; however, immunocompromised patients, such as those with cutaneous lymphomas, can have atypical clinical presentations of HZ that may be concerning for cutaneous lymphoma.6 Furthermore, cutaneous malignancies can occur in dermatomal distributions that may mimic HZ.7 Therefore, the threshold for biopsy should be lowered in those patients with dermatomal lesions and history concerning for possible malignancy.

Classically, histologic examination of MF demonstrates an infiltrate of haloed cells at the dermoepidermal junction, which are atypical T cells with hyperchromatic cerebriform nuclei that are larger, darker, and more angulated than the benign recruited lymphocytes in the perivascular infiltrate seen in VZV infection (Figure 1).3 Papillary dermal fibrosis typically is present, and the perivascular infiltrate is denser above the postcapillary venule rather than being symmetrical around the vessel (bare underbelly sign). Clusters of these cells may form within the epidermis, which are called Pautrier microabscesses.3 Mycosis fungoides also can exhibit large cell transformation in which small lymphocytes transform into larger cells, thereby associated with a poorer prognosis.8

Figure 1. Transformed mycosis fungoides is evidenced by an infiltrate of large atypical T cells with hyperchromatic cerebriform nuclei that are larger, darker, and more angulated than the benign lymphocytes (H&E, original magnification ×200).

Lymphomatoid papulosis is a CD30+-predominant form of cutaneous T-cell lymphoma characterized by papules and nodules that spontaneously involute.9 This condition is most commonly associated with MF but can be associated with other lymphomas. This condition may be mistaken for HZ clinically, but histology classically demonstrates large atypical lymphocytes resembling Reed-Sternberg cells in small clusters rather than follicular necrosis (Figure 2).9

Figure 2. Lymphomatoid papulosis type A is evidenced by large atypical lymphocytes resembling Reed-Sternberg cells (H&E, original magnification ×400).

Patients with lymphoma may sequentially develop a secondary lymphoma. There have been reports of secondary B-cell lymphomas associated with MF, but this phenomenon is rare.10 The histology depends on the type of B-cell lymphoma present, but follicular necrosis would not be expected (Figure 3).

Figure 3. Secondary B-cell lymphoma is evidenced by sheets of atypical lymphocytes (H&E, original magnification ×400).

Unusual hypersensitivity reactions to arthropod attacks have been described in patients with lymphoproliferative disorders and could be mistaken for HZ. Histology may demonstrate a wedge-shaped perivascular and/or interstitial infiltrate containing eosinophils with endothelial swelling (Figure 4), but these findings may vary depending on the type of arthropod involved.11

Our case provided a unique example of HZ in a patient with a known history of MF. Clinically, there was concern for progression of the patient’s underlying disease; however, histology demonstrated ballooning keratinocytes and follicular necrosis, which are classically seen in HZ infection.

Figure 4. Exaggerated arthropod reaction is evidenced by a wedgeshaped perivascular and interstitial infiltrate containing eosinophils with endothelial swelling (H&E, original magnification ×40).

References
  1. Downing C, Medoza N, Sra K, et al. Human herpesviruses. In: Bolognia JL, Schaffer JV, Cerroni L, eds. Dermatology. 4th ed. China: Elsevier; 2018:1400-1424.
  2. Chisholm C, Lopez L. Cutaneous infections caused by Herpesviridae: a review. Arch Pathol Lab Med. 2011;135:1357-1362.
  3. Jawed SI, Myskowski PL, Horwitz S, et al. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. diagnosis: clinical and histopathologic features and new molecular and biologic markers. J Am Acad Dermatol. 2014;70: 205.e1-205.e16.
  4. Vonderheid EC, van Voorst Vader PC. Herpes zoster-varicella in cutaneous T-cell lymphomas. Arch Dermatol. 1980;116:408-412.
  5. Lebas E, Arrese JE, Nikkels AF. Risk factors for skin infections in mycosis fungoides. Dermatology. 2016;232:731-737.
  6. Leinweber B, Kerl H, Cerroni L. Histopathologic features of cutaneous herpes virus infections (herpes simplex, herpes varicella/zoster): a broad spectrum of presentations with common pseudolymphomatous aspects. Am J Surg Pathol. 2006;30:50-58.
  7. Niiyama S, Satoh K, Kaneko S, et al. Zosteriform skin involvement of nodal T-cell lymphoma: a review of the published work of cutaneous malignancies mimicking herpes zoster. J Dermatol. 2007;34:68-73.
  8. Pulitzer M, Myskowski PL, Horwitz SM, et al. Mycosis fungoides with large cell transformation:clinicopathological features and prognostic factors. Pathology. 2014;46:610-616.
  9. Zackheim HS, Jones C, Leboit PE, et al. Lymphomatoid papulosis associated with mycosis fungoides: a study of 21 patients including analyses for clonality. J Am Acad Dermatol. 2003;49:620-623.
  10. Barzilai A, Trau H, David M, et al. Mycosis fungoides associated with B-cell malignancies. Br J Dermatol. 2006;155:379-386.
  11. Vassallo C, Passamonti F, Cananzi R, et al. Exaggerated insect bite-like reaction in patients affected by oncohaematological diseases. Acta Derm Venereol. 2005;85:76-77.
Article PDF
Author and Disclosure Information

Ms. VanDyke is from the University of Virginia School of Medicine, Charlottesville. Drs. Hilton and Elston are from the Medical University of South Carolina, Charleston. Dr. Elston is from the Department of Dermatology and Dermatologic Surgery.

The authors report no conflict of interest.

Correspondence: Dirk M. Elston, MD, Medical University of South Carolina, Department of Dermatology and Dermatologic Surgery, 135 Rutledge Ave, Charleston, SC 29425 (elstond@musc.edu).

Issue
Cutis - 103(3)
Publications
Topics
Page Number
144, 147-148
Sections
Author and Disclosure Information

Ms. VanDyke is from the University of Virginia School of Medicine, Charlottesville. Drs. Hilton and Elston are from the Medical University of South Carolina, Charleston. Dr. Elston is from the Department of Dermatology and Dermatologic Surgery.

The authors report no conflict of interest.

Correspondence: Dirk M. Elston, MD, Medical University of South Carolina, Department of Dermatology and Dermatologic Surgery, 135 Rutledge Ave, Charleston, SC 29425 (elstond@musc.edu).

Author and Disclosure Information

Ms. VanDyke is from the University of Virginia School of Medicine, Charlottesville. Drs. Hilton and Elston are from the Medical University of South Carolina, Charleston. Dr. Elston is from the Department of Dermatology and Dermatologic Surgery.

The authors report no conflict of interest.

Correspondence: Dirk M. Elston, MD, Medical University of South Carolina, Department of Dermatology and Dermatologic Surgery, 135 Rutledge Ave, Charleston, SC 29425 (elstond@musc.edu).

Article PDF
Article PDF
Related Articles

Herpes zoster (HZ) is a painful skin condition caused by reactivation of latent varicella-zoster virus (VZV) in dorsal root ganglion cells.1 Upon reactivation, VZV replicates in the dorsal root ganglion, which ultimately results in inflammation and necrosis of the neuron and intense neuralgia. Reactivation of latent VZV may occur spontaneously or may be induced by various factors including immunosuppression, stress, illness, and trauma. Prior to the development of skin lesions, many patients experience a prodrome of tingling, pain, or pruritus. Herpes zoster classically presents with grouped vesicles on an erythematous base in a unilateral dermatomal distribution; however, more than one adjacent dermatome may be involved, and the lesions can cross the midline. Furthermore, the development of vesicles may be preceded by the development of edematous papules or plaques.1

On histology, VZV closely resembles herpes simplex virus type 1 and herpes simplex virus type 2 infections.2 Classic histologic findings include ballooning degeneration of keratinocytes, acantholysis, nuclear molding, ground-glass nuclear inclusions, marginated chromatin, and multinucleated keratinocytes, as well as necrosis of follicles and sebaceous glands.2 Varicella-zoster virus polymerase chain reaction or immunostaining can be used to confirm the diagnosis.2

Classic mycosis fungoides (MF) presents with well-circumscribed erythematous patches in non–sun-exposed areas and eventually may progress to plaques and tumors.3 Patients with cutaneous T-cell lymphomas, such as MF, are at a higher risk for skin infections including HZ4,5; however, immunocompromised patients, such as those with cutaneous lymphomas, can have atypical clinical presentations of HZ that may be concerning for cutaneous lymphoma.6 Furthermore, cutaneous malignancies can occur in dermatomal distributions that may mimic HZ.7 Therefore, the threshold for biopsy should be lowered in those patients with dermatomal lesions and history concerning for possible malignancy.

Classically, histologic examination of MF demonstrates an infiltrate of haloed cells at the dermoepidermal junction, which are atypical T cells with hyperchromatic cerebriform nuclei that are larger, darker, and more angulated than the benign recruited lymphocytes in the perivascular infiltrate seen in VZV infection (Figure 1).3 Papillary dermal fibrosis typically is present, and the perivascular infiltrate is denser above the postcapillary venule rather than being symmetrical around the vessel (bare underbelly sign). Clusters of these cells may form within the epidermis, which are called Pautrier microabscesses.3 Mycosis fungoides also can exhibit large cell transformation in which small lymphocytes transform into larger cells, thereby associated with a poorer prognosis.8

Figure 1. Transformed mycosis fungoides is evidenced by an infiltrate of large atypical T cells with hyperchromatic cerebriform nuclei that are larger, darker, and more angulated than the benign lymphocytes (H&E, original magnification ×200).

Lymphomatoid papulosis is a CD30+-predominant form of cutaneous T-cell lymphoma characterized by papules and nodules that spontaneously involute.9 This condition is most commonly associated with MF but can be associated with other lymphomas. This condition may be mistaken for HZ clinically, but histology classically demonstrates large atypical lymphocytes resembling Reed-Sternberg cells in small clusters rather than follicular necrosis (Figure 2).9

Figure 2. Lymphomatoid papulosis type A is evidenced by large atypical lymphocytes resembling Reed-Sternberg cells (H&E, original magnification ×400).

Patients with lymphoma may sequentially develop a secondary lymphoma. There have been reports of secondary B-cell lymphomas associated with MF, but this phenomenon is rare.10 The histology depends on the type of B-cell lymphoma present, but follicular necrosis would not be expected (Figure 3).

Figure 3. Secondary B-cell lymphoma is evidenced by sheets of atypical lymphocytes (H&E, original magnification ×400).

Unusual hypersensitivity reactions to arthropod attacks have been described in patients with lymphoproliferative disorders and could be mistaken for HZ. Histology may demonstrate a wedge-shaped perivascular and/or interstitial infiltrate containing eosinophils with endothelial swelling (Figure 4), but these findings may vary depending on the type of arthropod involved.11

Our case provided a unique example of HZ in a patient with a known history of MF. Clinically, there was concern for progression of the patient’s underlying disease; however, histology demonstrated ballooning keratinocytes and follicular necrosis, which are classically seen in HZ infection.

Figure 4. Exaggerated arthropod reaction is evidenced by a wedgeshaped perivascular and interstitial infiltrate containing eosinophils with endothelial swelling (H&E, original magnification ×40).

Herpes zoster (HZ) is a painful skin condition caused by reactivation of latent varicella-zoster virus (VZV) in dorsal root ganglion cells.1 Upon reactivation, VZV replicates in the dorsal root ganglion, which ultimately results in inflammation and necrosis of the neuron and intense neuralgia. Reactivation of latent VZV may occur spontaneously or may be induced by various factors including immunosuppression, stress, illness, and trauma. Prior to the development of skin lesions, many patients experience a prodrome of tingling, pain, or pruritus. Herpes zoster classically presents with grouped vesicles on an erythematous base in a unilateral dermatomal distribution; however, more than one adjacent dermatome may be involved, and the lesions can cross the midline. Furthermore, the development of vesicles may be preceded by the development of edematous papules or plaques.1

On histology, VZV closely resembles herpes simplex virus type 1 and herpes simplex virus type 2 infections.2 Classic histologic findings include ballooning degeneration of keratinocytes, acantholysis, nuclear molding, ground-glass nuclear inclusions, marginated chromatin, and multinucleated keratinocytes, as well as necrosis of follicles and sebaceous glands.2 Varicella-zoster virus polymerase chain reaction or immunostaining can be used to confirm the diagnosis.2

Classic mycosis fungoides (MF) presents with well-circumscribed erythematous patches in non–sun-exposed areas and eventually may progress to plaques and tumors.3 Patients with cutaneous T-cell lymphomas, such as MF, are at a higher risk for skin infections including HZ4,5; however, immunocompromised patients, such as those with cutaneous lymphomas, can have atypical clinical presentations of HZ that may be concerning for cutaneous lymphoma.6 Furthermore, cutaneous malignancies can occur in dermatomal distributions that may mimic HZ.7 Therefore, the threshold for biopsy should be lowered in those patients with dermatomal lesions and history concerning for possible malignancy.

Classically, histologic examination of MF demonstrates an infiltrate of haloed cells at the dermoepidermal junction, which are atypical T cells with hyperchromatic cerebriform nuclei that are larger, darker, and more angulated than the benign recruited lymphocytes in the perivascular infiltrate seen in VZV infection (Figure 1).3 Papillary dermal fibrosis typically is present, and the perivascular infiltrate is denser above the postcapillary venule rather than being symmetrical around the vessel (bare underbelly sign). Clusters of these cells may form within the epidermis, which are called Pautrier microabscesses.3 Mycosis fungoides also can exhibit large cell transformation in which small lymphocytes transform into larger cells, thereby associated with a poorer prognosis.8

Figure 1. Transformed mycosis fungoides is evidenced by an infiltrate of large atypical T cells with hyperchromatic cerebriform nuclei that are larger, darker, and more angulated than the benign lymphocytes (H&E, original magnification ×200).

Lymphomatoid papulosis is a CD30+-predominant form of cutaneous T-cell lymphoma characterized by papules and nodules that spontaneously involute.9 This condition is most commonly associated with MF but can be associated with other lymphomas. This condition may be mistaken for HZ clinically, but histology classically demonstrates large atypical lymphocytes resembling Reed-Sternberg cells in small clusters rather than follicular necrosis (Figure 2).9

Figure 2. Lymphomatoid papulosis type A is evidenced by large atypical lymphocytes resembling Reed-Sternberg cells (H&E, original magnification ×400).

Patients with lymphoma may sequentially develop a secondary lymphoma. There have been reports of secondary B-cell lymphomas associated with MF, but this phenomenon is rare.10 The histology depends on the type of B-cell lymphoma present, but follicular necrosis would not be expected (Figure 3).

Figure 3. Secondary B-cell lymphoma is evidenced by sheets of atypical lymphocytes (H&E, original magnification ×400).

Unusual hypersensitivity reactions to arthropod attacks have been described in patients with lymphoproliferative disorders and could be mistaken for HZ. Histology may demonstrate a wedge-shaped perivascular and/or interstitial infiltrate containing eosinophils with endothelial swelling (Figure 4), but these findings may vary depending on the type of arthropod involved.11

Our case provided a unique example of HZ in a patient with a known history of MF. Clinically, there was concern for progression of the patient’s underlying disease; however, histology demonstrated ballooning keratinocytes and follicular necrosis, which are classically seen in HZ infection.

Figure 4. Exaggerated arthropod reaction is evidenced by a wedgeshaped perivascular and interstitial infiltrate containing eosinophils with endothelial swelling (H&E, original magnification ×40).

References
  1. Downing C, Medoza N, Sra K, et al. Human herpesviruses. In: Bolognia JL, Schaffer JV, Cerroni L, eds. Dermatology. 4th ed. China: Elsevier; 2018:1400-1424.
  2. Chisholm C, Lopez L. Cutaneous infections caused by Herpesviridae: a review. Arch Pathol Lab Med. 2011;135:1357-1362.
  3. Jawed SI, Myskowski PL, Horwitz S, et al. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. diagnosis: clinical and histopathologic features and new molecular and biologic markers. J Am Acad Dermatol. 2014;70: 205.e1-205.e16.
  4. Vonderheid EC, van Voorst Vader PC. Herpes zoster-varicella in cutaneous T-cell lymphomas. Arch Dermatol. 1980;116:408-412.
  5. Lebas E, Arrese JE, Nikkels AF. Risk factors for skin infections in mycosis fungoides. Dermatology. 2016;232:731-737.
  6. Leinweber B, Kerl H, Cerroni L. Histopathologic features of cutaneous herpes virus infections (herpes simplex, herpes varicella/zoster): a broad spectrum of presentations with common pseudolymphomatous aspects. Am J Surg Pathol. 2006;30:50-58.
  7. Niiyama S, Satoh K, Kaneko S, et al. Zosteriform skin involvement of nodal T-cell lymphoma: a review of the published work of cutaneous malignancies mimicking herpes zoster. J Dermatol. 2007;34:68-73.
  8. Pulitzer M, Myskowski PL, Horwitz SM, et al. Mycosis fungoides with large cell transformation:clinicopathological features and prognostic factors. Pathology. 2014;46:610-616.
  9. Zackheim HS, Jones C, Leboit PE, et al. Lymphomatoid papulosis associated with mycosis fungoides: a study of 21 patients including analyses for clonality. J Am Acad Dermatol. 2003;49:620-623.
  10. Barzilai A, Trau H, David M, et al. Mycosis fungoides associated with B-cell malignancies. Br J Dermatol. 2006;155:379-386.
  11. Vassallo C, Passamonti F, Cananzi R, et al. Exaggerated insect bite-like reaction in patients affected by oncohaematological diseases. Acta Derm Venereol. 2005;85:76-77.
References
  1. Downing C, Medoza N, Sra K, et al. Human herpesviruses. In: Bolognia JL, Schaffer JV, Cerroni L, eds. Dermatology. 4th ed. China: Elsevier; 2018:1400-1424.
  2. Chisholm C, Lopez L. Cutaneous infections caused by Herpesviridae: a review. Arch Pathol Lab Med. 2011;135:1357-1362.
  3. Jawed SI, Myskowski PL, Horwitz S, et al. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. diagnosis: clinical and histopathologic features and new molecular and biologic markers. J Am Acad Dermatol. 2014;70: 205.e1-205.e16.
  4. Vonderheid EC, van Voorst Vader PC. Herpes zoster-varicella in cutaneous T-cell lymphomas. Arch Dermatol. 1980;116:408-412.
  5. Lebas E, Arrese JE, Nikkels AF. Risk factors for skin infections in mycosis fungoides. Dermatology. 2016;232:731-737.
  6. Leinweber B, Kerl H, Cerroni L. Histopathologic features of cutaneous herpes virus infections (herpes simplex, herpes varicella/zoster): a broad spectrum of presentations with common pseudolymphomatous aspects. Am J Surg Pathol. 2006;30:50-58.
  7. Niiyama S, Satoh K, Kaneko S, et al. Zosteriform skin involvement of nodal T-cell lymphoma: a review of the published work of cutaneous malignancies mimicking herpes zoster. J Dermatol. 2007;34:68-73.
  8. Pulitzer M, Myskowski PL, Horwitz SM, et al. Mycosis fungoides with large cell transformation:clinicopathological features and prognostic factors. Pathology. 2014;46:610-616.
  9. Zackheim HS, Jones C, Leboit PE, et al. Lymphomatoid papulosis associated with mycosis fungoides: a study of 21 patients including analyses for clonality. J Am Acad Dermatol. 2003;49:620-623.
  10. Barzilai A, Trau H, David M, et al. Mycosis fungoides associated with B-cell malignancies. Br J Dermatol. 2006;155:379-386.
  11. Vassallo C, Passamonti F, Cananzi R, et al. Exaggerated insect bite-like reaction in patients affected by oncohaematological diseases. Acta Derm Venereol. 2005;85:76-77.
Issue
Cutis - 103(3)
Issue
Cutis - 103(3)
Page Number
144, 147-148
Page Number
144, 147-148
Publications
Publications
Topics
Article Type
Display Headline
Indurated Plaque on the Shoulder
Display Headline
Indurated Plaque on the Shoulder
Sections
Questionnaire Body

H&E, original magnification ×20.

A 66-year-old man with mycosis fungoides presented with a new indurated plaque on the left shoulder. Biopsies of the left shoulder and back lesions were obtained.

Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Wed, 03/06/2019 - 15:15
Un-Gate On Date
Wed, 03/06/2019 - 15:15
Use ProPublica
CFC Schedule Remove Status
Wed, 03/06/2019 - 15:15
Hide sidebar & use full width
render the right sidebar.
Article PDF Media

Solitary Nodule on the Thigh

Article Type
Changed
Wed, 05/22/2019 - 09:21
Display Headline
Solitary Nodule on the Thigh

The Diagnosis: Ruptured Molluscum

Molluscum contagiosum (MC) is caused by a DNA virus (MC virus) belonging to the poxvirus family. Molluscum contagiosum is common and predominantly seen in children and young adults. In sexually active adults, the lesions commonly occur in the genital region, abdomen, and inner thighs. In immunocompromised individuals, including those with AIDS, the lesions are more extensive and may cause disfigurement.1 Molluscum contagiosum involving epidermoid cysts has been reported.2

Histopathologically, MC can be classified as noninflammatory or inflammatory. In noninflamed lesions, multiple large, intracytoplasmic, eosinophilic inclusions (Henderson-Paterson bodies) appear within the lobulated endophytic and hyperplastic epidermis. Ultrastructurally, these bodies show membrane-bound collections of MC virus.1 Replicating Henderson-Paterson bodies can result in rupture and inflammation. This case demonstrates a palisading granuloma containing keratin with few Henderson-Paterson bodies (quiz image) due to prior rupture of a molluscum or molluscoid cyst.

Rheumatoid nodules, the most characteristic histopathologic lesions of rheumatoid arthritis, are most commonly found in the subcutis at points of pressure and may occur in connective tissue of numerous organs. Rheumatoid nodules are firm, nontender, and mobile within the subcutaneous tissue but may be fixed to underlying structures including the periosteum, tendons, or bursae.3,4 Occasionally, superficial nodules may perforate the epidermis.5 The inner central necrobiotic zone appears as intensely eosinophilic, amorphous fibrin and other cellular debris. This central area is surrounded by histiocytes in a palisaded configuration (Figure 1). Multinucleated foreign body giant cells also may be present. Occasionally, mast cells, eosinophils, and neutrophils are present.6,7

Figure 1. Rheumatoid nodule histopathology with a central fibrinous area surrounded by histiocytes in a palisaded pattern (H&E, original magnification ×200).

Lupus miliaris disseminatus faciei presents with multiple discrete, smooth, yellow-brown to red, dome-shaped papules. The lesions typically are located on the central and lateral sides of the face and infrequently involve the neck. Other sites including the axillae, arms, hands, legs, and groin occasionally can be involved. Diascopy may reveal an apple jelly color.8,9 The histopathologic hallmark of lupus miliaris disseminatus faciei is an epithelioid cell granuloma with central necrosis (Figure 2).

Figure 2. Lupus miliaris disseminatus faciei histopathology with palisading epithelioid cell granuloma with central necrosis (H&E, original magnification ×100).

Epithelioid sarcoma (ES) is a soft tissue tumor with a known propensity for local recurrence, regional lymph node involvement, sporotrichoid spread, and distant metastases.10 The name was coined by Enzinger11 in 1970 during a review of 62 cases of a “peculiar form of sarcoma that has repeatedly been confused with a chronic inflammatory process, a necrotizing granuloma, and a squamous cell carcinoma.” Epithelioid sarcoma tends to grow slowly in a nodular or multinodular manner along fascial structures and tendons, often with central necrosis and ulceration of the overlying skin. Histopathologically, classic ES shows nodular masses of uniform plump epithelioid cells with abundant eosinophilic cytoplasm and prominent central necrosis. A biphasic pattern is typical with spindle cells merging with epithelioid cells. Cellular atypia is relatively mild and mitoses are rare (Figure 3). Recurrent or metastatic lesions can show a greater degree of pleomorphism.12 Given the low-grade atypia in early lesions, this sarcoma is easily misdiagnosed as granulomatous dermatitis. Immunohistochemically, the majority of ES cases are positive for cytokeratins and epithelial membrane antigen; SMARCB1/INI-1 expression is characteristically lost.13

Figure 3. Epithelioid sarcoma histopathology with plump epithelioid and spindled cells with abundant eosinophilic cytoplasm and prominent necrosis (H&E, original magnification ×200).

Granulomatosis with polyangiitis (formerly Wegener granulomatosis) is an autoimmune vasculitis highly associated with antineutrophil cytoplasmic antibodies. Clinical manifestations include systemic necrotizing vasculitis; necrotizing glomerulonephritis; and granulomatous inflammation, which predominantly involves the upper respiratory tract, skin, and mucosa.14,15 Skin involvement may be the initial manifestation of the disease and consists of palpable purpura, papules, ulcerations, vesicles, subcutaneous nodules, necrotizing ulcerations, papulonecrotic lesions, and petechiae. None of the findings are pathognomonic. The cutaneous histopathologic spectrum includes leukocytoclastic vasculitis, extravascular palisading granulomas, and granulomatous vasculitis.16 In the acute lesions of granulomatosis with polyangiitis, the predominant pattern of inflammation is not granulomatous but purulent with the appearance of an abscess. As it evolves, it develops a central zone of necrosis with extensive karyorrhectic debris and palisades of macrophages with scattered multinucleated giant cells (Figure 4).17

Figure 4. Granulomatosis with polyangiitis histopathology with necrosis and palisades of macrophages with scattered multinucleated giant cells with a central neutrophilic infiltrate (H&E, original magnification ×100).

 

 

 

References

1. Nandhini G, Rajkumar K, Kanth KS, et al. Molluscum contagiosum in a 12-year-old child—report of a case and review of literature. J Int Oral Health. 2015;7:63-66.

2. Phelps A, Murphy M, Elaba Z, et al. Molluscum contagiosum virus infection in benign cutaneous epithelial cystic lesions-report of 2 cases with different pathogenesis? Am J Dermatopathol. 2010;32:740-742.

3. Sayah A, English JC 3rd. Rheumatoid arthritis: a review of the cutaneous manifestations. J Am Acad Dermatol. 2005;53:191-209; quiz 210-192.

4. Sibbitt WL Jr, Williams RC Jr. Cutaneous manifestations of rheumatoid arthritis. Int J Dermatol. 1982;21:563-572.

5. Barzilai A, Huszar M, Shpiro D, et al. Pseudorheumatoid nodules in adults: a juxta-articular form of nodular granuloma annulare. Am J Dermatopathol. 2005;27:1-5.

6. Garcia-Patos V. Rheumatoid nodule. Semin Cutan Med Surg. 2007;26:100-107.

7. Patterson JW. Rheumatoid nodule and subcutaneous granuloma annulare. a comparative histologic study. Am J Dermatopathol. 1988;10:1-8.

8. Sehgal VN, Srivastava G, Aggarwal AK, et al. Lupus miliaris disseminatus faciei part II: an overview. Skinmed. 2005;4:234-238.

9. Cymerman R, Rosenstein R, Shvartsbeyn M, et al. Lupus miliaris disseminatus faciei. Dermatol Online J. 2015;21. pii:13030/qt6b83q5gp.

10. Sobanko JF, Meijer L, Nigra TP. Epithelioid sarcoma: a review and update. J Clin Aesthet Dermatol. 2009;2:49-54.

11. Enzinger FM. Epitheloid sarcoma. a sarcoma simulating a granuloma or a carcinoma. Cancer. 1970;26:1029-1041.

12. Fisher C. Epithelioid sarcoma of Enzinger. Adv Anat Pathol. 2006;13:114-121.

13. Miettinen M, Fanburg-Smith JC, Virolainen M, et al. Epithelioid sarcoma: an immunohistochemical analysis of 112 classical and variant cases and a discussion of the differential diagnosis. Hum Pathol. 1999;30:934-942.

14. Lutalo PM, D’Cruz DP. Diagnosis and classification of granulomatosis with polyangiitis (aka Wegener’s granulomatosis)[published online January 29, 2014]. J Autoimmun. 2014;48-49:94-98.

15. Frances C, Du LT, Piette JC, et al. Wegener’s granulomatosis. dermatological manifestations in 75 cases with clinicopathologic correlation. Arch Dermatol. 1994;130:861-867.

16. Daoud MS, Gibson LE, DeRemee RA, et al. Cutaneous Wegener’s granulomatosis: clinical, histopathologic, and immunopathologic features of thirty patients. J Am Acad Dermatol. 1994;31:605-612.

17. Jennette JC. Nomenclature and classification of vasculitis: lessons learned from granulomatosis with polyangiitis (Wegener’s granulomatosis). Clin Exp Immunol. 2011;164 (suppl 1):7-10.

Article PDF
Author and Disclosure Information

Dr. Wu is from the Department of Dermatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, China. Dr. Wu also is from and Drs. Skipper, Elston, and Forcucci are from the Medical University of South Carolina, Charleston. Drs. Wu and Elston are from the Department of Dermatology and Dermatologic Surgery, and Drs. Skipper and Forcucci are from the Department of Pathology and Laboratory Medicine.

The authors report no conflict of interest.

Correspondence: Dirk M. Elston, MD, Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, 135 Rutledge Ave, MSC 578, Charleston, SC 29425 (elstond@musc.edu).

Issue
Cutis - 103(1)
Publications
Topics
Page Number
16, 19-20
Sections
Author and Disclosure Information

Dr. Wu is from the Department of Dermatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, China. Dr. Wu also is from and Drs. Skipper, Elston, and Forcucci are from the Medical University of South Carolina, Charleston. Drs. Wu and Elston are from the Department of Dermatology and Dermatologic Surgery, and Drs. Skipper and Forcucci are from the Department of Pathology and Laboratory Medicine.

The authors report no conflict of interest.

Correspondence: Dirk M. Elston, MD, Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, 135 Rutledge Ave, MSC 578, Charleston, SC 29425 (elstond@musc.edu).

Author and Disclosure Information

Dr. Wu is from the Department of Dermatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, China. Dr. Wu also is from and Drs. Skipper, Elston, and Forcucci are from the Medical University of South Carolina, Charleston. Drs. Wu and Elston are from the Department of Dermatology and Dermatologic Surgery, and Drs. Skipper and Forcucci are from the Department of Pathology and Laboratory Medicine.

The authors report no conflict of interest.

Correspondence: Dirk M. Elston, MD, Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, 135 Rutledge Ave, MSC 578, Charleston, SC 29425 (elstond@musc.edu).

Article PDF
Article PDF
Related Articles

The Diagnosis: Ruptured Molluscum

Molluscum contagiosum (MC) is caused by a DNA virus (MC virus) belonging to the poxvirus family. Molluscum contagiosum is common and predominantly seen in children and young adults. In sexually active adults, the lesions commonly occur in the genital region, abdomen, and inner thighs. In immunocompromised individuals, including those with AIDS, the lesions are more extensive and may cause disfigurement.1 Molluscum contagiosum involving epidermoid cysts has been reported.2

Histopathologically, MC can be classified as noninflammatory or inflammatory. In noninflamed lesions, multiple large, intracytoplasmic, eosinophilic inclusions (Henderson-Paterson bodies) appear within the lobulated endophytic and hyperplastic epidermis. Ultrastructurally, these bodies show membrane-bound collections of MC virus.1 Replicating Henderson-Paterson bodies can result in rupture and inflammation. This case demonstrates a palisading granuloma containing keratin with few Henderson-Paterson bodies (quiz image) due to prior rupture of a molluscum or molluscoid cyst.

Rheumatoid nodules, the most characteristic histopathologic lesions of rheumatoid arthritis, are most commonly found in the subcutis at points of pressure and may occur in connective tissue of numerous organs. Rheumatoid nodules are firm, nontender, and mobile within the subcutaneous tissue but may be fixed to underlying structures including the periosteum, tendons, or bursae.3,4 Occasionally, superficial nodules may perforate the epidermis.5 The inner central necrobiotic zone appears as intensely eosinophilic, amorphous fibrin and other cellular debris. This central area is surrounded by histiocytes in a palisaded configuration (Figure 1). Multinucleated foreign body giant cells also may be present. Occasionally, mast cells, eosinophils, and neutrophils are present.6,7

Figure 1. Rheumatoid nodule histopathology with a central fibrinous area surrounded by histiocytes in a palisaded pattern (H&E, original magnification ×200).

Lupus miliaris disseminatus faciei presents with multiple discrete, smooth, yellow-brown to red, dome-shaped papules. The lesions typically are located on the central and lateral sides of the face and infrequently involve the neck. Other sites including the axillae, arms, hands, legs, and groin occasionally can be involved. Diascopy may reveal an apple jelly color.8,9 The histopathologic hallmark of lupus miliaris disseminatus faciei is an epithelioid cell granuloma with central necrosis (Figure 2).

Figure 2. Lupus miliaris disseminatus faciei histopathology with palisading epithelioid cell granuloma with central necrosis (H&E, original magnification ×100).

Epithelioid sarcoma (ES) is a soft tissue tumor with a known propensity for local recurrence, regional lymph node involvement, sporotrichoid spread, and distant metastases.10 The name was coined by Enzinger11 in 1970 during a review of 62 cases of a “peculiar form of sarcoma that has repeatedly been confused with a chronic inflammatory process, a necrotizing granuloma, and a squamous cell carcinoma.” Epithelioid sarcoma tends to grow slowly in a nodular or multinodular manner along fascial structures and tendons, often with central necrosis and ulceration of the overlying skin. Histopathologically, classic ES shows nodular masses of uniform plump epithelioid cells with abundant eosinophilic cytoplasm and prominent central necrosis. A biphasic pattern is typical with spindle cells merging with epithelioid cells. Cellular atypia is relatively mild and mitoses are rare (Figure 3). Recurrent or metastatic lesions can show a greater degree of pleomorphism.12 Given the low-grade atypia in early lesions, this sarcoma is easily misdiagnosed as granulomatous dermatitis. Immunohistochemically, the majority of ES cases are positive for cytokeratins and epithelial membrane antigen; SMARCB1/INI-1 expression is characteristically lost.13

Figure 3. Epithelioid sarcoma histopathology with plump epithelioid and spindled cells with abundant eosinophilic cytoplasm and prominent necrosis (H&E, original magnification ×200).

Granulomatosis with polyangiitis (formerly Wegener granulomatosis) is an autoimmune vasculitis highly associated with antineutrophil cytoplasmic antibodies. Clinical manifestations include systemic necrotizing vasculitis; necrotizing glomerulonephritis; and granulomatous inflammation, which predominantly involves the upper respiratory tract, skin, and mucosa.14,15 Skin involvement may be the initial manifestation of the disease and consists of palpable purpura, papules, ulcerations, vesicles, subcutaneous nodules, necrotizing ulcerations, papulonecrotic lesions, and petechiae. None of the findings are pathognomonic. The cutaneous histopathologic spectrum includes leukocytoclastic vasculitis, extravascular palisading granulomas, and granulomatous vasculitis.16 In the acute lesions of granulomatosis with polyangiitis, the predominant pattern of inflammation is not granulomatous but purulent with the appearance of an abscess. As it evolves, it develops a central zone of necrosis with extensive karyorrhectic debris and palisades of macrophages with scattered multinucleated giant cells (Figure 4).17

Figure 4. Granulomatosis with polyangiitis histopathology with necrosis and palisades of macrophages with scattered multinucleated giant cells with a central neutrophilic infiltrate (H&E, original magnification ×100).

 

 

 

The Diagnosis: Ruptured Molluscum

Molluscum contagiosum (MC) is caused by a DNA virus (MC virus) belonging to the poxvirus family. Molluscum contagiosum is common and predominantly seen in children and young adults. In sexually active adults, the lesions commonly occur in the genital region, abdomen, and inner thighs. In immunocompromised individuals, including those with AIDS, the lesions are more extensive and may cause disfigurement.1 Molluscum contagiosum involving epidermoid cysts has been reported.2

Histopathologically, MC can be classified as noninflammatory or inflammatory. In noninflamed lesions, multiple large, intracytoplasmic, eosinophilic inclusions (Henderson-Paterson bodies) appear within the lobulated endophytic and hyperplastic epidermis. Ultrastructurally, these bodies show membrane-bound collections of MC virus.1 Replicating Henderson-Paterson bodies can result in rupture and inflammation. This case demonstrates a palisading granuloma containing keratin with few Henderson-Paterson bodies (quiz image) due to prior rupture of a molluscum or molluscoid cyst.

Rheumatoid nodules, the most characteristic histopathologic lesions of rheumatoid arthritis, are most commonly found in the subcutis at points of pressure and may occur in connective tissue of numerous organs. Rheumatoid nodules are firm, nontender, and mobile within the subcutaneous tissue but may be fixed to underlying structures including the periosteum, tendons, or bursae.3,4 Occasionally, superficial nodules may perforate the epidermis.5 The inner central necrobiotic zone appears as intensely eosinophilic, amorphous fibrin and other cellular debris. This central area is surrounded by histiocytes in a palisaded configuration (Figure 1). Multinucleated foreign body giant cells also may be present. Occasionally, mast cells, eosinophils, and neutrophils are present.6,7

Figure 1. Rheumatoid nodule histopathology with a central fibrinous area surrounded by histiocytes in a palisaded pattern (H&E, original magnification ×200).

Lupus miliaris disseminatus faciei presents with multiple discrete, smooth, yellow-brown to red, dome-shaped papules. The lesions typically are located on the central and lateral sides of the face and infrequently involve the neck. Other sites including the axillae, arms, hands, legs, and groin occasionally can be involved. Diascopy may reveal an apple jelly color.8,9 The histopathologic hallmark of lupus miliaris disseminatus faciei is an epithelioid cell granuloma with central necrosis (Figure 2).

Figure 2. Lupus miliaris disseminatus faciei histopathology with palisading epithelioid cell granuloma with central necrosis (H&E, original magnification ×100).

Epithelioid sarcoma (ES) is a soft tissue tumor with a known propensity for local recurrence, regional lymph node involvement, sporotrichoid spread, and distant metastases.10 The name was coined by Enzinger11 in 1970 during a review of 62 cases of a “peculiar form of sarcoma that has repeatedly been confused with a chronic inflammatory process, a necrotizing granuloma, and a squamous cell carcinoma.” Epithelioid sarcoma tends to grow slowly in a nodular or multinodular manner along fascial structures and tendons, often with central necrosis and ulceration of the overlying skin. Histopathologically, classic ES shows nodular masses of uniform plump epithelioid cells with abundant eosinophilic cytoplasm and prominent central necrosis. A biphasic pattern is typical with spindle cells merging with epithelioid cells. Cellular atypia is relatively mild and mitoses are rare (Figure 3). Recurrent or metastatic lesions can show a greater degree of pleomorphism.12 Given the low-grade atypia in early lesions, this sarcoma is easily misdiagnosed as granulomatous dermatitis. Immunohistochemically, the majority of ES cases are positive for cytokeratins and epithelial membrane antigen; SMARCB1/INI-1 expression is characteristically lost.13

Figure 3. Epithelioid sarcoma histopathology with plump epithelioid and spindled cells with abundant eosinophilic cytoplasm and prominent necrosis (H&E, original magnification ×200).

Granulomatosis with polyangiitis (formerly Wegener granulomatosis) is an autoimmune vasculitis highly associated with antineutrophil cytoplasmic antibodies. Clinical manifestations include systemic necrotizing vasculitis; necrotizing glomerulonephritis; and granulomatous inflammation, which predominantly involves the upper respiratory tract, skin, and mucosa.14,15 Skin involvement may be the initial manifestation of the disease and consists of palpable purpura, papules, ulcerations, vesicles, subcutaneous nodules, necrotizing ulcerations, papulonecrotic lesions, and petechiae. None of the findings are pathognomonic. The cutaneous histopathologic spectrum includes leukocytoclastic vasculitis, extravascular palisading granulomas, and granulomatous vasculitis.16 In the acute lesions of granulomatosis with polyangiitis, the predominant pattern of inflammation is not granulomatous but purulent with the appearance of an abscess. As it evolves, it develops a central zone of necrosis with extensive karyorrhectic debris and palisades of macrophages with scattered multinucleated giant cells (Figure 4).17

Figure 4. Granulomatosis with polyangiitis histopathology with necrosis and palisades of macrophages with scattered multinucleated giant cells with a central neutrophilic infiltrate (H&E, original magnification ×100).

 

 

 

References

1. Nandhini G, Rajkumar K, Kanth KS, et al. Molluscum contagiosum in a 12-year-old child—report of a case and review of literature. J Int Oral Health. 2015;7:63-66.

2. Phelps A, Murphy M, Elaba Z, et al. Molluscum contagiosum virus infection in benign cutaneous epithelial cystic lesions-report of 2 cases with different pathogenesis? Am J Dermatopathol. 2010;32:740-742.

3. Sayah A, English JC 3rd. Rheumatoid arthritis: a review of the cutaneous manifestations. J Am Acad Dermatol. 2005;53:191-209; quiz 210-192.

4. Sibbitt WL Jr, Williams RC Jr. Cutaneous manifestations of rheumatoid arthritis. Int J Dermatol. 1982;21:563-572.

5. Barzilai A, Huszar M, Shpiro D, et al. Pseudorheumatoid nodules in adults: a juxta-articular form of nodular granuloma annulare. Am J Dermatopathol. 2005;27:1-5.

6. Garcia-Patos V. Rheumatoid nodule. Semin Cutan Med Surg. 2007;26:100-107.

7. Patterson JW. Rheumatoid nodule and subcutaneous granuloma annulare. a comparative histologic study. Am J Dermatopathol. 1988;10:1-8.

8. Sehgal VN, Srivastava G, Aggarwal AK, et al. Lupus miliaris disseminatus faciei part II: an overview. Skinmed. 2005;4:234-238.

9. Cymerman R, Rosenstein R, Shvartsbeyn M, et al. Lupus miliaris disseminatus faciei. Dermatol Online J. 2015;21. pii:13030/qt6b83q5gp.

10. Sobanko JF, Meijer L, Nigra TP. Epithelioid sarcoma: a review and update. J Clin Aesthet Dermatol. 2009;2:49-54.

11. Enzinger FM. Epitheloid sarcoma. a sarcoma simulating a granuloma or a carcinoma. Cancer. 1970;26:1029-1041.

12. Fisher C. Epithelioid sarcoma of Enzinger. Adv Anat Pathol. 2006;13:114-121.

13. Miettinen M, Fanburg-Smith JC, Virolainen M, et al. Epithelioid sarcoma: an immunohistochemical analysis of 112 classical and variant cases and a discussion of the differential diagnosis. Hum Pathol. 1999;30:934-942.

14. Lutalo PM, D’Cruz DP. Diagnosis and classification of granulomatosis with polyangiitis (aka Wegener’s granulomatosis)[published online January 29, 2014]. J Autoimmun. 2014;48-49:94-98.

15. Frances C, Du LT, Piette JC, et al. Wegener’s granulomatosis. dermatological manifestations in 75 cases with clinicopathologic correlation. Arch Dermatol. 1994;130:861-867.

16. Daoud MS, Gibson LE, DeRemee RA, et al. Cutaneous Wegener’s granulomatosis: clinical, histopathologic, and immunopathologic features of thirty patients. J Am Acad Dermatol. 1994;31:605-612.

17. Jennette JC. Nomenclature and classification of vasculitis: lessons learned from granulomatosis with polyangiitis (Wegener’s granulomatosis). Clin Exp Immunol. 2011;164 (suppl 1):7-10.

References

1. Nandhini G, Rajkumar K, Kanth KS, et al. Molluscum contagiosum in a 12-year-old child—report of a case and review of literature. J Int Oral Health. 2015;7:63-66.

2. Phelps A, Murphy M, Elaba Z, et al. Molluscum contagiosum virus infection in benign cutaneous epithelial cystic lesions-report of 2 cases with different pathogenesis? Am J Dermatopathol. 2010;32:740-742.

3. Sayah A, English JC 3rd. Rheumatoid arthritis: a review of the cutaneous manifestations. J Am Acad Dermatol. 2005;53:191-209; quiz 210-192.

4. Sibbitt WL Jr, Williams RC Jr. Cutaneous manifestations of rheumatoid arthritis. Int J Dermatol. 1982;21:563-572.

5. Barzilai A, Huszar M, Shpiro D, et al. Pseudorheumatoid nodules in adults: a juxta-articular form of nodular granuloma annulare. Am J Dermatopathol. 2005;27:1-5.

6. Garcia-Patos V. Rheumatoid nodule. Semin Cutan Med Surg. 2007;26:100-107.

7. Patterson JW. Rheumatoid nodule and subcutaneous granuloma annulare. a comparative histologic study. Am J Dermatopathol. 1988;10:1-8.

8. Sehgal VN, Srivastava G, Aggarwal AK, et al. Lupus miliaris disseminatus faciei part II: an overview. Skinmed. 2005;4:234-238.

9. Cymerman R, Rosenstein R, Shvartsbeyn M, et al. Lupus miliaris disseminatus faciei. Dermatol Online J. 2015;21. pii:13030/qt6b83q5gp.

10. Sobanko JF, Meijer L, Nigra TP. Epithelioid sarcoma: a review and update. J Clin Aesthet Dermatol. 2009;2:49-54.

11. Enzinger FM. Epitheloid sarcoma. a sarcoma simulating a granuloma or a carcinoma. Cancer. 1970;26:1029-1041.

12. Fisher C. Epithelioid sarcoma of Enzinger. Adv Anat Pathol. 2006;13:114-121.

13. Miettinen M, Fanburg-Smith JC, Virolainen M, et al. Epithelioid sarcoma: an immunohistochemical analysis of 112 classical and variant cases and a discussion of the differential diagnosis. Hum Pathol. 1999;30:934-942.

14. Lutalo PM, D’Cruz DP. Diagnosis and classification of granulomatosis with polyangiitis (aka Wegener’s granulomatosis)[published online January 29, 2014]. J Autoimmun. 2014;48-49:94-98.

15. Frances C, Du LT, Piette JC, et al. Wegener’s granulomatosis. dermatological manifestations in 75 cases with clinicopathologic correlation. Arch Dermatol. 1994;130:861-867.

16. Daoud MS, Gibson LE, DeRemee RA, et al. Cutaneous Wegener’s granulomatosis: clinical, histopathologic, and immunopathologic features of thirty patients. J Am Acad Dermatol. 1994;31:605-612.

17. Jennette JC. Nomenclature and classification of vasculitis: lessons learned from granulomatosis with polyangiitis (Wegener’s granulomatosis). Clin Exp Immunol. 2011;164 (suppl 1):7-10.

Issue
Cutis - 103(1)
Issue
Cutis - 103(1)
Page Number
16, 19-20
Page Number
16, 19-20
Publications
Publications
Topics
Article Type
Display Headline
Solitary Nodule on the Thigh
Display Headline
Solitary Nodule on the Thigh
Sections
Questionnaire Body

H&E, original magnification ×40 (inset, original magnification ×100).

A 17-year-old adolescent girl presented with a discrete nodule on the thigh.  

Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Article PDF Media

Progressive and Translucent Plaques on the Soles

Article Type
Changed
Thu, 01/10/2019 - 13:54
Display Headline
Progressive and Translucent Plaques on the Soles

The Diagnosis: Cutaneous Macroglobulinosis

Waldenström macroglobulinemia is a lymphoplasmacytic lymphoma that produces a circulating monoclonal IgM. Incidence in the United States is 1500 patients annually, most commonly men in their 70s.1 The disease process is largely indolent, with early symptoms consisting of generalized weakness, weight loss, and fatigue. Signs of lymphadenopathy, hepatosplenomegaly, and cytopenia may emerge as the disease progresses. Diagnostic criteria include bone marrow biopsy with plasmacytoid/plasmacellular infiltrate; IgM monoclonal gammopathy; and end-organ damage, which may include cutaneous manifestations.2

Cutaneous findings in Waldenström macroglobulinemia are nonspecific and secondary to the disease's hematologic manifestations, presenting as livedo reticularis, purpura, and mucosal bleeding.3 True cutaneous involvement of the disease is rare and was first described in 1978 by Tichenor.4 Specific cutaneous lesions have 2 separate clinical presentations: (1) a primary cutaneous infiltrate of lymphoplasmacytic cells, and (2) deposition of IgM in the dermis.5 Although the primary infiltrate of neoplastic cells appears as erythematous firm papules or plaques on the face and trunk, similar to other manifestations of leukemia cutis, deposition of IgM presents as translucent papules and plaques and is located more distally, particularly on the extensor extremities.6 These depositional plaques are not pruritic but may be tender if located over sites of pressure, as seen with the plantar presentation in our patient.

Histologically, cutaneous macroglobulinosis demonstrates IgM deposition in perieccrine, perivascular, or intravascular tissue that is periodic acid-Schiff (PAS) positive.7 Staining with Congo red and Alcian blue is negative. In our case, biopsy showed a nodular deposition of hypocellular globular material that stained brightly with PAS and PAS diastase. With Masson trichome stain, intensity of staining diminished, suggesting that the deposition was not composed of collagen; rather, this deposition appeared to consist of IgM storage papules on immunohistochemistry (Figure 1). Further workup revealed borderline pancytopenia and elevated globulins with a monoclonal peak on serum protein electrophoresis, confirming the diagnosis of cutaneous macroglobulinosis secondary to Waldenström macroglobulinemia.

Figure1
Figure 1. Cutaneous macroglobulinosis. Elevated levels of circulating IgM lead to nodular dermal depositions in the form of IgM storage papules on immunohistochemistry (original magnification ×40).

A PubMed search of articles indexed for MEDLINE using the terms cutaneous, macroglobulinosis, macroglobulinemia, Waldenström's macroglobulinemia, Waldenström's macroglobulinaemia, and macroglobulinemia cutis revealed a total of 19 cases of cutaneous macroglobulinosis (including this case). The average age of presentation in these cases is 60 years (range, 29-83 years) with a predisposition for men (68% [13/19]). The development of cutaneous macroglobulinosis primarily has been noted following diagnosis of Waldenström macroglobulinemia (53% [10/19]), with some cases prior to diagnosis (37% [7/19]) or at the time of diagnosis (11% [2/19]). The presence of cutaneous lesions does not correlate with prognosis of the underlying malignancy.5,8,9

Systemic treatment of the underlying macroglobulinemia has been suggested for symptomatic cases of cutaneous macroglobulinosis.3 Prior therapy has consisted primarily of chlorambucil; however, treatment with rituximab, occasionally in conjunction with the proteasome inhibitor bortezomib, recently has been reported.10 Because of the symptomatic nature of our patient's lesions, she was referred to the oncology department and started on rituximab therapy. The lesions improved with therapy and have remained stable following treatment.

The differential diagnosis for tender pink papules and plaques on the arms and legs includes tophaceous gout, plantar fibromatosis, erythropoietic protoporphyria, and acral fibrokeratoma.

Gouty tophi commonly accumulate as painful, edematous, yellow to whitish nodules and tumors with erythema, often overlying joints or extensor surfaces. Histopathologic examination after formalin fixation shows needle-shaped clefts within feathery amorphous pink areas surrounded by granuloma (Figure 2).11 Yellow, needle-shaped, negatively birefringent crystals can be viewed under polarized microscopy in alcohol-fixed samples.

Figure2
Figure 2. Tophaceous gout. Following formalin fixation, feathery amorphous pink areas are seen within the dermis and subcutaneous tissue surrounded by granulomatous inflammation (H&E, original magnification ×40).

Plantar fibromatosis (Ledderhose disease) is a benign proliferation of the plantar aponeurosis linked to alcohol use; liver disease; and notably epilepsy,12 a component of our patient's medical history. Large nodules appear grossly on the plantar feet and may progress to contractures in more advanced lesions. Biopsy reveals bland hyperproliferation of fibroblasts in a background of fascial fibrous tissue (Figure 3).12 Clinically, this diagnosis is part of the differential diagnosis of plantar nodules but appears histologically different than cutaneous macroglobulinosis because there are no hyaline deposits in plantar fibromatosis.

Figure3
Figure 3. Plantar fibromatosis. A bland hyperproliferation of fibroblasts is evident within a background of fascial fibrous tissue (H&E, original magnification ×40).

Erythropoietic protoporphyria is a rare disorder that primarily arises due to a congenital deficiency in the ferrochelatase enzyme involved in heme biosynthesis. Erythropoietic protoporphyria is the most common porphyria among children and typically presents in infancy or early childhood as a painful photosensitivity with ensuing cutaneous manifestations and possible hepatobiliary disease. Edema and severe burning pain can be noted within minutes of sun exposure in a dose-response relationship.13 Histologic findings of erythropoietic protoporphyria differ based on acute or chronic skin changes. Acute lesions exhibit a predominantly neutrophilic interstitial dermal infiltrate with vacuoles and intercellular edema. Chronic changes include the accumulation of a PAS-positive, amorphous, hyalinelike substance, similar to the microscopic findings of cutaneous macroglobulinosis (Figure 4).13

Figure4
Figure 4. Chronic erythropoietic protoporphyria reflects cumulative skin damage and the deposition of a hyalinelike substance in the upper dermis that stains positive for periodic acid–Schiff (H&E, original magnification ×40).

An acral fibrokeratoma is a benign fibroepithelial tumor that clinically appears as a flesh-colored or slightly erythematous exophytic nodule that most commonly is found on the fingers or toes. Thought to arise from trauma to the affected area, it is histologically characterized by interwoven collagenous bundles with overlying epidermal hyperkeratosis, acanthosis, and deep thickened rete ridges14 (Figure 5). Although multiple acral fibrokeratomas have been reported (similar to presentations of prurigo nodularis),15 they more commonly appear as solitary lesions as opposed to the numerous translucent papules seen in our patient.

Figure5
Figure 5. Acral fibrokeratoma. Epidermal hyperkeratosis, acanthosis, and thickened rete ridges overlie a core of collagen fiber bundles with interwoven and parallel arrangements (H&E, original magnification ×20).

References
  1. Camp BJ, Magro CM. Cutaneous macroglobulinosis: a case series. J Cutan Pathol. 2012;39:962-970.
  2. Dimopoulos MA, Alexanian R. Waldenstrom's macroglobulinemia. Blood. 1994;83:1452-1459.
  3. D'Acunto C, Nigrisoli E, Liardo EV, et al. Painful plantar nodules: a specific manifestation of cutaneous macroglobulinosis. J Am Acad Dermatol. 2014;71:E251-E252.
  4. Tichenor RE. Macroglobulinemia cutis. Arch Dermatol. 1978;114:280-281.  
  5. Gressier L, Hotz C, Lelièvre JD, et al. Cutaneous macroglobulinosis: a report of 2 cases. Arch Dermatol. 2010;146:165-169.
  6. Spicknall KE, Dubas LE, Mutasim DF. Cutaneous macroglobulinosis with monotypic plasma cells: a specific manifestation of Waldenström macroglobulinemia. J Cutan Pathol. 2013;40:442-444.
  7. Lüftl M, Sauter-Jenne B, Gramatzki M, et al. Cutaneous macroglobulinosis deposits in a patient with IgM paraproteinemia/incipient Waldenström macroglobulinemia. J Dtsch Dermatol Ges. 2010;8:1000-1003.
  8. Mascaro JM, Montserrat E, Estrach T, et al. Specific cutaneous manifestations of Waldenstrom macroglobulinaemia: a report of two cases. Br J Dermatol. 1982;106:217-222.
  9. Hanke CW, Steck WD, Bergfeld WF, et al. Cutaneous macroglobulinosis. Arch Dermatol. 1980;116:575-577.
  10. Oshio-Yoshii A, Fujimoto N, Shiba Y, et al. Cutaneous macroglobulinosis: successful treatment with rituximab. J Eur Acad Dermatol Venereol. 2017;31:E30-E31.
  11. Gupta A, Rai S, Sinha R, et al. Tophi as an initial manifestation of gout. J Cytol. 2009;26:165-166.
  12. Carroll P, Henshaw RM, Garwood C, et al. Plantar fibromatosis: pathophysiology, surgical and nonsurgical therapies: an evidence-based review. Foot Ankle Spec. 2018;11:168-176.
  13. Michaels BD, Del Rosso JQ, Mobini N, et al. Erythropoietic protoporphyria: a case report and literature review. J Clin Aesthet Dermatol. 2010;3:44-48.
  14. Boffeli TJ, Abben KW. Acral fibrokeratoma of the foot treated with excision and trap door flap closure: a case report. J Foot Ankle Surg. 2014;53:449-452.
  15. Reed RJ. Multiple acral fibrokeratomas (a variant of prurigo nodularis). discussion of classification of acral fibrous nodules and of histogenesis of acral fibrokeratomas. Arch Dermatol. 1971;103:287-297.
Article PDF
Author and Disclosure Information

From the University of Minnesota Medical School, Twin Cities, Minneapolis. Drs. Ronkainen and Gaddis also are from the Department of Dermatology.

The authors report no conflict of interest.

Correspondence: Kevin J. Gaddis, MD, 4-240 Phillips-Wangensteen Bldg, 516 Delaware St SE, Minneapolis, MN 55455 (gaddi013@umn.edu).

Issue
Cutis - 102(5)
Publications
Topics
Page Number
310, 313-314, 333
Sections
Author and Disclosure Information

From the University of Minnesota Medical School, Twin Cities, Minneapolis. Drs. Ronkainen and Gaddis also are from the Department of Dermatology.

The authors report no conflict of interest.

Correspondence: Kevin J. Gaddis, MD, 4-240 Phillips-Wangensteen Bldg, 516 Delaware St SE, Minneapolis, MN 55455 (gaddi013@umn.edu).

Author and Disclosure Information

From the University of Minnesota Medical School, Twin Cities, Minneapolis. Drs. Ronkainen and Gaddis also are from the Department of Dermatology.

The authors report no conflict of interest.

Correspondence: Kevin J. Gaddis, MD, 4-240 Phillips-Wangensteen Bldg, 516 Delaware St SE, Minneapolis, MN 55455 (gaddi013@umn.edu).

Article PDF
Article PDF
Related Articles

The Diagnosis: Cutaneous Macroglobulinosis

Waldenström macroglobulinemia is a lymphoplasmacytic lymphoma that produces a circulating monoclonal IgM. Incidence in the United States is 1500 patients annually, most commonly men in their 70s.1 The disease process is largely indolent, with early symptoms consisting of generalized weakness, weight loss, and fatigue. Signs of lymphadenopathy, hepatosplenomegaly, and cytopenia may emerge as the disease progresses. Diagnostic criteria include bone marrow biopsy with plasmacytoid/plasmacellular infiltrate; IgM monoclonal gammopathy; and end-organ damage, which may include cutaneous manifestations.2

Cutaneous findings in Waldenström macroglobulinemia are nonspecific and secondary to the disease's hematologic manifestations, presenting as livedo reticularis, purpura, and mucosal bleeding.3 True cutaneous involvement of the disease is rare and was first described in 1978 by Tichenor.4 Specific cutaneous lesions have 2 separate clinical presentations: (1) a primary cutaneous infiltrate of lymphoplasmacytic cells, and (2) deposition of IgM in the dermis.5 Although the primary infiltrate of neoplastic cells appears as erythematous firm papules or plaques on the face and trunk, similar to other manifestations of leukemia cutis, deposition of IgM presents as translucent papules and plaques and is located more distally, particularly on the extensor extremities.6 These depositional plaques are not pruritic but may be tender if located over sites of pressure, as seen with the plantar presentation in our patient.

Histologically, cutaneous macroglobulinosis demonstrates IgM deposition in perieccrine, perivascular, or intravascular tissue that is periodic acid-Schiff (PAS) positive.7 Staining with Congo red and Alcian blue is negative. In our case, biopsy showed a nodular deposition of hypocellular globular material that stained brightly with PAS and PAS diastase. With Masson trichome stain, intensity of staining diminished, suggesting that the deposition was not composed of collagen; rather, this deposition appeared to consist of IgM storage papules on immunohistochemistry (Figure 1). Further workup revealed borderline pancytopenia and elevated globulins with a monoclonal peak on serum protein electrophoresis, confirming the diagnosis of cutaneous macroglobulinosis secondary to Waldenström macroglobulinemia.

Figure1
Figure 1. Cutaneous macroglobulinosis. Elevated levels of circulating IgM lead to nodular dermal depositions in the form of IgM storage papules on immunohistochemistry (original magnification ×40).

A PubMed search of articles indexed for MEDLINE using the terms cutaneous, macroglobulinosis, macroglobulinemia, Waldenström's macroglobulinemia, Waldenström's macroglobulinaemia, and macroglobulinemia cutis revealed a total of 19 cases of cutaneous macroglobulinosis (including this case). The average age of presentation in these cases is 60 years (range, 29-83 years) with a predisposition for men (68% [13/19]). The development of cutaneous macroglobulinosis primarily has been noted following diagnosis of Waldenström macroglobulinemia (53% [10/19]), with some cases prior to diagnosis (37% [7/19]) or at the time of diagnosis (11% [2/19]). The presence of cutaneous lesions does not correlate with prognosis of the underlying malignancy.5,8,9

Systemic treatment of the underlying macroglobulinemia has been suggested for symptomatic cases of cutaneous macroglobulinosis.3 Prior therapy has consisted primarily of chlorambucil; however, treatment with rituximab, occasionally in conjunction with the proteasome inhibitor bortezomib, recently has been reported.10 Because of the symptomatic nature of our patient's lesions, she was referred to the oncology department and started on rituximab therapy. The lesions improved with therapy and have remained stable following treatment.

The differential diagnosis for tender pink papules and plaques on the arms and legs includes tophaceous gout, plantar fibromatosis, erythropoietic protoporphyria, and acral fibrokeratoma.

Gouty tophi commonly accumulate as painful, edematous, yellow to whitish nodules and tumors with erythema, often overlying joints or extensor surfaces. Histopathologic examination after formalin fixation shows needle-shaped clefts within feathery amorphous pink areas surrounded by granuloma (Figure 2).11 Yellow, needle-shaped, negatively birefringent crystals can be viewed under polarized microscopy in alcohol-fixed samples.

Figure2
Figure 2. Tophaceous gout. Following formalin fixation, feathery amorphous pink areas are seen within the dermis and subcutaneous tissue surrounded by granulomatous inflammation (H&E, original magnification ×40).

Plantar fibromatosis (Ledderhose disease) is a benign proliferation of the plantar aponeurosis linked to alcohol use; liver disease; and notably epilepsy,12 a component of our patient's medical history. Large nodules appear grossly on the plantar feet and may progress to contractures in more advanced lesions. Biopsy reveals bland hyperproliferation of fibroblasts in a background of fascial fibrous tissue (Figure 3).12 Clinically, this diagnosis is part of the differential diagnosis of plantar nodules but appears histologically different than cutaneous macroglobulinosis because there are no hyaline deposits in plantar fibromatosis.

Figure3
Figure 3. Plantar fibromatosis. A bland hyperproliferation of fibroblasts is evident within a background of fascial fibrous tissue (H&E, original magnification ×40).

Erythropoietic protoporphyria is a rare disorder that primarily arises due to a congenital deficiency in the ferrochelatase enzyme involved in heme biosynthesis. Erythropoietic protoporphyria is the most common porphyria among children and typically presents in infancy or early childhood as a painful photosensitivity with ensuing cutaneous manifestations and possible hepatobiliary disease. Edema and severe burning pain can be noted within minutes of sun exposure in a dose-response relationship.13 Histologic findings of erythropoietic protoporphyria differ based on acute or chronic skin changes. Acute lesions exhibit a predominantly neutrophilic interstitial dermal infiltrate with vacuoles and intercellular edema. Chronic changes include the accumulation of a PAS-positive, amorphous, hyalinelike substance, similar to the microscopic findings of cutaneous macroglobulinosis (Figure 4).13

Figure4
Figure 4. Chronic erythropoietic protoporphyria reflects cumulative skin damage and the deposition of a hyalinelike substance in the upper dermis that stains positive for periodic acid–Schiff (H&E, original magnification ×40).

An acral fibrokeratoma is a benign fibroepithelial tumor that clinically appears as a flesh-colored or slightly erythematous exophytic nodule that most commonly is found on the fingers or toes. Thought to arise from trauma to the affected area, it is histologically characterized by interwoven collagenous bundles with overlying epidermal hyperkeratosis, acanthosis, and deep thickened rete ridges14 (Figure 5). Although multiple acral fibrokeratomas have been reported (similar to presentations of prurigo nodularis),15 they more commonly appear as solitary lesions as opposed to the numerous translucent papules seen in our patient.

Figure5
Figure 5. Acral fibrokeratoma. Epidermal hyperkeratosis, acanthosis, and thickened rete ridges overlie a core of collagen fiber bundles with interwoven and parallel arrangements (H&E, original magnification ×20).

The Diagnosis: Cutaneous Macroglobulinosis

Waldenström macroglobulinemia is a lymphoplasmacytic lymphoma that produces a circulating monoclonal IgM. Incidence in the United States is 1500 patients annually, most commonly men in their 70s.1 The disease process is largely indolent, with early symptoms consisting of generalized weakness, weight loss, and fatigue. Signs of lymphadenopathy, hepatosplenomegaly, and cytopenia may emerge as the disease progresses. Diagnostic criteria include bone marrow biopsy with plasmacytoid/plasmacellular infiltrate; IgM monoclonal gammopathy; and end-organ damage, which may include cutaneous manifestations.2

Cutaneous findings in Waldenström macroglobulinemia are nonspecific and secondary to the disease's hematologic manifestations, presenting as livedo reticularis, purpura, and mucosal bleeding.3 True cutaneous involvement of the disease is rare and was first described in 1978 by Tichenor.4 Specific cutaneous lesions have 2 separate clinical presentations: (1) a primary cutaneous infiltrate of lymphoplasmacytic cells, and (2) deposition of IgM in the dermis.5 Although the primary infiltrate of neoplastic cells appears as erythematous firm papules or plaques on the face and trunk, similar to other manifestations of leukemia cutis, deposition of IgM presents as translucent papules and plaques and is located more distally, particularly on the extensor extremities.6 These depositional plaques are not pruritic but may be tender if located over sites of pressure, as seen with the plantar presentation in our patient.

Histologically, cutaneous macroglobulinosis demonstrates IgM deposition in perieccrine, perivascular, or intravascular tissue that is periodic acid-Schiff (PAS) positive.7 Staining with Congo red and Alcian blue is negative. In our case, biopsy showed a nodular deposition of hypocellular globular material that stained brightly with PAS and PAS diastase. With Masson trichome stain, intensity of staining diminished, suggesting that the deposition was not composed of collagen; rather, this deposition appeared to consist of IgM storage papules on immunohistochemistry (Figure 1). Further workup revealed borderline pancytopenia and elevated globulins with a monoclonal peak on serum protein electrophoresis, confirming the diagnosis of cutaneous macroglobulinosis secondary to Waldenström macroglobulinemia.

Figure1
Figure 1. Cutaneous macroglobulinosis. Elevated levels of circulating IgM lead to nodular dermal depositions in the form of IgM storage papules on immunohistochemistry (original magnification ×40).

A PubMed search of articles indexed for MEDLINE using the terms cutaneous, macroglobulinosis, macroglobulinemia, Waldenström's macroglobulinemia, Waldenström's macroglobulinaemia, and macroglobulinemia cutis revealed a total of 19 cases of cutaneous macroglobulinosis (including this case). The average age of presentation in these cases is 60 years (range, 29-83 years) with a predisposition for men (68% [13/19]). The development of cutaneous macroglobulinosis primarily has been noted following diagnosis of Waldenström macroglobulinemia (53% [10/19]), with some cases prior to diagnosis (37% [7/19]) or at the time of diagnosis (11% [2/19]). The presence of cutaneous lesions does not correlate with prognosis of the underlying malignancy.5,8,9

Systemic treatment of the underlying macroglobulinemia has been suggested for symptomatic cases of cutaneous macroglobulinosis.3 Prior therapy has consisted primarily of chlorambucil; however, treatment with rituximab, occasionally in conjunction with the proteasome inhibitor bortezomib, recently has been reported.10 Because of the symptomatic nature of our patient's lesions, she was referred to the oncology department and started on rituximab therapy. The lesions improved with therapy and have remained stable following treatment.

The differential diagnosis for tender pink papules and plaques on the arms and legs includes tophaceous gout, plantar fibromatosis, erythropoietic protoporphyria, and acral fibrokeratoma.

Gouty tophi commonly accumulate as painful, edematous, yellow to whitish nodules and tumors with erythema, often overlying joints or extensor surfaces. Histopathologic examination after formalin fixation shows needle-shaped clefts within feathery amorphous pink areas surrounded by granuloma (Figure 2).11 Yellow, needle-shaped, negatively birefringent crystals can be viewed under polarized microscopy in alcohol-fixed samples.

Figure2
Figure 2. Tophaceous gout. Following formalin fixation, feathery amorphous pink areas are seen within the dermis and subcutaneous tissue surrounded by granulomatous inflammation (H&E, original magnification ×40).

Plantar fibromatosis (Ledderhose disease) is a benign proliferation of the plantar aponeurosis linked to alcohol use; liver disease; and notably epilepsy,12 a component of our patient's medical history. Large nodules appear grossly on the plantar feet and may progress to contractures in more advanced lesions. Biopsy reveals bland hyperproliferation of fibroblasts in a background of fascial fibrous tissue (Figure 3).12 Clinically, this diagnosis is part of the differential diagnosis of plantar nodules but appears histologically different than cutaneous macroglobulinosis because there are no hyaline deposits in plantar fibromatosis.

Figure3
Figure 3. Plantar fibromatosis. A bland hyperproliferation of fibroblasts is evident within a background of fascial fibrous tissue (H&E, original magnification ×40).

Erythropoietic protoporphyria is a rare disorder that primarily arises due to a congenital deficiency in the ferrochelatase enzyme involved in heme biosynthesis. Erythropoietic protoporphyria is the most common porphyria among children and typically presents in infancy or early childhood as a painful photosensitivity with ensuing cutaneous manifestations and possible hepatobiliary disease. Edema and severe burning pain can be noted within minutes of sun exposure in a dose-response relationship.13 Histologic findings of erythropoietic protoporphyria differ based on acute or chronic skin changes. Acute lesions exhibit a predominantly neutrophilic interstitial dermal infiltrate with vacuoles and intercellular edema. Chronic changes include the accumulation of a PAS-positive, amorphous, hyalinelike substance, similar to the microscopic findings of cutaneous macroglobulinosis (Figure 4).13

Figure4
Figure 4. Chronic erythropoietic protoporphyria reflects cumulative skin damage and the deposition of a hyalinelike substance in the upper dermis that stains positive for periodic acid–Schiff (H&E, original magnification ×40).

An acral fibrokeratoma is a benign fibroepithelial tumor that clinically appears as a flesh-colored or slightly erythematous exophytic nodule that most commonly is found on the fingers or toes. Thought to arise from trauma to the affected area, it is histologically characterized by interwoven collagenous bundles with overlying epidermal hyperkeratosis, acanthosis, and deep thickened rete ridges14 (Figure 5). Although multiple acral fibrokeratomas have been reported (similar to presentations of prurigo nodularis),15 they more commonly appear as solitary lesions as opposed to the numerous translucent papules seen in our patient.

Figure5
Figure 5. Acral fibrokeratoma. Epidermal hyperkeratosis, acanthosis, and thickened rete ridges overlie a core of collagen fiber bundles with interwoven and parallel arrangements (H&E, original magnification ×20).

References
  1. Camp BJ, Magro CM. Cutaneous macroglobulinosis: a case series. J Cutan Pathol. 2012;39:962-970.
  2. Dimopoulos MA, Alexanian R. Waldenstrom's macroglobulinemia. Blood. 1994;83:1452-1459.
  3. D'Acunto C, Nigrisoli E, Liardo EV, et al. Painful plantar nodules: a specific manifestation of cutaneous macroglobulinosis. J Am Acad Dermatol. 2014;71:E251-E252.
  4. Tichenor RE. Macroglobulinemia cutis. Arch Dermatol. 1978;114:280-281.  
  5. Gressier L, Hotz C, Lelièvre JD, et al. Cutaneous macroglobulinosis: a report of 2 cases. Arch Dermatol. 2010;146:165-169.
  6. Spicknall KE, Dubas LE, Mutasim DF. Cutaneous macroglobulinosis with monotypic plasma cells: a specific manifestation of Waldenström macroglobulinemia. J Cutan Pathol. 2013;40:442-444.
  7. Lüftl M, Sauter-Jenne B, Gramatzki M, et al. Cutaneous macroglobulinosis deposits in a patient with IgM paraproteinemia/incipient Waldenström macroglobulinemia. J Dtsch Dermatol Ges. 2010;8:1000-1003.
  8. Mascaro JM, Montserrat E, Estrach T, et al. Specific cutaneous manifestations of Waldenstrom macroglobulinaemia: a report of two cases. Br J Dermatol. 1982;106:217-222.
  9. Hanke CW, Steck WD, Bergfeld WF, et al. Cutaneous macroglobulinosis. Arch Dermatol. 1980;116:575-577.
  10. Oshio-Yoshii A, Fujimoto N, Shiba Y, et al. Cutaneous macroglobulinosis: successful treatment with rituximab. J Eur Acad Dermatol Venereol. 2017;31:E30-E31.
  11. Gupta A, Rai S, Sinha R, et al. Tophi as an initial manifestation of gout. J Cytol. 2009;26:165-166.
  12. Carroll P, Henshaw RM, Garwood C, et al. Plantar fibromatosis: pathophysiology, surgical and nonsurgical therapies: an evidence-based review. Foot Ankle Spec. 2018;11:168-176.
  13. Michaels BD, Del Rosso JQ, Mobini N, et al. Erythropoietic protoporphyria: a case report and literature review. J Clin Aesthet Dermatol. 2010;3:44-48.
  14. Boffeli TJ, Abben KW. Acral fibrokeratoma of the foot treated with excision and trap door flap closure: a case report. J Foot Ankle Surg. 2014;53:449-452.
  15. Reed RJ. Multiple acral fibrokeratomas (a variant of prurigo nodularis). discussion of classification of acral fibrous nodules and of histogenesis of acral fibrokeratomas. Arch Dermatol. 1971;103:287-297.
References
  1. Camp BJ, Magro CM. Cutaneous macroglobulinosis: a case series. J Cutan Pathol. 2012;39:962-970.
  2. Dimopoulos MA, Alexanian R. Waldenstrom's macroglobulinemia. Blood. 1994;83:1452-1459.
  3. D'Acunto C, Nigrisoli E, Liardo EV, et al. Painful plantar nodules: a specific manifestation of cutaneous macroglobulinosis. J Am Acad Dermatol. 2014;71:E251-E252.
  4. Tichenor RE. Macroglobulinemia cutis. Arch Dermatol. 1978;114:280-281.  
  5. Gressier L, Hotz C, Lelièvre JD, et al. Cutaneous macroglobulinosis: a report of 2 cases. Arch Dermatol. 2010;146:165-169.
  6. Spicknall KE, Dubas LE, Mutasim DF. Cutaneous macroglobulinosis with monotypic plasma cells: a specific manifestation of Waldenström macroglobulinemia. J Cutan Pathol. 2013;40:442-444.
  7. Lüftl M, Sauter-Jenne B, Gramatzki M, et al. Cutaneous macroglobulinosis deposits in a patient with IgM paraproteinemia/incipient Waldenström macroglobulinemia. J Dtsch Dermatol Ges. 2010;8:1000-1003.
  8. Mascaro JM, Montserrat E, Estrach T, et al. Specific cutaneous manifestations of Waldenstrom macroglobulinaemia: a report of two cases. Br J Dermatol. 1982;106:217-222.
  9. Hanke CW, Steck WD, Bergfeld WF, et al. Cutaneous macroglobulinosis. Arch Dermatol. 1980;116:575-577.
  10. Oshio-Yoshii A, Fujimoto N, Shiba Y, et al. Cutaneous macroglobulinosis: successful treatment with rituximab. J Eur Acad Dermatol Venereol. 2017;31:E30-E31.
  11. Gupta A, Rai S, Sinha R, et al. Tophi as an initial manifestation of gout. J Cytol. 2009;26:165-166.
  12. Carroll P, Henshaw RM, Garwood C, et al. Plantar fibromatosis: pathophysiology, surgical and nonsurgical therapies: an evidence-based review. Foot Ankle Spec. 2018;11:168-176.
  13. Michaels BD, Del Rosso JQ, Mobini N, et al. Erythropoietic protoporphyria: a case report and literature review. J Clin Aesthet Dermatol. 2010;3:44-48.
  14. Boffeli TJ, Abben KW. Acral fibrokeratoma of the foot treated with excision and trap door flap closure: a case report. J Foot Ankle Surg. 2014;53:449-452.
  15. Reed RJ. Multiple acral fibrokeratomas (a variant of prurigo nodularis). discussion of classification of acral fibrous nodules and of histogenesis of acral fibrokeratomas. Arch Dermatol. 1971;103:287-297.
Issue
Cutis - 102(5)
Issue
Cutis - 102(5)
Page Number
310, 313-314, 333
Page Number
310, 313-314, 333
Publications
Publications
Topics
Article Type
Display Headline
Progressive and Translucent Plaques on the Soles
Display Headline
Progressive and Translucent Plaques on the Soles
Sections
Questionnaire Body

quiz_image
H&E, original magnification ×20 (inset, original magnification ×50).

A 64-year-old woman with a medical history of Waldenström macroglobulinemia, multiple sclerosis, and epilepsy presented with slowly growing papules on the plantar feet of 21 months' duration. She was diagnosed with Waldenström macroglobulinemia incidentally on routine blood work 3 years prior and declined treatment because she was asymptomatic. Physical examination revealed a total of 20 firm, variably sized, light pink to purple, partially translucent and telangiectatic papules and plaques bilaterally on the plantar feet. A plaque from the right sole was biopsied.

Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Wed, 10/31/2018 - 11:30
Un-Gate On Date
Wed, 10/31/2018 - 11:30
Use ProPublica
CFC Schedule Remove Status
Wed, 10/31/2018 - 11:30
Article PDF Media